const pubmedData1 = `<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
	<PubmedArticle>
		<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
			<PMID Version="1">39469291</PMID>
			<DateRevised>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>30</Day>
			</DateRevised>
			<Article PubModel="Electronic-eCollection">
				<Journal>
					<ISSN IssnType="Print">1178-2390</ISSN>
					<JournalIssue CitedMedium="Print">
						<Volume>17</Volume>
						<PubDate>
							<Year>2024</Year>
						</PubDate>
					</JournalIssue>
					<Title>Journal of multidisciplinary healthcare</Title>
					<ISOAbbreviation>J Multidiscip Healthc</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Trends and Hotspots in the Health Economics Evaluation of Chronic Fatigue Syndrome.</ArticleTitle>
				<Pagination>
					<StartPage>4877</StartPage>
					<EndPage>4892</EndPage>
					<MedlinePgn>4877-4892</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.2147/JMDH.S482100</ELocationID>
				<Abstract>
					<AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To explore the research trends and hotspots of health economics evaluations of patients with chronic fatigue syndrome.</AbstractText>
					<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">To explore the research trends and hotspots of health economics evaluations of chronic fatigue syndrome, 180 articles published between 1991 and 2024 were visualized and analyzed via CiteSpace 6.3 software. R3 and VOSviewer1.6.20 and R4.3.3. The content includes annual publication volume, journal distribution, author country, publishing organization, author collaboration, citation analysis, and keyword analysis in 7 aspects.</AbstractText>
					<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Fewer studies have evaluated the health economics of individuals with chronic fatigue syndrome in China and abroad, Chinese studies are especially rare, and research results in the UK are mostly found in other countries. Moreover, cooperation and linkages between institutions, as well as between authors, are not yet strong.</AbstractText>
					<AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The hotspot of health economics evaluation methods in this field is cost-effectiveness analysis, and the hotspot of diagnosis and treatment methods is cognitive&#x2012;behavioral therapy. We also found that chronic fatigue syndrome may also have a strong potential association with depression from the perspective of health economics. Health economic evaluations of multiple treatments should be conducted simultaneously to increase attention to this field and provide a reference basis for low-cost and high-quality diagnostic and treatment programs.</AbstractText>
					<CopyrightInformation>&#xa9; 2024 Wan et al.</CopyrightInformation>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y" EqualContrib="Y">
						<LastName>Wan</LastName>
						<ForeName>Hejia</ForeName>
						<Initials>H</Initials>
						<Identifier Source="ORCID">0009-0003-3900-1967</Identifier>
						<AffiliationInfo>
							<Affiliation>School of Nursing, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y" EqualContrib="Y">
						<LastName>Wei</LastName>
						<ForeName>Bingqi</ForeName>
						<Initials>B</Initials>
						<AffiliationInfo>
							<Affiliation>School of Traditional Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Qian</LastName>
						<ForeName>Wenli</ForeName>
						<Initials>W</Initials>
						<AffiliationInfo>
							<Affiliation>School of Management, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Zhang</LastName>
						<ForeName>Jing</ForeName>
						<Initials>J</Initials>
						<AffiliationInfo>
							<Affiliation>School of Nursing, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
					<PublicationType UI="D016454">Review</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>24</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>New Zealand</Country>
				<MedlineTA>J Multidiscip Healthc</MedlineTA>
				<NlmUniqueID>101512691</NlmUniqueID>
				<ISSNLinking>1178-2390</ISSNLinking>
			</MedlineJournalInfo>
			<KeywordList Owner="NOTNLM">
				<Keyword MajorTopicYN="N">CiteSpace</Keyword>
				<Keyword MajorTopicYN="N">bibliometrics</Keyword>
				<Keyword MajorTopicYN="N">chronic fatigue syndrome</Keyword>
				<Keyword MajorTopicYN="N">health economics</Keyword>
				<Keyword MajorTopicYN="N">myalgic encephalomyelitis</Keyword>
				<Keyword MajorTopicYN="N">visual analysis</Keyword>
			</KeywordList>
			<CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="received">
					<Year>2024</Year>
					<Month>6</Month>
					<Day>14</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="accepted">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>15</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>29</Day>
					<Hour>10</Hour>
					<Minute>56</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>29</Day>
					<Hour>10</Hour>
					<Minute>55</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>29</Day>
					<Hour>4</Hour>
					<Minute>39</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pmc-release">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>24</Day>
				</PubMedPubDate>
			</History>
			<PublicationStatus>epublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pubmed">39469291</ArticleId>
				<ArticleId IdType="pmc">PMC11514696</ArticleId>
				<ArticleId IdType="doi">10.2147/JMDH.S482100</ArticleId>
				<ArticleId IdType="pii">482100</ArticleId>
			</ArticleIdList>
			<ReferenceList>
				<Reference>
					<Citation>Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Internal Med. 1994;121(12):953&#x2013;959. doi:10.7326/0003-4819-121-12-199412150-00009</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.7326/0003-4819-121-12-199412150-00009</ArticleId>
						<ArticleId IdType="pubmed">7978722</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Helliwell AM, Stockwell PA, Edgar CD, Chatterjee A, Tate WP. Dynamic epigenetic changes during a relapse and recovery cycle in myalgic encephalomyelitis/chronic fatigue syndrome. Int J Mol Sci. 2022;23(19):11852. doi:10.3390/ijms231911852</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.3390/ijms231911852</ArticleId>
						<ArticleId IdType="pmc">PMC9570248</ArticleId>
						<ArticleId IdType="pubmed">36233152</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Reynolds KJ, Vernon SD, Bouchery E, Reeves WC. The economic impact of chronic fatigue syndrome. Cost Eff Resour Alloc. 2004;2(1):4. doi:10.1186/1478-7547-2-4</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1186/1478-7547-2-4</ArticleId>
						<ArticleId IdType="pmc">PMC449736</ArticleId>
						<ArticleId IdType="pubmed">15210053</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Nacul L, Authier FJ, Scheibenbogen C, et al. European network on myalgic encephalomyelitis/chronic fatigue syndrome (EUROMENE): expert consensus on the diagnosis, service provision, and care of people with ME/CFS in Europe. Medicina. 2021;57(5):510. doi:10.3390/medicina57050510</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.3390/medicina57050510</ArticleId>
						<ArticleId IdType="pmc">PMC8161074</ArticleId>
						<ArticleId IdType="pubmed">34069603</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Manu P, Lane TJ, Matthews DA. Chronic fatigue and chronic fatigue syndrome: clinical epidemiology and aetiological classification. Ciba Found Symp. 1993;173:23&#x2013;31. doi:10.1002/9780470514382.ch3.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1002/9780470514382.ch3</ArticleId>
						<ArticleId IdType="pubmed">8491100</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Bearn J, Wessely S. Neurobiological aspects of the chronic fatigue syndrome. Eur J Clin Invest. 1994;24(2):79&#x2013;90. doi:10.1111/j.1365-2362.1994.tb00971.x</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1111/j.1365-2362.1994.tb00971.x</ArticleId>
						<ArticleId IdType="pubmed">8206084</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Fischer A, Threlfall A, Cookson R, Meah S, Rutter H, Kelly MP. The appraisal of public health interventions. Lancet. 2012;380:S17&#x2013;S17. doi:10.1016/s0140-6736(13)60373-6</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/s0140-6736(13)60373-6</ArticleId>
						<ArticleId IdType="pubmed">23995712</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Trueman P, Anokye NK. Applying economic evaluation to public health interventions: the case of interventions to promote physical activity. J Public Health. 2013;35(1):32&#x2013;39. doi:10.1093/pubmed/fds050</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1093/pubmed/fds050</ArticleId>
						<ArticleId IdType="pmc">PMC3580051</ArticleId>
						<ArticleId IdType="pubmed">22753453</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Bombardier CH, Buchwald D. Chronic fatigue, chronic fatigue syndrome, and fibromyalgia. Disability and health-care use. Med Care. 1996;34(9):924&#x2013;930. doi:10.1097/00005650-199609000-00005</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1097/00005650-199609000-00005</ArticleId>
						<ArticleId IdType="pubmed">8792781</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Thomas PW, Thomas S, Kersten P, et al. Multi-centre parallel arm randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based cognitive behavioural approach to managing fatigue in people with multiple sclerosis. BMC Neurol. 2010;10:43. doi:10.1186/1471-2377-10-43</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1186/1471-2377-10-43</ArticleId>
						<ArticleId IdType="pmc">PMC2905353</ArticleId>
						<ArticleId IdType="pubmed">20553617</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Du Z, Wang Z, Guo F, Wang T. Dynamic structures and emerging trends in the management of major trauma: a bibliometric analysis of publications between 2012 and 2021. Front Public Health. 2022;10:1017817. doi:10.3389/fpubh.2022.1017817</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.3389/fpubh.2022.1017817</ArticleId>
						<ArticleId IdType="pmc">PMC9663840</ArticleId>
						<ArticleId IdType="pubmed">36388390</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Wei N, Xu Y, Li Y, et al. A bibliometric analysis of T cell and atherosclerosis. Front Immunol. 2022;13:948314. doi:10.3389/fimmu.2022.948314</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.3389/fimmu.2022.948314</ArticleId>
						<ArticleId IdType="pmc">PMC9606647</ArticleId>
						<ArticleId IdType="pubmed">36311729</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Ma D, Guan B, Song L, et al. A bibliometric analysis of exosomes in cardiovascular diseases from 2001 to 2021. Front Cardiovasc Med. 2021;8:734514. doi:10.3389/fcvm.2021.734514</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.3389/fcvm.2021.734514</ArticleId>
						<ArticleId IdType="pmc">PMC8424118</ArticleId>
						<ArticleId IdType="pubmed">34513962</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Vilker Zucolotto Pessin L, Harue yamane L, Ribeiro Siman R. Smart bibliometrics: an integrated method of science mapping and bibliometric analysis. Scientometrics. 2022;127:3695&#x2013;3718. doi:10.1007/s11192-022-04406-6</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1007/s11192-022-04406-6</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>PubMed. National Library of Medicine, U.S. National Library of Medicine. https://pubmed.ncbi.nlm.nih.gov/. Accessed October
21, 2024.</Citation>
				</Reference>
				<Reference>
					<Citation>Rons N. Bibliometric approximation of a scientific specialty by combining key sources, title words, authors and references. J Informetrics. 2018;12:113&#x2013;132. doi:10.1016/j.joi.2017.12.003</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/j.joi.2017.12.003</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Cao Y, Xiong F, Xia X, et al. Economic impact of powered stapler in video-assisted thoracic surgery lobectomy for lung cancer in a Chinese tertiary hospital: a cost-minimization analysis. Health Econ Rev. 2022;12(1):12. doi:10.1186/s13561-022-00359-x</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1186/s13561-022-00359-x</ArticleId>
						<ArticleId IdType="pmc">PMC8830080</ArticleId>
						<ArticleId IdType="pubmed">35141818</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Greenberg B, Hall S, Grabner M, Balu S, Zhang X, Kantor D. Multiple sclerosis relapse rates and healthcare costs of two versions of glatiramer acetate. Curr Med Res Opin. 2020;36(7):1167&#x2013;1175. doi:10.1080/03007995.2020.1760808</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1080/03007995.2020.1760808</ArticleId>
						<ArticleId IdType="pubmed">32329362</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Seixas BV, Dionne F, Mitton C. Practices of decision making in priority setting and resource allocation: a scoping review and narrative synthesis of existing frameworks. Health Econ Rev. 2021;11(1):2. doi:10.1186/s13561-020-00300-0</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1186/s13561-020-00300-0</ArticleId>
						<ArticleId IdType="pmc">PMC7789400</ArticleId>
						<ArticleId IdType="pubmed">33411161</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Giorgi MA, Caroli C, Giglio ND, et al. Estimation of the cost-effectiveness of apixaban versus vitamin K antagonists in the management of atrial fibrillation in Argentina. Health Econ Rev. 2015;5(1):52. doi:10.1186/s13561-015-0052-8</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1186/s13561-015-0052-8</ArticleId>
						<ArticleId IdType="pmc">PMC4480270</ArticleId>
						<ArticleId IdType="pubmed">26112219</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Garc&#xed;a-Ruiz AJ, P&#xe9;rez-Costillas L, Montesinos AC, Alcalde J, Oyag&#xfc;ez I, Casado MA. Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses. Health Econ Rev. 2012;2(1):8. doi:10.1186/2191-1991-2-8</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1186/2191-1991-2-8</ArticleId>
						<ArticleId IdType="pmc">PMC3402933</ArticleId>
						<ArticleId IdType="pubmed">22828390</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>McCrone P, Sharpe M, Chalder T, et al. Adaptive pacing, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome: a cost-effectiveness analysis. PLoS One. 2012;7(8):e40808. doi:10.1371/journal.pone.0040808</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1371/journal.pone.0040808</ArticleId>
						<ArticleId IdType="pmc">PMC3411573</ArticleId>
						<ArticleId IdType="pubmed">22870204</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Vos-Vromans D, Evers S, Huijnen I, et al. Economic evaluation of multidisciplinary rehabilitation treatment versus cognitive behavioural therapy for patients with chronic fatigue syndrome: a randomized controlled trial. PLoS One. 2017;12(6):e0177260. doi:10.1371/journal.pone.0177260</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1371/journal.pone.0177260</ArticleId>
						<ArticleId IdType="pmc">PMC5456034</ArticleId>
						<ArticleId IdType="pubmed">28574985</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Meng H, Friedberg F. Cost-utility of home-based fatigue self-management versus usual care for the treatment of chronic fatigue syndrome. Fatigue. 2017;5(4):202&#x2013;214. doi:10.1080/21641846.2017.1343171</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1080/21641846.2017.1343171</ArticleId>
						<ArticleId IdType="pmc">PMC6438387</ArticleId>
						<ArticleId IdType="pubmed">30931176</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Jacob L, Haro JM, Kostev K. Associations of physical and psychiatric conditions with chronic fatigue syndrome in Germany: an exploratory case-control study. Psychol Med. 2022;52(4):780&#x2013;786. doi:10.1017/S0033291720002470</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1017/S0033291720002470</ArticleId>
						<ArticleId IdType="pubmed">32686638</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Lee SH, Shin HS, Park HY, et al. Depression as a mediator of chronic fatigue and post-traumatic stress symptoms in middle east respiratory syndrome survivors. Psychiatry Invest. 2019;16(1):59&#x2013;64. doi:10.30773/pi.2018.10.22.3</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.30773/pi.2018.10.22.3</ArticleId>
						<ArticleId IdType="pmc">PMC6354037</ArticleId>
						<ArticleId IdType="pubmed">30605995</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Castro-Marrero J, Faro M, Zaragoz&#xe1; MC, Aliste L, de Sevilla TF, Alegre J. Unemployment and work disability in individuals with chronic fatigue syndrome/myalgic encephalomyelitis: a community-based cross-sectional study from Spain. BMC Public Health. 2019;19(1):840. doi:10.1186/s12889-019-7225-z</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1186/s12889-019-7225-z</ArticleId>
						<ArticleId IdType="pmc">PMC6599355</ArticleId>
						<ArticleId IdType="pubmed">31253111</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Cochrane M, Mitchell E, Hollingworth W, Crawley E, Tr&#xe9;pel D. Cost-effectiveness of interventions for chronic fatigue syndrome or myalgic encephalomyelitis: a systematic review of economic evaluations. Appl Health Econ Health Policy. 2021;19(4):473&#x2013;486. doi:10.1007/s40258-021-00635-7</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1007/s40258-021-00635-7</ArticleId>
						<ArticleId IdType="pmc">PMC7917957</ArticleId>
						<ArticleId IdType="pubmed">33646528</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Janse A, Bleijenberg G, Knoop H. Prediction of long-term outcome after cognitive behavioral therapy for chronic fatigue syndrome. J Psychosom Res. 2019;121:93&#x2013;99. doi:10.1016/j.jpsychores.2019.03.017</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/j.jpsychores.2019.03.017</ArticleId>
						<ArticleId IdType="pubmed">31006534</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Heald A, Barber L, Jones HL, Farman S, Walther A. Service based comparison of group cognitive behavior therapy to waiting list control for chronic fatigue syndrome with regard to symptom reduction and positive psychological dimensions. Medicine. 2019;98(39):e16720. doi:10.1097/MD.0000000000016720</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1097/MD.0000000000016720</ArticleId>
						<ArticleId IdType="pmc">PMC6775347</ArticleId>
						<ArticleId IdType="pubmed">31574792</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>O&#x2019;Dowd H, Beasant L, Ingram J, et al. The feasibility and acceptability of an early intervention in primary care to prevent chronic fatigue syndrome (CFS) in adults: randomised controlled trial. Pilot Feasibility Stud. 2020;6:65. doi:10.1186/s40814-020-00595-0</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1186/s40814-020-00595-0</ArticleId>
						<ArticleId IdType="pmc">PMC7216523</ArticleId>
						<ArticleId IdType="pubmed">32426159</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Leach H, Eccles A, Chew-Graham CA, Atherton H. Patient experiences of remote consulting with chronic fatigue syndrome/myalgic encephalomyelitis and fibromyalgia: a qualitative study. BJGP Open. 2024;27:BJGPO.2024.0079. doi:10.3399/BJGPO.2024.0079</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.3399/BJGPO.2024.0079</ArticleId>
						<ArticleId IdType="pubmed">39191480</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Carrasco-Querol N, Gonz&#xe1;lez Serra G, Bueno Hern&#xe1;ndez N, et al. Effectiveness and health benefits of a nutritional, chronobiological and physical exercise primary care intervention in fibromyalgia and chronic fatigue syndrome: SYNCHRONIZE + mixed-methods study protocol. Medicine. 2023;102(17):e33637. doi:10.1097/MD.0000000000033637</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1097/MD.0000000000033637</ArticleId>
						<ArticleId IdType="pmc">PMC10145802</ArticleId>
						<ArticleId IdType="pubmed">37115043</ArticleId>
					</ArticleIdList>
				</Reference>
			</ReferenceList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Status="Publisher" Owner="NLM">
			<PMID Version="1">39449566</PMID>
			<DateRevised>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>25</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1461-7277</ISSN>
					<JournalIssue CitedMedium="Internet">
						<PubDate>
							<Year>2024</Year>
							<Month>Oct</Month>
							<Day>25</Day>
						</PubDate>
					</JournalIssue>
					<Title>Journal of health psychology</Title>
					<ISOAbbreviation>J Health Psychol</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Much more than a biological phenomenon: A qualitative study of women's experiences of brain fog across their reproductive journey.</ArticleTitle>
				<Pagination>
					<StartPage>13591053241290656</StartPage>
					<MedlinePgn>13591053241290656</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1177/13591053241290656</ELocationID>
				<Abstract>
					<AbstractText>Whilst 'brain fog' is mostly considered a biological problem little is understood about an individual's experience. This qualitative study explored women's experiences of brain fog focusing on those at the start (aged 18-25; 
						<i>n</i>&#x2009;=&#x2009;10) and end (aged 45-60; 
						<i>n</i>&#x2009;=&#x2009;10) of their reproductive journey. Descriptive thematic analysis described three themes: (i) 'daily disruptions' describing cognitive dysfunctions and the main triggers; (ii) 'the cycle of impact' with a focus on women's emotional experiences and how these can exacerbate brain fog; (iii) 'taking control' highlighting the use of self-care, physical prompts and Hormonal Replacement Therapy (HRT) to manage brain fog. Transcending these themes was the notion of 'crisis of identity' illustrating the negative impact of brain fog on the women's sense of self with some older women describing acceptance and finding it less challenging. Brain fog is much more than a biological phenomenon and has broader implications for a woman's sense of self.
					</AbstractText>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Johnson</LastName>
						<ForeName>Hannah</ForeName>
						<Initials>H</Initials>
						<AffiliationInfo>
							<Affiliation>University of Surrey, UK.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Ogden</LastName>
						<ForeName>Jane</ForeName>
						<Initials>J</Initials>
						<Identifier Source="ORCID">0000-0003-4271-5621</Identifier>
						<AffiliationInfo>
							<Affiliation>University of Surrey, UK.</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>25</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>England</Country>
				<MedlineTA>J Health Psychol</MedlineTA>
				<NlmUniqueID>9703616</NlmUniqueID>
				<ISSNLinking>1359-1053</ISSNLinking>
			</MedlineJournalInfo>
			<CitationSubset>IM</CitationSubset>
			<KeywordList Owner="NOTNLM">
				<Keyword MajorTopicYN="N">brain fog</Keyword>
				<Keyword MajorTopicYN="N">experiences</Keyword>
				<Keyword MajorTopicYN="N">hormones</Keyword>
				<Keyword MajorTopicYN="N">identity</Keyword>
				<Keyword MajorTopicYN="N">reproductive journey</Keyword>
			</KeywordList>
			<CoiStatement>Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="medline">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>25</Day>
					<Hour>6</Hour>
					<Minute>23</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>25</Day>
					<Hour>6</Hour>
					<Minute>23</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>25</Day>
					<Hour>3</Hour>
					<Minute>22</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>aheadofprint</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pubmed">39449566</ArticleId>
				<ArticleId IdType="doi">10.1177/13591053241290656</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Status="Publisher" Owner="NLM">
			<PMID Version="1">39442002</PMID>
			<DateRevised>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>23</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1550-9109</ISSN>
					<JournalIssue CitedMedium="Internet">
						<PubDate>
							<Year>2024</Year>
							<Month>Oct</Month>
							<Day>23</Day>
						</PubDate>
					</JournalIssue>
					<Title>Sleep</Title>
					<ISOAbbreviation>Sleep</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Genetic variants associated with chronic fatigue syndrome predict population-level fatigue severity and actigraphic measurements.</ArticleTitle>
				<ELocationID EIdType="pii" ValidYN="Y">zsae243</ELocationID>
				<ELocationID EIdType="doi" ValidYN="Y">10.1093/sleep/zsae243</ELocationID>
				<Abstract>
					<AbstractText Label="STUDY OBJECTIVES" NlmCategory="OBJECTIVE">The diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome (CFS) is based on a constellation of symptoms which center around fatigue. However, fatigue is commonly reported in the general population by people without CFS. Does the biology underlying fatigue in patients with CFS also drive fatigue experienced by individuals without CFS?</AbstractText>
					<AbstractText Label="METHODS" NlmCategory="METHODS">We used UK Biobank actigraphy data to characterize differences in physical activity patterns and daily temperature rhythms between participants diagnosed with CFS compared to controls. We then tested if single nucleotide variants (SNVs) previously associated with CFS are also associated with the variation of these actigraphic CFS correlates and/or subjective fatigue symptoms in the general population.</AbstractText>
					<AbstractText Label="RESULTS" NlmCategory="RESULTS">Participants diagnosed with CFS (n = 295) had significantly decreased overall movement (Cohen's d = 0.220, 95% CI of -0.335 to -0.106, p-value = 2.42x10-15), lower activity amplitudes (Cohen's d = -0.377, 95% CI of -0.492 to -0.262, p-value = 1.74x10-6), and lower wrist temperature amplitudes (Cohen's d = -0.173, 95% CI of -0.288 -0.059, p-value = 0.002) compared to controls (n = 63,133). Of 30 tested SNVs associated in the literature with CFS, one was associated in the control population with subjective fatigue and one with actigraphic measurements (FDR &lt; 0.05).</AbstractText>
					<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The genetic overlap of CFS risk with actigraphy and subjective fatigue phenotypes suggests that some biological mechanisms underlying pathologic fatigue in CFS patients also underlie fatigue symptoms at a broader population level. Therefore, understanding the biology of fatigue in general may inform our understanding of CFS pathophysiology.</AbstractText>
					<CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press on behalf of Sleep Research Society. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site&#x2014;for further information please contact journals.permissions@oup.com.</CopyrightInformation>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Liu</LastName>
						<ForeName>Patrick Z</ForeName>
						<Initials>PZ</Initials>
						<Identifier Source="ORCID">0000-0001-9663-8233</Identifier>
						<AffiliationInfo>
							<Affiliation>Chronobiology and Sleep Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Raizen</LastName>
						<ForeName>David M</ForeName>
						<Initials>DM</Initials>
						<Identifier Source="ORCID">0000-0001-5935-0476</Identifier>
						<AffiliationInfo>
							<Affiliation>Chronobiology and Sleep Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation>
						</AffiliationInfo>
						<AffiliationInfo>
							<Affiliation>Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Skarke</LastName>
						<ForeName>Carsten</ForeName>
						<Initials>C</Initials>
						<AffiliationInfo>
							<Affiliation>Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation>
						</AffiliationInfo>
						<AffiliationInfo>
							<Affiliation>Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Brooks</LastName>
						<ForeName>Thomas G</ForeName>
						<Initials>TG</Initials>
						<Identifier Source="ORCID">0000-0002-6980-0079</Identifier>
						<AffiliationInfo>
							<Affiliation>Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Anafi</LastName>
						<ForeName>Ron C</ForeName>
						<Initials>RC</Initials>
						<AffiliationInfo>
							<Affiliation>Chronobiology and Sleep Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation>
						</AffiliationInfo>
						<AffiliationInfo>
							<Affiliation>Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>23</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>United States</Country>
				<MedlineTA>Sleep</MedlineTA>
				<NlmUniqueID>7809084</NlmUniqueID>
				<ISSNLinking>0161-8105</ISSNLinking>
			</MedlineJournalInfo>
			<CitationSubset>IM</CitationSubset>
			<KeywordList Owner="NOTNLM">
				<Keyword MajorTopicYN="N">SNVs</Keyword>
				<Keyword MajorTopicYN="N">UK Biobank</Keyword>
				<Keyword MajorTopicYN="N">actigraphy</Keyword>
				<Keyword MajorTopicYN="N">dysautonomia</Keyword>
				<Keyword MajorTopicYN="N">fatigue</Keyword>
				<Keyword MajorTopicYN="N">myalgic encephalomyelitis/chronic fatigue syndrome</Keyword>
			</KeywordList>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="received">
					<Year>2024</Year>
					<Month>4</Month>
					<Day>7</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>23</Day>
					<Hour>22</Hour>
					<Minute>28</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>23</Day>
					<Hour>22</Hour>
					<Minute>28</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>23</Day>
					<Hour>15</Hour>
					<Minute>13</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>aheadofprint</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pubmed">39442002</ArticleId>
				<ArticleId IdType="doi">10.1093/sleep/zsae243</ArticleId>
				<ArticleId IdType="pii">7833455</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
			<PMID Version="1">39434583</PMID>
			<DateCompleted>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>29</Day>
			</DateCompleted>
			<DateRevised>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>29</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1746-1561</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>94</Volume>
						<Issue>11</Issue>
						<PubDate>
							<Year>2024</Year>
							<Month>Nov</Month>
						</PubDate>
					</JournalIssue>
					<Title>The Journal of school health</Title>
					<ISOAbbreviation>J Sch Health</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Planning for Long-Term Recovery: The Impact of COVID-19 on Educators Working With Children From Seasonal and Migrant Farmworker Families.</ArticleTitle>
				<Pagination>
					<StartPage>1049</StartPage>
					<EndPage>1057</EndPage>
					<MedlinePgn>1049-1057</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1111/josh.13514</ELocationID>
				<Abstract>
					<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Education faced challenges during the COVID-19 pandemic. Although the United States has declared an end to the public health emergency, schools continue to be impacted. While considerable research has focused on the impact of the pandemic on students, fewer studies have focused on educators, and even less on educators who specialize in working with marginalized student populations.</AbstractText>
					<AbstractText Label="METHODS" NlmCategory="METHODS">This study measured the impact of the pandemic impact on educators working with students from seasonal and migrant farmworker families to understand what supports educators need as schools plan for long-term recovery. A total of 1024 educators including early childhood education and K-12 teachers, as well as administrators, completed a COVID-19 questionnaire between October 2020 and January 2021, measuring their experiences as well as personal and work-related stressors during the pandemic.</AbstractText>
					<AbstractText Label="RESULTS" NlmCategory="RESULTS">Educators underwent difficult COVID-19 experiences and faced several factors contributing to personal and work-related stress. Personal stress factors included concerns about they themselves, or family members, becoming ill, concerns about the emotional/mental health of their family, and fear of loss/reduction in employment. Work-related stress factors included concerns about the emotional and mental health of co-workers.</AbstractText>
					<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Educators working with migrant children need additional supports-including support from administrators, psychological services, and opportunities to give/receive colleague/peer support.</AbstractText>
					<CopyrightInformation>&#xa9; 2024 American School Health Association.</CopyrightInformation>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Rosado</LastName>
						<ForeName>Javier I</ForeName>
						<Initials>JI</Initials>
						<Identifier Source="ORCID">0000-0002-0210-2743</Identifier>
						<AffiliationInfo>
							<Affiliation>Florida State University College of Medicine, Isabel Collier Read Medical Campus, Immokalee, FL.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Torres-Aponte</LastName>
						<ForeName>Lisandra</ForeName>
						<Initials>L</Initials>
						<Identifier Source="ORCID">0009-0000-5019-9351</Identifier>
						<AffiliationInfo>
							<Affiliation>Florida State University College of Medicine, Isabel Collier Read Medical Campus, Immokalee, FL.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Wang</LastName>
						<ForeName>Yuxia</ForeName>
						<Initials>Y</Initials>
						<AffiliationInfo>
							<Affiliation>Florida State University College of Medicine, Tallahassee, FL.</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>22</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>United States</Country>
				<MedlineTA>J Sch Health</MedlineTA>
				<NlmUniqueID>0376370</NlmUniqueID>
				<ISSNLinking>0022-4391</ISSNLinking>
			</MedlineJournalInfo>
			<CitationSubset>IM</CitationSubset>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
					<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D014171" MajorTopicYN="Y">Transients and Migrants</DescriptorName>
					<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
					<QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000070777" MajorTopicYN="Y">School Teachers</DescriptorName>
					<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
					<QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000067565" MajorTopicYN="Y">Farmers</DescriptorName>
					<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
					<QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D013334" MajorTopicYN="N">Students</DescriptorName>
					<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
					<QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
				</MeshHeading>
			</MeshHeadingList>
			<KeywordList Owner="NOTNLM">
				<Keyword MajorTopicYN="N">COVID&#x2010;19</Keyword>
				<Keyword MajorTopicYN="N">educator wellbeing</Keyword>
				<Keyword MajorTopicYN="N">migrant education</Keyword>
			</KeywordList>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="revised">
					<Year>2024</Year>
					<Month>8</Month>
					<Day>16</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="received">
					<Year>2023</Year>
					<Month>12</Month>
					<Day>1</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="accepted">
					<Year>2024</Year>
					<Month>8</Month>
					<Day>28</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>29</Day>
					<Hour>12</Hour>
					<Minute>28</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>22</Day>
					<Hour>6</Hour>
					<Minute>28</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>22</Day>
					<Hour>3</Hour>
					<Minute>13</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pubmed">39434583</ArticleId>
				<ArticleId IdType="doi">10.1111/josh.13514</ArticleId>
			</ArticleIdList>
			<ReferenceList>
				<Title>REFERENCES</Title>
				<Reference>
					<Citation>Atiles JT, Almod&#xf3;var M, Chavarr&#xed;a Vargas A, Dias MJA, Z&#xfa;&#xf1;iga Le&#xf3;n IM. International responses to COVID&#x2010;19: challenges faced by early childhood professionals. Eur Early Child Educ Res J. 2021;29(1):66&#x2010;78. https://doi.org/10.1080/1350293x.2021.1872674.</Citation>
				</Reference>
				<Reference>
					<Citation>Brainard J. &#x201c;COVID&#x2010;ization&#x201d; of research levels off. Science. 2022;376(6595):782&#x2010;783. https://doi.org/10.1126/science.add0532.</Citation>
				</Reference>
				<Reference>
					<Citation>Pokhrel S, Chhetri R. A literature review on impact of COVID&#x2010;19 pandemic on teaching and learning. High Educ Future. 2021;8(1):133&#x2010;141. https://doi.org/10.1177/2347631120983481.</Citation>
				</Reference>
				<Reference>
					<Citation>Quandt SA, LaMonto NJ, Mora DC, Talton JW, Laurienti PJ, Arcury TA. COVID&#x2010;19 pandemic among immigrant Latinx farmworker and non&#x2010;farmworker families: a rural&#x2010;urban comparison of economic, educational, healthcare, and immigration concerns. New Solut. 2021;31(1):30&#x2010;47. https://doi.org/10.1177/1048291121992468.</Citation>
				</Reference>
				<Reference>
					<Citation>Habib RR, El Khayat M, Ghanawi J, Katrib RS, Hneiny L, Halwani DA. Child labor and associated risk factors in the wake of the COVID&#x2010;19 pandemic: a scoping review. Front Public Health. 2024;11:1240988. https://doi.org/10.3389/fpubh.2023.1240988.</Citation>
				</Reference>
				<Reference>
					<Citation>Daumiller M, Rinas R, Schoon I, L&#xfc;ftenegger M. How did COVID&#x2010;19 affect education and what can Be learned moving forward? Z Psychol. 2023;231(3):177&#x2010;191. https://doi.org/10.1027/2151&#x2010;2604/a000527.</Citation>
				</Reference>
				<Reference>
					<Citation>Oducado RM, Rabacal J, Moralista R, Tamdang K. Perceived stress due COVID&#x2010;19 pandemic among employed professional teachers. Int J Educ Res Innov. 2020;15(15):305&#x2010;316. https://doi.org/10.46661/ijeri.5284.</Citation>
				</Reference>
				<Reference>
					<Citation>Klapproth F, Federkeil L, Heinschke F, Jungmann T. Teachers experiences of stress and their coping strategies during COVID &#x2010; 19 induced distance teaching. J Pedagogic Res. 2020;4(4):444&#x2010;452. https://doi.org/10.33902/jpr.2020062805.</Citation>
				</Reference>
				<Reference>
					<Citation>Natale R, Davidson B, Woody M, et al. A model of care for delivering supports to childcare providers during the COVID&#x2010;19 pandemic. Res Sq. 2020:1:1. https://doi.org/10.21203/rs.3.rs&#x2010;39115/v1.</Citation>
				</Reference>
				<Reference>
					<Citation>Rosado J, Torres Aponte L, Velazques J, Wang Y. COVID&#x2010;19 Impact on Migrant Education Teachers &amp; Staff. Presented at: Poster presentation at the American Psychological Association Annual Convention, American Psychological Association, Virtual (National); 2021.</Citation>
				</Reference>
				<Reference>
					<Citation>Chitra A. Study on impact of occupational stress on job satisfaction of teachers during Covid&#x2010;19 pandemic period. Glob Develop Rev. 2020;4(2):52&#x2010;62.</Citation>
				</Reference>
				<Reference>
					<Citation>Ko&#x161;ir K, Dugonik &#x160;, Huski&#x107; A, Gra&#x10d;ner J, Kokol Z, Krajnc &#x17d;. Predictors of perceived teachers' and school counsellors' work stress in the transition period of online education in schools during the COVID&#x2010;19 pandemic. Educ Stud. 2022;48(6):844&#x2010;848. https://doi.org/10.1080/03055698.2020.1833840.</Citation>
				</Reference>
				<Reference>
					<Citation>MacDonald M, Hill C. The educational impact of the Covid&#x2010;19 rapid response on teachers, students, and families: insights from British Columbia, Canada. Prospects. 2021;51:627&#x2010;641. https://doi.org/10.1007/s11125&#x2010;020&#x2010;09527&#x2010;5.</Citation>
				</Reference>
				<Reference>
					<Citation>Mulvihill T, Martin L. Voices in education: the social&#x2013;emotional impact on teachers in a COVID&#x2010;19 world: how can teacher education lend a hand? Teach Educ. 2022;57(3):239&#x2010;248. https://doi.org/10.1080/08878730.2022.2076389.</Citation>
				</Reference>
				<Reference>
					<Citation>Regional Terrorism and Disaster Coalitions for Child and Family Resilience. COVID&#x2010;19 Survey for Pre&#x2010;k to 12 Teachers and School Staff. Montclaire, NJ: Montclair State University; 2020.</Citation>
				</Reference>
				<Reference>
					<Citation>Grasso DJ, Briggs&#x2010;Gowan MJ, Carter AS, Goldstein BL, Ford JD. Profiling COVID&#x2010;related experiences in the United States with the epidemic&#x2010;pandemic impacts inventory: linkages to psychosocial functioning. Brain Behav. 2021;11(8):e02197. https://doi.org/10.1002/brb3.2197.</Citation>
				</Reference>
				<Reference>
					<Citation>Montiel Ishino FA, McNab P, Villalobos K, Cohen JH, N&#xe1;poles AM, Williams F. Hispanic/Latino acculturation profiles and telomere length: latent class analysis on a nationally representative sample. Front Public Health. 2021;9:640226.</Citation>
				</Reference>
				<Reference>
					<Citation>Susilaningsih F, Komariah M, Mediawati A, Lumbantobing V. Quality of work&#x2010;life among lecturers during online learning in COVID&#x2010;19 pandemic period: a scoping review. Malaysian J Med Health Sci. 2021;17(Suppl 4):2636&#x2010;9346.</Citation>
				</Reference>
				<Reference>
					<Citation>Bottiani JH, Duran CAK, Pas ET, Bradshaw CP. Teacher stress and burnout in urban middle schools: associations with job demands, resources, and effective classroom practices. J Sch Psychol. 2019;77:36&#x2010;51. https://doi.org/10.1016/j.jsp.2019.10.002.</Citation>
				</Reference>
				<Reference>
					<Citation>Skaalvik EM, Skaalvik S. Job demands and job resources as predictors of teacher motivation and well&#x2010;being. Soc Psychol Educ. 2018;21(5):1251&#x2010;1275. https://doi.org/10.1007/s11218&#x2010;018&#x2010;9464&#x2010;8.</Citation>
				</Reference>
				<Reference>
					<Citation>Walsh C. Developing Teacher Capacity and Resilience to Support Vulnerable High School Learners. The Organizational Improvement Plan at Western University. London, Canada: Western University; 2022:271. https://ir.lib.uwo.ca/oip/271/.</Citation>
				</Reference>
				<Reference>
					<Citation>Ortega L, Thompson I, Daniels H. School staff advice&#x2010;seeking patterns regarding support for vulnerable students. J Educ Adm. 2019;58(2):151&#x2010;170. https://doi.org/10.1108/jea&#x2010;12&#x2010;2018&#x2010;0236.</Citation>
				</Reference>
				<Reference>
					<Citation>Madrid JE. Title I's migrant education program: the challenges of addressing migrant students' educational needs in the 21st century. Georgetown J Law Modern Critical Race Perspect. 2019;11(1):67&#x2010;98.</Citation>
				</Reference>
				<Reference>
					<Citation>Zheng M, Asif M, Tufail MS, et al. COVID academic pandemic: techno stress faced by teaching staff for online academic activities. Front Psychol. 2022;13:895371. https://doi.org/10.3389/fpsyg.2022.895371.</Citation>
				</Reference>
				<Reference>
					<Citation>Daumiller M, Rinas R, Hein J, Janke S, Dickh&#xe4;user O, Dresel M. Shifting from face&#x2010;to&#x2010;face to online teaching during COVID&#x2010;19: the role of university faculty achievement goals for attitudes towards this sudden change, and their relevance for burnout/engagement and student evaluations of teaching quality. Comput Hum Behav. 2021;118:1&#x2010;20. https://doi.org/10.1016/j.chb.2020.106677.</Citation>
				</Reference>
				<Reference>
					<Citation>Kakepotoa I, Talpur Q, Memon IA, Halepoto IA, Jalbani KB. Pedagogical shift: faculty insights about E&#x2010;teaching barriers during COVID pandemic. Int J Innov Creativity Change. 2024;15(6):1147&#x2010;1160.</Citation>
				</Reference>
				<Reference>
					<Citation>Robinson LE, Valido A, Drescher A, et al. Teachers, stress, and the COVID&#x2010;19 pandemic: a qualitative analysis. Sch Ment Heal. 2023;15:78&#x2010;89. https://doi.org/10.1007/s12310&#x2010;022&#x2010;09533&#x2010;2.</Citation>
				</Reference>
				<Reference>
					<Citation>U.S. Health and Human Services. COVID&#x2010;19 Public Health Emergency (PHE); 2023. https://www.hhs.gov/coronavirus/covid&#x2010;19&#x2010;public&#x2010;health&#x2010;emergency/index.html. Accessed May 8, 2020.</Citation>
				</Reference>
				<Reference>
					<Citation>Mucci GA, Collins E, Pearce E, et al. The lost years: an integrative review of the mental health, educational, and social impact of the pandemic on children and adolescents from 2019 to 2022. J Pediatr Neuropsychol. 2024;10:49&#x2010;90. https://doi.org/10.1007/s40817&#x2010;024&#x2010;00160&#x2010;0.</Citation>
				</Reference>
				<Reference>
					<Citation>Zimmerman KO, Benjamin DK. Lessons learned from the COVID&#x2010;19 pandemic in K&#x2010;12 education. Pediatrics. 2023;152(Supp 1):e2023060352O.</Citation>
				</Reference>
				<Reference>
					<Citation>Betth&#xe4;user BA, Bach&#x2010;Mortensen AM, Engzell P. A systematic review and meta&#x2010;analysis of the evidence on learning during the COVID&#x2010;19 pandemic. Nat Hum Behav. 2023;7(3):375&#x2010;385. https://doi.org/10.1038/s41562&#x2010;022&#x2010;01506&#x2010;4.</Citation>
				</Reference>
				<Reference>
					<Citation>Namkung JM, Goodrich JM, Hebert M, Koziol N. Impacts of the COVID&#x2010;19 pandemic on student learning and opportunity gaps across the 2020&#x2013;2021 school year: a National Survey of teachers. Front Educ. 2022;7:921497. https://doi.org/10.3389/feduc.2022.921497.</Citation>
				</Reference>
				<Reference>
					<Citation>Hesham Abdou Ahmed G. Special education teachers' mental health after reopening schools during Covid&#x2010;19. PLoS One. 2023;18(5):E0284870. https://doi.org/10.1371/journal.pone.0284870.</Citation>
				</Reference>
				<Reference>
					<Citation>Smith P, Oudyk J, Cedillo L, Inouye K, Potter G, Mustard C. The psychosocial work environment among educators during the COVID&#x2010;19 pandemic. Occup Med (Lond). 2022;72(7):439&#x2010;445. https://doi.org/10.1093/occmed/kqac050.</Citation>
				</Reference>
				<Reference>
					<Citation>Buskila Y, Chen&#x2010;Levi T. The role of authentic school leaders in promoting teachers' well&#x2010;being: perceptions of Israeli teachers. Athens J Educ. 2021;8(2):161&#x2010;180. https://doi.org/10.30958/aje.8&#x2010;2&#x2010;3.</Citation>
				</Reference>
				<Reference>
					<Citation>Dosil Santamar&#xed;a M, Idoiaga Mondragon N, Berasategi Santxo N, Ozamiz&#x2010;Etxebarria N. Teacher stress, anxiety and depression at the beginning of the academic year during the COVID&#x2010;19 pandemic. Glob Mental Health (Camb). 2021;8(14):1&#x2010;8. https://doi.org/10.1017/gmh.2021.14.</Citation>
				</Reference>
				<Reference>
					<Citation>Fan X. Study on stress management of college teachers based on employee assistance program. J Educ. 2023;203(4):812&#x2010;817. https://doi.org/10.1177/0022057421996255.</Citation>
				</Reference>
				<Reference>
					<Citation>Kim LE, Oxley L, Asbury K. &#x201c;My brain feels like a browser with 100 tabs open&#x201d;: a longitudinal study of teachers' mental health and well&#x2010;being during the COVID&#x2010;19 pandemic. Br J Educ Psychol. 2022;92(1):299&#x2010;318. https://doi.org/10.1111/bjep.12450.</Citation>
				</Reference>
				<Reference>
					<Citation>Nawaz K, Saeed H, Sajeel T. Covid&#x2010;19 and the state of research from the perspective of psychology. Int J Bus Psychol. 2020;2:35&#x2010;44.</Citation>
				</Reference>
				<Reference>
					<Citation>Codding RS, Collier&#x2010;Meek M, Jimerson S, Klingbeil DA, Mayer MJ, Miller F. School psychology reflections on COVID&#x2010;19, antiracism, and gender and racial disparities in publishing. Sch Psychol. 2020;35(4):227&#x2010;232. https://doi.org/10.1037/spq0000399.</Citation>
				</Reference>
			</ReferenceList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
			<PMID Version="1">39425035</PMID>
			<DateCompleted>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>18</Day>
			</DateCompleted>
			<DateRevised>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>21</Day>
			</DateRevised>
			<Article PubModel="Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1471-2377</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>24</Volume>
						<Issue>1</Issue>
						<PubDate>
							<Year>2024</Year>
							<Month>Oct</Month>
							<Day>18</Day>
						</PubDate>
					</JournalIssue>
					<Title>BMC neurology</Title>
					<ISOAbbreviation>BMC Neurol</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Chronic Overlapping Pain Conditions in people with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a sample from the Multi-site Clinical Assessment of ME/CFS (MCAM) study.</ArticleTitle>
				<Pagination>
					<StartPage>399</StartPage>
					<MedlinePgn>399</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="pii" ValidYN="Y">399</ELocationID>
				<ELocationID EIdType="doi" ValidYN="Y">10.1186/s12883-024-03872-0</ELocationID>
				<Abstract>
					<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Chronic overlapping pain conditions (COPCs), pain-related conditions that frequently occur together, may occur in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and could impact illness severity. This study aimed to identify comorbid COPCs in patients with ME/CFS and evaluate their&#xa0;impact on illness severity.</AbstractText>
					<AbstractText Label="METHODS" NlmCategory="METHODS">We used data from 923 participants in the Multi-Site Clinical Assessment of ME/CFS study, conducted in seven U.S. specialty clinics between 2012 and 2020, who completed the baseline assessment (595 ME/CFS and 328 healthy controls (HC)). COPCs included chronic low back pain (cLBP), chronic migraine/headache (cMHA), fibromyalgia (FM), interstitial cystitis/irritable bladder (IC/IB), irritable bowel syndrome (IBS), temporomandibular disorder (TMD). Illness severity was assessed through questionnaires measuring symptoms and functioning. Multivariate analysis of variance and analysis of covariance models were used for analyses. Log-binomial regression analyses were used to compute prevalence of COPCs and prevalence ratios (PR) between groups with 95% confidence intervals. Both unadjusted and adjusted results with age and sex are presented.</AbstractText>
					<AbstractText Label="RESULTS" NlmCategory="RESULTS">76% of participants with ME/CFS had at least one COPCs compared to 17.4% of HC. Among ME/CFS participants, cMHA was most prevalent (48.1%), followed by FM (45.0%), cLBP (33.1%), and IBS (31.6%). All individual COPCs, except TMD, were significantly more frequent in females than males. The unadjusted PR (ME/CFS compared to HC) was highest for FM [147.74 (95% confidence interval (CI)&#x2009;=&#x2009;20.83-1047.75], followed by cLBP [39.45 (12.73-122.27)], and IC/IB [13.78 (1.88-101.24)]. The significance and order did not change after age and sex adjustment. The COPC comorbidities of cLBP and FM each had a significant impact on most health measures, particularly in pain attributes (Cohen's d effect size 0.8 or larger). While the impact of COPC comorbidities on non-pain attributes and quality of life measures was less pronounced than that&#xa0;on pain, statistically significant differences between ME/CFS participants with and without COPCs were still evident.</AbstractText>
					<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">More than 75% of ME/CFS participants had one or more COPCs. Multiple COPCs further exacerbated illness severity, especially among females with ME/CFS. Assessment and management of COPCs may help improve the health and quality of life for patients with ME/CFS.</AbstractText>
					<CopyrightInformation>&#xa9; 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.</CopyrightInformation>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y" EqualContrib="Y">
						<LastName>Fall</LastName>
						<ForeName>Elizabeth A</ForeName>
						<Initials>EA</Initials>
						<AffiliationInfo>
							<Affiliation>Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. oki4@cdc.gov.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y" EqualContrib="Y">
						<LastName>Chen</LastName>
						<ForeName>Yang</ForeName>
						<Initials>Y</Initials>
						<AffiliationInfo>
							<Affiliation>Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. njl3@cdc.gov.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y" EqualContrib="Y">
						<LastName>Lin</LastName>
						<ForeName>Jin-Mann S</ForeName>
						<Initials>JS</Initials>
						<AffiliationInfo>
							<Affiliation>Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. dwe3@cdc.gov.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Issa</LastName>
						<ForeName>Anindita</ForeName>
						<Initials>A</Initials>
						<AffiliationInfo>
							<Affiliation>Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Brimmer</LastName>
						<ForeName>Dana J</ForeName>
						<Initials>DJ</Initials>
						<AffiliationInfo>
							<Affiliation>Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Bateman</LastName>
						<ForeName>Lucinda</ForeName>
						<Initials>L</Initials>
						<AffiliationInfo>
							<Affiliation>Bateman Horne Center, Salt Lake City, UT, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Lapp</LastName>
						<ForeName>Charles W</ForeName>
						<Initials>CW</Initials>
						<AffiliationInfo>
							<Affiliation>Hunter-Hopkins Center, Charlotte, NC, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Podell</LastName>
						<ForeName>Richard N</ForeName>
						<Initials>RN</Initials>
						<AffiliationInfo>
							<Affiliation>Richard N. Podell Medical, Summit, NJ, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Natelson</LastName>
						<ForeName>Benjamin H</ForeName>
						<Initials>BH</Initials>
						<AffiliationInfo>
							<Affiliation>Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Kogelnik</LastName>
						<ForeName>Andreas M</ForeName>
						<Initials>AM</Initials>
						<AffiliationInfo>
							<Affiliation>Basis Diagnostics, Redwood City, CA, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Klimas</LastName>
						<ForeName>Nancy G</ForeName>
						<Initials>NG</Initials>
						<AffiliationInfo>
							<Affiliation>Institute for Neuro Immune Medicine, Nova Southeastern University, Fort Lauderdale, FL, USA.</Affiliation>
						</AffiliationInfo>
						<AffiliationInfo>
							<Affiliation>Geriatric Research and Education Clinical Center, VA Medical Center, Miami, FL, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Peterson</LastName>
						<ForeName>Daniel L</ForeName>
						<Initials>DL</Initials>
						<AffiliationInfo>
							<Affiliation>Sierra Internal Medicine, Incline Village, NV, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Unger</LastName>
						<ForeName>Elizabeth R</ForeName>
						<Initials>ER</Initials>
						<AffiliationInfo>
							<Affiliation>Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<CollectiveName>MCAM Study Group</CollectiveName>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
					<PublicationType UI="D016448">Multicenter Study</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>18</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>England</Country>
				<MedlineTA>BMC Neurol</MedlineTA>
				<NlmUniqueID>100968555</NlmUniqueID>
				<ISSNLinking>1471-2377</ISSNLinking>
			</MedlineJournalInfo>
			<CitationSubset>IM</CitationSubset>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
					<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
					<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D005356" MajorTopicYN="Y">Fibromyalgia</DescriptorName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
					<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
					<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D059350" MajorTopicYN="Y">Chronic Pain</DescriptorName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
					<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D018856" MajorTopicYN="N">Cystitis, Interstitial</DescriptorName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
					<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
					<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D043183" MajorTopicYN="N">Irritable Bowel Syndrome</DescriptorName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
					<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
					<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D017116" MajorTopicYN="N">Low Back Pain</DescriptorName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
					<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D008881" MajorTopicYN="N">Migraine Disorders</DescriptorName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
					<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D013705" MajorTopicYN="N">Temporomandibular Joint Disorders</DescriptorName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
					<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
					<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName>
				</MeshHeading>
			</MeshHeadingList>
			<KeywordList Owner="NOTNLM">
				<Keyword MajorTopicYN="N">Chronic low back pain (cLBP)</Keyword>
				<Keyword MajorTopicYN="N">Chronic migraine/Headache (cMHA)</Keyword>
				<Keyword MajorTopicYN="N">Endometriosis</Keyword>
				<Keyword MajorTopicYN="N">Fibromyalgia (FM)</Keyword>
				<Keyword MajorTopicYN="N">Interstitial cystitis/Irritable bladder (IC/IB)</Keyword>
				<Keyword MajorTopicYN="N">Irritable bowel syndrome (IBS)</Keyword>
				<Keyword MajorTopicYN="N">Multimorbidity</Keyword>
				<Keyword MajorTopicYN="N">Myalgic encephalomyelitis/Chronic fatigue syndrome (ME/CFS)</Keyword>
				<Keyword MajorTopicYN="N">Temporomandibular disorder (TMD)</Keyword>
				<Keyword MajorTopicYN="N">Vulvodynia</Keyword>
			</KeywordList>
			<CoiStatement>The authors declare no competing interests.</CoiStatement>
			<InvestigatorList>
				<Investigator ValidYN="Y">
					<LastName>Tian</LastName>
					<ForeName>Hao</ForeName>
					<Initials>H</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Bonner</LastName>
					<ForeName>Kathleen</ForeName>
					<Initials>K</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Cornelius</LastName>
					<ForeName>Monica</ForeName>
					<Initials>M</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Dimulescu</LastName>
					<ForeName>Irina</ForeName>
					<Initials>I</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Helton</LastName>
					<ForeName>Britany</ForeName>
					<Initials>B</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Khin</LastName>
					<ForeName>Maung</ForeName>
					<Initials>M</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Rajeevan</LastName>
					<ForeName>Mangalathu</ForeName>
					<Initials>M</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Bland</LastName>
					<ForeName>Jennifer</ForeName>
					<Initials>J</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Jeys</LastName>
					<ForeName>Patricia</ForeName>
					<Initials>P</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Parkinson</LastName>
					<ForeName>Veronica</ForeName>
					<Initials>V</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Springs</LastName>
					<ForeName>Wendy</ForeName>
					<Initials>W</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Balbin</LastName>
					<ForeName>Elizabeth</ForeName>
					<Initials>E</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Cournoyer</LastName>
					<ForeName>Jeffry</ForeName>
					<Initials>J</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Fernandez</LastName>
					<ForeName>Melissa</ForeName>
					<Initials>M</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Parnell</LastName>
					<ForeName>Shuntae</ForeName>
					<Initials>S</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Leaks-Gutierrez</LastName>
					<ForeName>Precious</ForeName>
					<Initials>P</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Blate</LastName>
					<ForeName>Michelle</ForeName>
					<Initials>M</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Lange</LastName>
					<ForeName>Gudrun</ForeName>
					<Initials>G</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Khan</LastName>
					<ForeName>Sarah</ForeName>
					<Initials>S</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Vu</LastName>
					<ForeName>Diana</ForeName>
					<Initials>D</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Danver</LastName>
					<ForeName>Joan</ForeName>
					<Initials>J</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Kaufman</LastName>
					<ForeName>David</ForeName>
					<Initials>D</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Pa</LastName>
					<ForeName>Macy</ForeName>
					<Initials>M</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Phan</LastName>
					<ForeName>Catt</ForeName>
					<Initials>C</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Taleghani</LastName>
					<ForeName>Sophia</ForeName>
					<Initials>S</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Fitzpatrick</LastName>
					<ForeName>Trisha</ForeName>
					<Initials>T</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Licata</LastName>
					<ForeName>Beverly</ForeName>
					<Initials>B</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Lascu</LastName>
					<ForeName>Elena</ForeName>
					<Initials>E</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Gottschalk</LastName>
					<ForeName>Gunnar</ForeName>
					<Initials>G</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Maynard</LastName>
					<ForeName>Marco</ForeName>
					<Initials>M</Initials>
				</Investigator>
			</InvestigatorList>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="received">
					<Year>2024</Year>
					<Month>6</Month>
					<Day>12</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="accepted">
					<Year>2024</Year>
					<Month>9</Month>
					<Day>19</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>19</Day>
					<Hour>16</Hour>
					<Minute>24</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>19</Day>
					<Hour>16</Hour>
					<Minute>23</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>18</Day>
					<Hour>23</Hour>
					<Minute>44</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pmc-release">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>18</Day>
				</PubMedPubDate>
			</History>
			<PublicationStatus>epublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pubmed">39425035</ArticleId>
				<ArticleId IdType="pmc">PMC11488184</ArticleId>
				<ArticleId IdType="doi">10.1186/s12883-024-03872-0</ArticleId>
				<ArticleId IdType="pii">10.1186/s12883-024-03872-0</ArticleId>
			</ArticleIdList>
			<ReferenceList>
				<Reference>
					<Citation>Institute of Medicine. Beyond myalgic Encephalomyelitis/Chronic fatigue syndrome: redefining an illness. Natl Acad Press. 2015. 10.17226/19012.</Citation>
				</Reference>
				<Reference>
					<Citation>Bateman L, Darakjy S, Klimas N, Peterson D, Levine SM, Allen A, et al. Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study. Fatigue: Biomed Health Behav. 2014;3:1&#x2013;15. 10.1080/21641846.2014.978109.</Citation>
				</Reference>
				<Reference>
					<Citation>Bateman L, Bested AC, Bonilla HF, Chheda BV, Chu L, Curtin JM, et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: essentials of diagnosis and management. Mayo Clin Proc. 2021;96:96. 10.1016/j.mayocp.2021.07.004.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">34454716</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Glette M, Stiles TC, Woodhouse A, Ivar T, Landmark T. Chronic fatigue in the general population: prevalence, natural course and associations with chronic pain (the HUNT pain study). Eur J Pain. 2024. 10.1002/ejp.2307.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">38940382</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Maixner W, Fillingim RB, Williams DA, Smith SB, Slade GD. Overlapping chronic pain conditions: implications for diagnosis and classification. J Pain. 2016;17:T93&#x2013;107. 10.1016/j.jpain.2016.06.002.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC6193199</ArticleId>
						<ArticleId IdType="pubmed">27586833</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Tietjen GE, Brandes JL, Peterlin BL, Eloff A, Dafer RM, Stein MR, Drexler E, Martin VT, Hutchinson S, Aurora SK, Recober A. Allodynia in migraine: association with comorbid pain conditions. Headache: J Head Face Pain. 2009;49(9):1333&#x2013;44. 10.1111/j.1526-4610.2009.01521.x.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">19788473</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Bourke JH, Johnson AL, Sharpe M, Chalder T, White PD. Pain in chronic fatigue syndrome: response to rehabilitative treatments in the PACE trial. Psychol Med. 2013;44:1545&#x2013;52. 10.1017/s0033291713002201.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">23967878</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Ciccone DS, Natelson BH. Comorbid Illness in Women with chronic fatigue syndrome: a test of the single syndrome hypothesis. Psychosom Med. 2003;65:268&#x2013;75. 10.1097/01.PSY.0000033125.08272.A9.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">12651994</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Castro-Marrero J, Faro M, Aliste L, S&#xe1;ez-Franc&#xe0;s N, Calvo N, Mart&#xed;nez-Mart&#xed;nez A, de Sevilla TF, Alegre J. Comorbidity in chronic fatigue syndrome/myalgic encephalomyelitis: a nationwide population-based cohort study. Psychosomatics. 2017;58(5):533&#x2013;43. 10.1016/j.psym.2017.04.010.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">28596045</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Natelson BH, Lin J-MS, Lange G, Khan S, Stegner A, Unger ER. The effect of comorbid medical and psychiatric diagnoses on chronic fatigue syndrome. Ann Med. 2019;51:371&#x2013;8. 10.1080/07853890.2019.1683601.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC7877877</ArticleId>
						<ArticleId IdType="pubmed">31642345</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Robinson LJ, Durham J, Newton JL. A systematic review of the comorbidity between Temporomandibular disorders and chronic fatigue syndrome. J Rehabil. 2015;43:306&#x2013;16. 10.1111/joor.12367.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">26549386</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Chu L, Valencia IJ, Garvert DW, Montoya JG. Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome. Front Pead. 2019;7:12. 10.3389/fped.2019.00012.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC6370741</ArticleId>
						<ArticleId IdType="pubmed">30805319</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Ravindran MK, Zheng Y, Timbol C, Merck SJ, Baraniuk JN. Migraine headaches in chronic fatigue syndrome (CFS): comparison of two prospective cross-sectional studies. BMC Neurol. 2011;11:1&#x2013;9. 10.1186/1471-2377-11-30.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC3058027</ArticleId>
						<ArticleId IdType="pubmed">21375763</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Boneva RS, Lin JMS, Unger ER. Early menopause and other gynecologic risk indicators for chronic fatigue syndrome in women. Menopause. 2015;22:826&#x2013;34. 10.1097/GME.0000000000000411.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC5745581</ArticleId>
						<ArticleId IdType="pubmed">25647777</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Boneva RS, Lin J-MS, Wieser F, Nater UM, Ditzen B, Taylor RN, et al. Endometriosis as a comorbid condition in Chronic Fatigue Syndrome (CFS): secondary analysis of data from a CFS case-control study. Front Pead. 2019;7:195.10.3389/fped.2019.00195</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC6537603</ArticleId>
						<ArticleId IdType="pubmed">31179251</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Rusu C, Gee ME, Lagac&#xe9; C, Parlor M. Chronic fatigue syndrome and fibromyalgia in Canada: prevalence and associations with six health status indicators. Health Promot Chronic Dis Prev Can. 2015;35(1):3&#x2013;11. 10.24095/hpcdp.35.1.02.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC4939456</ArticleId>
						<ArticleId IdType="pubmed">25811400</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Schmaling KB, Betterton KL. Neurocognitive complaints and functional status among patients with chronic fatigue syndrome and fibromyalgia. Qual Life Res. 2016;25:1257&#x2013;63. 10.1007/s11136-015-1160-y.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC6115195</ArticleId>
						<ArticleId IdType="pubmed">26471263</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Brown MM, Jason LA. Functioning in individuals with chronic fatigue syndrome: increased impairment with co-occurring multiple chemical sensitivity and fibromyalgia. Dynamic Med. 2007;6:6. 10.1186/1476-5918-6-6.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC1890280</ArticleId>
						<ArticleId IdType="pubmed">17540028</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Jason LA, McManimen S, Sunnquist M, Newton JL, Strand EB. Examining those meeting IOM criteria versus IOM plus Fibromyalgia. Neurol (E-Cronicon). 2017;5(1):19.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC5510658</ArticleId>
						<ArticleId IdType="pubmed">28713879</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Reynolds KJ, Vernon SD, Bouchery E, Reeves WC. The economic impact of chronic fatigue syndrome. Cost Eff Resourc Alloc. 2004;2(1):4. 10.1186/1478-7547-2-4.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC449736</ArticleId>
						<ArticleId IdType="pubmed">15210053</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Bombardier CH, Buchwald D. Chronic fatigue, chronic fatigue syndrome, and fibromyalgia: disability and health-care use. Med Care. 1996;34(9):924. 10.1097/00005650-199609000-00005.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">8792781</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37&#x2013;43. 10.1016/S0140-6736(12)60240-2.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">22579043</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Unger ER, Lin J-MS, Tian H, Natelson BH, Lange G, Vu D, et al. Multi-site Clinical Assessment of myalgic Encephalomyelitis/Chronic fatigue syndrome (MCAM): design and implementation of a prospective/retrospective rolling cohort study. Am J Epidemiol. 2017;185:617&#x2013;26. 10.1093/aje/kwx029.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC5565838</ArticleId>
						<ArticleId IdType="pubmed">28338983</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Unger ER, Lin JM, Chen Y, Cornelius ME, Helton B, Issa AN, Bertolli J, Klimas NG, Balbin EG, Bateman L, Lapp CW. Heterogeneity in measures of illness among patients with myalgic Encephalomyelitis/Chronic fatigue syndrome is not explained by clinical practice: a study in seven US Specialty Clinics. J Clin Med. 2024;13(5):1369. 10.3390/jcm13051369.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC10931716</ArticleId>
						<ArticleId IdType="pubmed">38592199</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Cleeland C, Ryan K. Pain assessment: global use of the brief Pain Inventory. Ann Acad Med Singapore. 1994;23(2):129&#x2013;38.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">8080219</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Wagner D, Nisenbaum R, Heim C, Jones JF, Unger ER, Reeves WC. Psychometric properties of the CDC Symptom Inventory for assessment of chronic fatigue syndrome. Popul Health Metrics. 2005;3(1):1&#x2013;8. 10.1186/1478-7954-3-8.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC1183246</ArticleId>
						<ArticleId IdType="pubmed">16042777</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Smets E, Garssen B, Bonke B, De de J. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39(3):315&#x2013;25. 10.1016/0022-3999(94)00125-O.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">7636775</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Lin JMS, Brimmer DJ, Maloney EM, Nyarko E, BeLue R, Reeves WC. Further validation of the multidimensional fatigue inventory in a US adult population sample. Popul Health Metrics. 2009;7(1):1&#x2013;13. 10.1186/1478-7954-7-18.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC2801470</ArticleId>
						<ArticleId IdType="pubmed">20003524</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Lai J-S, Cella D, Choi S, Junghaenel DU, Christodoulou C, Gershon R, et al. How item banks and their application can influence measurement practice in rehabilitation medicine: a PROMIS fatigue item bank example. Arch Phys Med Rehabil. 2011;92:S20&#x2013;7. 10.1016/j.apmr.2010.08.033.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC3696589</ArticleId>
						<ArticleId IdType="pubmed">21958919</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Yang M, Keller S, Lin JMS. Psychometric properties of the PROMIS&#xae; fatigue short form 7a among adults with myalgic encephalomyelitis/chronic fatigue syndrome. Qual Life Res. 2019;28:3375&#x2013;84. 10.1007/s11136-019-02289-4.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">31506915</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Revicki DA, Chen WH, Harnam N, et al. Development and psychometric analysis of the PROMIS pain behavior item bank. Pain. 2009;146(1&#x2013;2):158&#x2013;69. 10.1016/j.pain.2009.07.029.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC2775487</ArticleId>
						<ArticleId IdType="pubmed">19683873</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Yang M, Keller S, Lin JMS. Assessing sleep and pain among adults with myalgic encephalomyelitis/chronic fatigue syndrome: psychometric evaluation of the PROMIS&#xae; sleep and pain short forms. Qual Life Res. 2022;31(12):3483&#x2013;99. 10.1007/s11136-022-03199-8.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC9331042</ArticleId>
						<ArticleId IdType="pubmed">35896905</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Amtmann D, Cook KF, Jensen MP, et al. Development of a PROMIS item bank to measure pain interference. Pain. 2010;150(1):173&#x2013;82. 10.1016/j.pain.2010.04.025.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC2916053</ArticleId>
						<ArticleId IdType="pubmed">20554116</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Buysse DJ, Yu L, Moul DE, et al. Development and validation of patient-reported outcome measures for sleep disturbance and sleep-related impairments. Sleep. 2010;33(6):781&#x2013;92. 10.1093/sleep/33.6.781.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC2880437</ArticleId>
						<ArticleId IdType="pubmed">20550019</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Ware JE Jr. SF-36 health survey update. Spine. 2000;25(24):3130&#x2013;9. 10.1097/00007632-200012150-00008.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">11124729</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Moriarty DG, Zack MM, Kobau R. The Centers for Disease Control and Prevention&#x2019;s Healthy days measures&#x2013;Population tracking of perceived physical and mental health over time. Health Qual Life Outcomes. 2003;1(1):1&#x2013;8. 10.1186/1477-7525-1-37.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC201011</ArticleId>
						<ArticleId IdType="pubmed">14498988</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>SAS Institute Inc. SAS [software]. Version 9.4. Cary: SAS Institute Inc; 2013.</Citation>
				</Reference>
				<Reference>
					<Citation>Wickham H. Ggplot2: elegant graphics for data analysis. New York: Springer; 2016.</Citation>
				</Reference>
				<Reference>
					<Citation>Conway JR, Lex A, Gehlenborg N. UpSetR: an R package for the visualization of intersecting sets and their properties. Bioinformatics. 2017;33(18):2938&#x2013;40. 10.1093/bioinformatics/btx364.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC5870712</ArticleId>
						<ArticleId IdType="pubmed">28645171</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Faro M, S&#xe0;ez-Franc&#xe1;s N, Castro-Marrero J, Aliste L, Fern&#xe1;ndez de Sevilla T, Alegre J. Gender differences in chronic fatigue syndrome. Reumatol Cl&#xed;n (English Edition). 2016;12(2):72&#x2013;7. 10.1016/j.reuma.2015.05.007.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">26190206</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Schmaling KB, Fales JL, McPherson S. Longitudinal outcomes associated with significant other responses to chronic fatigue and pain. J Health Psychol. 2020;25(5):692&#x2013;702. 10.1177/1359105317731824.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">28925285</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Aaron LA, Burke MM, Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med. 2000;160(2):221&#x2013;7. 10.1001/archinte.160.2.221.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">10647761</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Haider S, Janowski AJ, Lesnak JB, Hayashi K, Dailey DL, Chimenti R, Frey-Law LA, Sluka KA, Berardi G. A comparison of pain, fatigue, and function between post&#x2013;COVID-19 condition, fibromyalgia, and chronic fatigue syndrome: a survey study. Pain. 2023;164(2):385&#x2013;401. 10.1097/j.pain.0000000000002711.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC9797623</ArticleId>
						<ArticleId IdType="pubmed">36006296</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Robinson LJ, Durham J, MacLachlan LL, Newton JL. Autonomic function in chronic fatigue syndrome with and without painful temporomandibular disorder. Fatigue: Biomed Health Behav. 2015;3(4):205&#x2013;19. 10.1080/21641846.2015.1091152.</Citation>
				</Reference>
				<Reference>
					<Citation>Ciccone DS, Chandler HK, Natelson BH. Illness trajectories in the chronic fatigue syndrome. J Nerv Mental Disease. 2010;198:486&#x2013;93. 10.1097/NMD.0b013e3181e4ce0b.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">20611051</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Terkawi AS, Popat RA, Mackey S. Characterization and burden of localized back pain versus back pain with chronic overlapping pain conditions. Pain Pract. 2023;23(8):904&#x2013;13. 10.1111/papr.13267.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">37392043</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Ickmans K, Meeus M, De Kooning M, Lambrecht L, Pattyn N, Nijs J. Associations between cognitive performance and pain in chronic fatigue syndrome: comorbidity with fibromyalgia does matter. Physiotherapy. 2015;101:e635&#x2013;6. 10.1016/j.physio.2015.03.3465.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">26431138</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>McDonagh MS, Selph SS, Buckley DI, Holmes RS, Mauer K, Ramirez S, Hsu FC, Dana T, Fu R, Chou R. Nonopioid pharmacologic treatments for chronic pain. Comparative effectiveness review No. 228. (prepared by the Pacific Northwest Evidence-based Practice Center under contract No. 290-2015-00009-I.) AHRQ publication No. 20-EHC010. Rockville: Agency for Healthcare Research and Quality; 2020. 10.23970/AHRQEPCCER228.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">32338847</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC clinical practice guideline for prescribing opioids for pain&#x2014;United States, 2022. MMWR Recommend Rep. 2022;71(3):1. 10.15585/mmwr.rr7103a1.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC9639433</ArticleId>
						<ArticleId IdType="pubmed">36327391</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Lacy BE, Pimentel M, Brenner DM, et al. ACG Clinical Guideline: management of irritable bowel syndrome. Official J Am Coll Gastroenterol | ACG. 2021;116(1). 10.14309/ajg.0000000000001036.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">33315591</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Clemens JQ, Erickson DR, Varela NP, Lai HH. Diagnosis and treatment of interstitial Cystitis/Bladder Pain Syndrome. J Urol. 2022;208(1):34&#x2013;42. 10.1097/JU.0000000000002756.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">35536143</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Busse JW, Casassus R, Carrasco-Labra A, Durham J, Mock D, Zakrzewska JM, et al. Management of chronic pain associated with temporomandibular disorders: a clinical practice guideline. BMJ. 2023;383:e076227. 10.1136/bmj-2023-076227.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">38101929</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Hovaguimian A, Roth J. Management of chronic migraine. BMJ. 2022;379:e067670. 10.1136/bmj-2021-067670.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">36216384</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Becker CM, Bokor A, Heikinheimo O, Horne A, Jansen F, Kiesel L, King K, Kvaskoff M, Nap A, Petersen K, Saridogan E. ESHRE guideline: endometriosis. Hum Reprod open. 2022;2022(2):hoac009. 10.1093/hropen/hoac009.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC8951218</ArticleId>
						<ArticleId IdType="pubmed">35350465</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Schlaeger JM, Glayzer JE, Villegas-Downs M, Li H, Glayzer EJ, He Y, et al. Evaluation and treatment of Vulvodynia: state of the Science. J Midwifery Women&#x2019;s Health. 2022;68:9&#x2013;34. 10.1111/jmwh.13456.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC10107324</ArticleId>
						<ArticleId IdType="pubmed">36533637</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Unger ER, Lin JMS, Brimmer DJ, et al. CDC grand rounds: chronic fatigue syndrome&#x2014;advancing research and clinical education. MMWR Morbidity Mortal Wkly Rep. 2016;65:1434&#x2013;8. 10.15585/mmwr.mm655051a4.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">28033311</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Skelly AC, Chou R, Dettori JR, Turner JA, Friedly JL, Rundell SD, Fu R, Brodt ED, Wasson N, Kantner S, Ferguson AJR. April. Noninvasive Nonpharmacological Treatment for Chronic Pain: A Systematic Review Update. Comparative Effectiveness Review No. 227. (Prepared by the Pacific Northwest Evidence-based Practice Center under Contract No. 290-2015-00009-I.) AHRQ Publication No. 20-EHC009. Rockville, MD: Agency for Healthcare Research and Quality; 2020. 10.23970/AHRQEPCCER227</Citation>
				</Reference>
			</ReferenceList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Status="Publisher" Owner="NLM">
			<PMID Version="1">39423465</PMID>
			<DateRevised>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>18</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1879-1360</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>187</Volume>
						<PubDate>
							<Year>2024</Year>
							<Month>Oct</Month>
							<Day>11</Day>
						</PubDate>
					</JournalIssue>
					<Title>Journal of psychosomatic research</Title>
					<ISOAbbreviation>J Psychosom Res</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Predictors of treatment response trajectories to cognitive behavioral therapy for chronic fatigue syndrome: A cohort study.</ArticleTitle>
				<Pagination>
					<StartPage>111954</StartPage>
					<MedlinePgn>111954</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jpsychores.2024.111954</ELocationID>
				<ELocationID EIdType="pii" ValidYN="Y">S0022-3999(24)00366-0</ELocationID>
				<Abstract>
					<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The response to cognitive behavioral therapy (CBT) for chronic fatigue syndrome (CFS) varies greatly between patients, but predictors of treatment success remain to be elucidated. We aimed to identify patient subgroups based on fatigue trajectory during CBT, identify pre-treatment predictors of subgroup membership, and disentangle the direction of predictor - outcome relationships over time.</AbstractText>
					<AbstractText Label="METHODS" NlmCategory="METHODS">297 individuals with CFS were enrolled in a standardized CBT program consisting of 17 sessions, with session timing variable between participants. Self-reported levels of fatigue, depressive, anxiety, and somatic symptoms, perceived stress, and positive affect were collected pre-treatment, and after 3, 10, and 15 sessions. Latent Class Growth Analysis (LCGA) was used to identify subgroups based on fatigue trajectories and baseline predictors of group membership. Cross-lagged structural equation models were used to disentangle predictor-outcome relationships.</AbstractText>
					<AbstractText Label="RESULTS" NlmCategory="RESULTS">LCGA identified four fatigue trajectory subgroups, which were labelled as "no improvement" (23&#xa0;%), "weak improvement" (45&#xa0;%), "moderate improvement" (23&#xa0;%), and "strong improvement" (9&#xa0;%) classes. Higher pre-treatment levels of depressive, anxiety, and somatic symptoms, stress, and lower levels of positive affect predicted membership of the "no improvement" subgroup. Reductions in anxiety preceded reductions in fatigue, while the depressive symptoms - fatigue relationship was bidirectional.</AbstractText>
					<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">On a group level, there were statistically significant reductions in fatigue after 15 sessions of CBT, with important individual differences in treatment response. Higher pre-treatment levels of anxious, depressive, and somatic symptoms and perceived stress are predictors of lack of response, with reductions in anxiety and stress preceding improvements in fatigue.</AbstractText>
					<CopyrightInformation>Copyright &#xa9; 2024. Published by Elsevier Inc.</CopyrightInformation>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Van Oudenhove</LastName>
						<ForeName>Lukas</ForeName>
						<Initials>L</Initials>
						<AffiliationInfo>
							<Affiliation>Laboratory for Brain-Gut Axis Studies (LaBGAS), Translational Research in Gastrointestinal Disorders (TARGID), Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, Leuven, Belgium; Leuven Brain Institute, KU Leuven, Leuven, Belgium; Cognitive &amp; Affective Neuroscience Lab (CANLab), Department of Psychological and Brain Sciences, Dartmouth College, Hanover, NH, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Debyser</LastName>
						<ForeName>Soetkin</ForeName>
						<Initials>S</Initials>
						<AffiliationInfo>
							<Affiliation>Laboratory for Brain-Gut Axis Studies (LaBGAS), Translational Research in Gastrointestinal Disorders (TARGID), Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, Leuven, Belgium.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Vergaelen</LastName>
						<ForeName>Elfi</ForeName>
						<Initials>E</Initials>
						<AffiliationInfo>
							<Affiliation>University Psychiatric Center KU Leuven, University Hospital Leuven, Leuven, Belgium; Mind Body Research, Psychiatry Research Group, Department of Neurosciences, KULeuven, Leuven, Belgium.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Claes</LastName>
						<ForeName>Stephan</ForeName>
						<Initials>S</Initials>
						<AffiliationInfo>
							<Affiliation>University Psychiatric Center KU Leuven, University Hospital Leuven, Leuven, Belgium; Mind Body Research, Psychiatry Research Group, Department of Neurosciences, KULeuven, Leuven, Belgium.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Van Den Houte</LastName>
						<ForeName>Maaike</ForeName>
						<Initials>M</Initials>
						<AffiliationInfo>
							<Affiliation>Laboratory for Brain-Gut Axis Studies (LaBGAS), Translational Research in Gastrointestinal Disorders (TARGID), Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, Leuven, Belgium; Leuven Brain Institute, KU Leuven, Leuven, Belgium; REVAL - Rehabilitation Research Center, Faculty of Rehabilitation Sciences, Hasselt University, Diepenbeek, Belgium. Electronic address: maaike.vandenhoute@kuleuven.be.</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>11</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>England</Country>
				<MedlineTA>J Psychosom Res</MedlineTA>
				<NlmUniqueID>0376333</NlmUniqueID>
				<ISSNLinking>0022-3999</ISSNLinking>
			</MedlineJournalInfo>
			<CitationSubset>IM</CitationSubset>
			<KeywordList Owner="NOTNLM">
				<Keyword MajorTopicYN="N">Chronic fatigue syndrome</Keyword>
				<Keyword MajorTopicYN="N">Cognitive behavioral therapy</Keyword>
				<Keyword MajorTopicYN="N">Cross-lagged panel models</Keyword>
				<Keyword MajorTopicYN="N">Predictors</Keyword>
			</KeywordList>
			<CoiStatement>Declaration of competing interest Elfi Vergaelen has been coordinator of the multidisciplinary diagnostic CFS center and Stephan Claes is coordinator of the multidisciplinary diagnostic CFS center which is subsidized by the Belgian social security system (RIZIV).</CoiStatement>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="received">
					<Year>2024</Year>
					<Month>6</Month>
					<Day>10</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="revised">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>8</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="accepted">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>9</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>18</Day>
					<Hour>18</Hour>
					<Minute>22</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>18</Day>
					<Hour>18</Hour>
					<Minute>22</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>18</Day>
					<Hour>18</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>aheadofprint</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pubmed">39423465</ArticleId>
				<ArticleId IdType="doi">10.1016/j.jpsychores.2024.111954</ArticleId>
				<ArticleId IdType="pii">S0022-3999(24)00366-0</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
			<PMID Version="1">39418958</PMID>
			<DateCompleted>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>26</Day>
			</DateCompleted>
			<DateRevised>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>26</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1876-035X</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>17</Volume>
						<Issue>11</Issue>
						<PubDate>
							<Year>2024</Year>
							<Month>Nov</Month>
						</PubDate>
					</JournalIssue>
					<Title>Journal of infection and public health</Title>
					<ISOAbbreviation>J Infect Public Health</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Risk of chronic fatigue syndrome after COVID-19: A retrospective cohort study of 3227281 patients.</ArticleTitle>
				<Pagination>
					<StartPage>102559</StartPage>
					<MedlinePgn>102559</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jiph.2024.102559</ELocationID>
				<ELocationID EIdType="pii" ValidYN="Y">S1876-0341(24)00293-4</ELocationID>
				<Abstract>
					<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Many patients who recovered from COVID-19 still suffer from chronic fatigue syndrome (CFS). It was observed that patients with comorbidities were more prone to developing CFS. This research investigates the risk of post-COVID-19 CFS to assist healthcare professionals in reducing the risk of CFS.</AbstractText>
					<AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective cohort study is conducted to investigate the risk of post-COVID-19 CFS based on the TriNetX-sourced electronic health records. Factors including age, sex, race, vaccination, and severity of COVID-19 are analysed. Propensity score matching was applied to balance COVID-19 and non-COVID-19 cohorts. Kaplan-Meier analysis and Cox proportional hazard model were used to perform the relationship between COVID-19 and CFS risk.</AbstractText>
					<AbstractText Label="RESULTS" NlmCategory="RESULTS">This research involved 3227281 patients with COVID-19 and 3227281 with non-COVID-19 between 1st January 2020 and 31st December 2023. The incidence of CFS was higher in the COVID-19 group compared to the non-COVID-19 group at 1 follow-up intervals (HR 1.59, 95&#xa0;% CI = 1.54-1.63). Subgroup analysis revealed increased CFS risk across different age groups (&gt;18), sexes, races, and comorbid conditions, with notable variations.</AbstractText>
					<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">COVID-19 patients have a higher risk of developing CFS compared to individuals without COVID-19. The increased risk is particularly significant in adults aged 18 years and older.</AbstractText>
					<CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Chen</LastName>
						<ForeName>Chih-Wei</ForeName>
						<Initials>CW</Initials>
						<AffiliationInfo>
							<Affiliation>National Yang Ming Chiao Tung University, Hsinchu, Taiwan; National Council for Sustainable Development (NCSD), Executive Yuan, Taiwan Govt, Taiwan; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; University College London, London, UK.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Lee</LastName>
						<ForeName>Hsun-Hua</ForeName>
						<Initials>HH</Initials>
						<AffiliationInfo>
							<Affiliation>Department of Neurology, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan; Department of Neurology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Dizziness and Balance Disorder Center, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan; Department of Neurology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan; Dizziness and Balance Disorder Center, Taipei Medical University Hospital, Taipei Medical University, Taipei City, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Chang</LastName>
						<ForeName>Shu-Hao</ForeName>
						<Initials>SH</Initials>
						<AffiliationInfo>
							<Affiliation>Division of Pulmonary Medicine, Department of Internal Medicine, Cheng Ching Hospital, Taichung, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Chen</LastName>
						<ForeName>Yi-Ling</ForeName>
						<Initials>YL</Initials>
						<AffiliationInfo>
							<Affiliation>Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Cheng Ching Hospital, Taichung, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Wang</LastName>
						<ForeName>Yu-Hsun</ForeName>
						<Initials>YH</Initials>
						<AffiliationInfo>
							<Affiliation>Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Leong</LastName>
						<ForeName>Pui-Ying</ForeName>
						<Initials>PY</Initials>
						<AffiliationInfo>
							<Affiliation>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Division of Allergy, Immunology &amp; Rheumatology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan. Electronic address: fiona.leong@gmail.com.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Wei</LastName>
						<ForeName>James Cheng-Chung</ForeName>
						<Initials>JC</Initials>
						<AffiliationInfo>
							<Affiliation>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Division of Allergy, Immunology &amp; Rheumatology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan; Department of Nursing, Chung Shan Medical University, Taichung, Taiwan; Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan; Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan. Electronic address: jccwei@gmail.com.</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>03</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>England</Country>
				<MedlineTA>J Infect Public Health</MedlineTA>
				<NlmUniqueID>101487384</NlmUniqueID>
				<ISSNLinking>1876-0341</ISSNLinking>
			</MedlineJournalInfo>
			<CitationSubset>IM</CitationSubset>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
					<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
				</MeshHeading>
			</MeshHeadingList>
			<KeywordList Owner="NOTNLM">
				<Keyword MajorTopicYN="N">COVID-19</Keyword>
				<Keyword MajorTopicYN="N">Chronic fatigue syndrome</Keyword>
				<Keyword MajorTopicYN="N">Hypertensive disease</Keyword>
				<Keyword MajorTopicYN="N">Ischemic heart diseases</Keyword>
				<Keyword MajorTopicYN="N">Overweight and obesity</Keyword>
			</KeywordList>
			<CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="received">
					<Year>2024</Year>
					<Month>4</Month>
					<Day>30</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="revised">
					<Year>2024</Year>
					<Month>9</Month>
					<Day>5</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="accepted">
					<Year>2024</Year>
					<Month>9</Month>
					<Day>30</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>27</Day>
					<Hour>17</Hour>
					<Minute>12</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>18</Day>
					<Hour>7</Hour>
					<Minute>19</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>17</Day>
					<Hour>18</Hour>
					<Minute>9</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pubmed">39418958</ArticleId>
				<ArticleId IdType="doi">10.1016/j.jiph.2024.102559</ArticleId>
				<ArticleId IdType="pii">S1876-0341(24)00293-4</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Status="Publisher" Owner="NLM">
			<PMID Version="1">39405447</PMID>
			<DateRevised>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>15</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1469-7793</ISSN>
					<JournalIssue CitedMedium="Internet">
						<PubDate>
							<Year>2024</Year>
							<Month>Oct</Month>
							<Day>15</Day>
						</PubDate>
					</JournalIssue>
					<Title>The Journal of physiology</Title>
					<ISOAbbreviation>J Physiol</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Sweet relief: make the brain Glo against diabetic cognitive fog.</ArticleTitle>
				<ELocationID EIdType="doi" ValidYN="Y">10.1113/JP287622</ELocationID>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Dabertrand</LastName>
						<ForeName>Fabrice</ForeName>
						<Initials>F</Initials>
						<Identifier Source="ORCID">0000-0003-2541-9185</Identifier>
						<AffiliationInfo>
							<Affiliation>Department of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation>
						</AffiliationInfo>
						<AffiliationInfo>
							<Affiliation>Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<GrantList CompleteYN="Y">
					<Grant>
						<GrantID>MDBR-23-025-CADASIL</GrantID>
						<Agency>Orphan Disease Center, Perelman School of Medicine, University of Pennsylvania (ODC)</Agency>
						<Country/>
					</Grant>
					<Grant>
						<GrantID>RF1NS140137</GrantID>
						<Agency>National Institute of Neurological Disorders and Stroke (NINDS)</Agency>
						<Country/>
					</Grant>
					<Grant>
						<GrantID>RF1NS129022</GrantID>
						<Agency>National Institute of Neurological Disorders and Stroke (NINDS)</Agency>
						<Country/>
					</Grant>
					<Grant>
						<GrantID>R01HL136636</GrantID>
						<Agency>National Heart, Lung, and Blood Institute (NHLBI)</Agency>
						<Country/>
					</Grant>
					<Grant>
						<Agency>Leducq Foundation for Cardiovascular Research (Leducq Transatlantic Network of Excellence 22CVD01 BRENDA)</Agency>
						<Country/>
					</Grant>
				</GrantList>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>15</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>England</Country>
				<MedlineTA>J Physiol</MedlineTA>
				<NlmUniqueID>0266262</NlmUniqueID>
				<ISSNLinking>0022-3751</ISSNLinking>
			</MedlineJournalInfo>
			<CitationSubset>IM</CitationSubset>
			<KeywordList Owner="NOTNLM">
				<Keyword MajorTopicYN="N">diabetes</Keyword>
				<Keyword MajorTopicYN="N">methylglyoxal</Keyword>
				<Keyword MajorTopicYN="N">neurovascular coupling</Keyword>
				<Keyword MajorTopicYN="N">vascular contribution to cognitive impairment and dementia</Keyword>
			</KeywordList>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="received">
					<Year>2024</Year>
					<Month>9</Month>
					<Day>30</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="accepted">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>3</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>15</Day>
					<Hour>18</Hour>
					<Minute>22</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>15</Day>
					<Hour>18</Hour>
					<Minute>22</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>15</Day>
					<Hour>15</Hour>
					<Minute>13</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>aheadofprint</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pubmed">39405447</ArticleId>
				<ArticleId IdType="doi">10.1113/JP287622</ArticleId>
			</ArticleIdList>
			<ReferenceList>
				<Title>References</Title>
				<Reference>
					<Citation>Barbiellini Amidei, C., Fayosse, A., Dumurgier, J., Machado&#x2010;Fragua, M. D., Tabak, A. G., van Sloten, T., Kivimaki, M., Dugravot, A., Sabia, S., &amp; Singh&#x2010;Manoux, A. (2021). Association between age at diabetes onset and subsequent risk of dementia. Journal of the American Medical Association, 325(16), 1640&#x2013;1649.</Citation>
				</Reference>
				<Reference>
					<Citation>Berends, E., Pencheva, M. G., van de Waarenburg, M. P. H., Scheijen, J., Hermes, D., Wouters, K., van Oostenbrugge, R. J., Foulquier, S., &amp; Schalkwijk, C. G. (2024). Glyoxalase 1 overexpression improves neurovascular coupling and limits development of mild cognitive impairment in a mouse model of type 1 diabetes. The Journal of Physiology. Advance online publication. https://doi.org/10.1113/JP286723</Citation>
				</Reference>
				<Reference>
					<Citation>Bosetti, F., Galis, Z. S., Bynoe, M. S., Charette, M., Cipolla, M. J., del Zoppo, G. J., Gould, D., Hatsukami, T. S., Jones, T. L., Koenig, J. I., Lutty, G. A., Maric&#x2010;Bilkan, C., Stevens, T., Tolunay, H. E., Koroshetz, W., &amp; &#x201c;Small Blood Vessels: Big Health Problems&#x201d; Workshop P. (2016). &#x201c;Small Blood Vessels: Big Health Problems?&#x201d;: Scientific recommendations of the national institutes of health workshop. Journal of the American Heart Association, 5(11), e004389.</Citation>
				</Reference>
				<Reference>
					<Citation>Dabertrand, F., Harraz, O. F., Koide, M., Longden, T. A., Rosehart, A. C., Hill&#x2010;Eubanks, D. C., Joutel, A., &amp; Nelson, M. T. (2021). PIP2 corrects cerebral blood flow deficits in small vessel disease by rescuing capillary Kir2.1 activity. Proceedings of the National Academy of Sciences of the United States of America, 118(17), e2025998118.</Citation>
				</Reference>
				<Reference>
					<Citation>Schalkwijk, C. G., &amp; Stehouwer, C. D. A. (2020). Methylglyoxal, a highly reactive Dicarbonyl compound, in diabetes, its vascular complications, and other age&#x2010;related diseases. Physiological Reviews, 100(1), 407&#x2013;461.</Citation>
				</Reference>
			</ReferenceList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
			<PMID Version="1">39399822</PMID>
			<DateRevised>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>15</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Print">2213-4220</ISSN>
					<JournalIssue CitedMedium="Print">
						<Volume>13</Volume>
						<Issue>4</Issue>
						<PubDate>
							<Year>2024</Year>
							<Month>Dec</Month>
						</PubDate>
					</JournalIssue>
					<Title>Integrative medicine research</Title>
					<ISOAbbreviation>Integr Med Res</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Long-term follow-up of the treatment for severe COVID-19 with qigong exercise and acupressure: A randomized controlled trial.</ArticleTitle>
				<Pagination>
					<StartPage>101084</StartPage>
					<MedlinePgn>101084</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="pii" ValidYN="Y">101084</ELocationID>
				<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.imr.2024.101084</ELocationID>
				<Abstract>
					<AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Most clinical trials have reported significant short-term effects of traditional medicine therapies on COVID-19 patients. However, there is no clinical trial to determine the long-term effects of traditional medicine therapies on severe COVID-19 patients.</AbstractText>
					<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A total of 128 patients with severe COVID-19, who were recruited in our previous clinical trial following hospital discharge, were monitored at months 14 and 28. This trial aims to evaluate the long-term effect of an early Qigong exercise and acupressure rehabilitation program on patients with severe COVID-19.The intervention group received qigong exercise and acupressure therapy, plus standard therapies. The control group received standard therapies.The study was a single-center, parallel, randomized, prospective follow-up study. The outcomes of the study included changes in the modified Borg dyspnea scale (MBS), the modified Medical Research Council dyspnea scale (mMRC), the patient health questionnaire-9 scale (PHQ-9), the activity of daily living (ADL), the remaining clinical symptoms and any intervention related adverse events.</AbstractText>
					<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The intervention group showed a statistically significant improvement in the mMRC scores (-0.4, 95 % CI (-0.6, 0.2), 
						<i>P</i> &lt; 0.001) and the MBS scores (-0.6, 95 % CI (-0.9, -0.3), 
						<i>P</i> &lt; 0.001) after 14 months of discharge compared with the control group. At 28 months of discharge, the intervention group, compared with the control group alone, significantly increased their MBS scores (-0.4, 95 % CI (-0.7, -0.1), 
						<i>P</i> = 0.024) and a significantly decreased positive rate of dyspnea symptoms after 14 months of discharge (
						<i>P</i> &lt; 0.05). However, ADL and PHQ-9 scores showed no significant difference between the two groups during the follow-up (
						<i>P</i> &gt; 0.05).
					</AbstractText>
					<AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">QARP had long-term sustained efficacy for dyspnea, chest tightness, and cough in patients with COVID-19, especially in young and middle-aged patients, and the effect was significant at the 14th month of follow-up.</AbstractText>
					<AbstractText Label="TRIAL REGISTRATION" NlmCategory="UNASSIGNED">This trial was registered at the China Clinical Trial Registry (ChiCTR2100044572).</AbstractText>
					<CopyrightInformation>&#xa9; 2024 Korea Institute of Oriental Medicine. Published by Elsevier B.V.</CopyrightInformation>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Liu</LastName>
						<ForeName>Shuting</ForeName>
						<Initials>S</Initials>
						<AffiliationInfo>
							<Affiliation>School of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation>
						</AffiliationInfo>
						<AffiliationInfo>
							<Affiliation>Department of Rehabilitation Medicine, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China.</Affiliation>
						</AffiliationInfo>
						<AffiliationInfo>
							<Affiliation>Department of Rehabilitation Medicine, Suzhou Hospital of Traditional Chinese Medicine, Suzhou, China.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Zhu</LastName>
						<ForeName>Ranran</ForeName>
						<Initials>R</Initials>
						<AffiliationInfo>
							<Affiliation>School of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Yao</LastName>
						<ForeName>Chongjie</ForeName>
						<Initials>C</Initials>
						<AffiliationInfo>
							<Affiliation>School of Acupuncture-Moxibustion and Tuina, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation>
						</AffiliationInfo>
						<AffiliationInfo>
							<Affiliation>Department of Rehabilitation Medicine, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Zhan</LastName>
						<ForeName>Chao</ForeName>
						<Initials>C</Initials>
						<AffiliationInfo>
							<Affiliation>Department of Rehabilitation Medicine, Huangshi Hospital of Traditional Chinese Medicine, Hubei, China.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Wang</LastName>
						<ForeName>Jinxiang</ForeName>
						<Initials>J</Initials>
						<AffiliationInfo>
							<Affiliation>School of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Fang</LastName>
						<ForeName>Min</ForeName>
						<Initials>M</Initials>
						<AffiliationInfo>
							<Affiliation>Department of Rehabilitation Medicine, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Fang</LastName>
						<ForeName>Lei</ForeName>
						<Initials>L</Initials>
						<AffiliationInfo>
							<Affiliation>School of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation>
						</AffiliationInfo>
						<AffiliationInfo>
							<Affiliation>Department of Rehabilitation Medicine, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China.</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2024</Year>
					<Month>09</Month>
					<Day>05</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>Netherlands</Country>
				<MedlineTA>Integr Med Res</MedlineTA>
				<NlmUniqueID>101612707</NlmUniqueID>
				<ISSNLinking>2213-4220</ISSNLinking>
			</MedlineJournalInfo>
			<KeywordList Owner="NOTNLM">
				<Keyword MajorTopicYN="N">Acupressure</Keyword>
				<Keyword MajorTopicYN="N">COVID-19</Keyword>
				<Keyword MajorTopicYN="N">Qigong</Keyword>
				<Keyword MajorTopicYN="N">Randomized controlled trial</Keyword>
			</KeywordList>
			<CoiStatement>The authors declare no conflict of interests.</CoiStatement>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="received">
					<Year>2024</Year>
					<Month>4</Month>
					<Day>12</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="revised">
					<Year>2024</Year>
					<Month>7</Month>
					<Day>30</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="accepted">
					<Year>2024</Year>
					<Month>9</Month>
					<Day>2</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>14</Day>
					<Hour>16</Hour>
					<Minute>19</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>14</Day>
					<Hour>16</Hour>
					<Minute>18</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>14</Day>
					<Hour>7</Hour>
					<Minute>29</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pmc-release">
					<Year>2024</Year>
					<Month>9</Month>
					<Day>5</Day>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pubmed">39399822</ArticleId>
				<ArticleId IdType="pmc">PMC11465148</ArticleId>
				<ArticleId IdType="doi">10.1016/j.imr.2024.101084</ArticleId>
				<ArticleId IdType="pii">S2213-4220(24)00064-7</ArticleId>
			</ArticleIdList>
			<ReferenceList>
				<Reference>
					<Citation>Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J] Lancet. 2020;395(10223):497&#x2013;506.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC7159299</ArticleId>
						<ArticleId IdType="pubmed">31986264</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. Accessed 17 February 2023. https://Covid19.who.int/.</Citation>
				</Reference>
				<Reference>
					<Citation>Yang X., Hou C., Shen Y., et al. Two-year health outcomes in hospitalized COVID-19 survivors in China. JAMA Netw Open. 2022;5(9) doi: 10.1001/jamanetworkopen.2022.31790.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1001/jamanetworkopen.2022.31790</ArticleId>
						<ArticleId IdType="pmc">PMC9478774</ArticleId>
						<ArticleId IdType="pubmed">36107425</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Feng F., Tuchman S., Denninger J.W., Fricchione G.L., Yeung A. Qigong for the prevention, treatment, and rehabilitation of COVID-19 infection in older adults. Am J Geriatr Psychiatry. 2020;28(8):812&#x2013;819. doi: 10.1016/j.jagp.2020.05.012.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/j.jagp.2020.05.012</ArticleId>
						<ArticleId IdType="pmc">PMC7227578</ArticleId>
						<ArticleId IdType="pubmed">32425471</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Polkey M.I., Qiu Z.H., Zhou L., et al. Tai Chi and pulmonary rehabilitation compared for treatment-naive patients with COPD: a randomized controlled trial. Chest. 2018;153(5):1116&#x2013;1124. doi: 10.1016/j.chest.2018.01.053.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/j.chest.2018.01.053</ArticleId>
						<ArticleId IdType="pubmed">29625777</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Xiao C.M., Zhuang Y.C. Efficacy of liuzijue qigong in individuals with chronic obstructive pulmonary disease in remission. J Am Geriatr Soc. 2015;63(7):1420&#x2013;1425. doi: 10.1111/jgs.13478.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1111/jgs.13478</ArticleId>
						<ArticleId IdType="pubmed">26131612</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Bi J., Yang W., Hao P., et al. WeChat as a platform for baduanjin intervention in patients with stable chronic obstructive pulmonary disease in China: retrospective randomized controlled trial. JMIR Mhealth Uhealth. 2021;9(2):e23548. doi: 10.2196/23548.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.2196/23548</ArticleId>
						<ArticleId IdType="pmc">PMC7886617</ArticleId>
						<ArticleId IdType="pubmed">33528369</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Wu H.S., Wu S.C., Lin J.G., Lin L.C. Effectiveness of acupressure in improving dyspnoea in chronic obstructive pulmonary disease. J Adv Nurs. 2004;45(3):252&#x2013;259. doi: 10.1046/j.1365-2648.2003.02886.x.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1046/j.1365-2648.2003.02886.x</ArticleId>
						<ArticleId IdType="pubmed">14720242</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Qingguang Z., Shuaipan Z., Jingxian L.I., et al. Effectiveness of Liu-zi-jue exercise on coronavirus disease 2019 in the patients: a randomized controlled trial. J Tradit Chin Med. 2022;42(6):997&#x2013;10053. doi: 10.19852/j.cnki.jtcm.2022.06.009.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.19852/j.cnki.jtcm.2022.06.009</ArticleId>
						<ArticleId IdType="pmc">PMC9924758</ArticleId>
						<ArticleId IdType="pubmed">36378059</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Tang Y., Jiang J., Shen P., et al. Liuzijue is a promising exercise option for rehabilitating discharged COVID-19 patients. Medicine (Baltimore) 2021;100(6):e24564. doi: 10.1097/MD.0000000000024564.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1097/MD.0000000000024564</ArticleId>
						<ArticleId IdType="pmc">PMC7886442</ArticleId>
						<ArticleId IdType="pubmed">33578552</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Zha L., Xu X., Wang D., Qiao G., Zhuang W., Huang S. Modified rehabilitation exercises for mild cases of COVID-19. Ann Palliat Med. 2020;9(5):3100&#x2013;3106. doi: 10.21037/apm-20-753.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.21037/apm-20-753</ArticleId>
						<ArticleId IdType="pubmed">32787373</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Liu S.T., Zhan C., Ma Y.J., et al. Effect of qigong exercise and acupressure rehabilitation program on pulmonary function and respiratory symptoms in patients hospitalized with severe COVID-19: a randomized controlled trial. Integr Med Res. 2021;10 doi: 10.1016/j.imr.2021.100796. Suppl.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/j.imr.2021.100796</ArticleId>
						<ArticleId IdType="pmc">PMC8553411</ArticleId>
						<ArticleId IdType="pubmed">34733607</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Junfang J., Yingchun H., Qiang L., Meng S. The effect of Liuzijue breathingexercises combined with acupoint massage on improving lung function and quality of life in elderly patients with COPD. Chin Mod Doct. 2019;57(27):100&#x2013;103.</Citation>
				</Reference>
				<Reference>
					<Citation>Zhang S., Zhu Q., Zhan C., et al. Acupressure therapy and Liu Zi Jue Qigong for pulmonary function and quality of life in patients with severe novel coronavirus pneumonia (COVID-19): a study protocol for a randomized controlled trial. Trials. 2020;21(1):751. doi: 10.1186/s13063-020-04693-5.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1186/s13063-020-04693-5</ArticleId>
						<ArticleId IdType="pmc">PMC7450683</ArticleId>
						<ArticleId IdType="pubmed">32854761</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Hygiene Emergency Office. Revision of "New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Eighth Edition)" National Health Commission of the People's Republic of China home page 2020. https://www.nhc.gov.cn. Assessed by 15 March 2021.</Citation>
				</Reference>
				<Reference>
					<Citation>Bestall J.C., Paul E.A., Garrod R., Garnham R., Jones P.W., Wedzicha J.A. Usefulness of the medical research council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581&#x2013;586. doi: 10.1136/thx.54.7.581.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1136/thx.54.7.581</ArticleId>
						<ArticleId IdType="pmc">PMC1745516</ArticleId>
						<ArticleId IdType="pubmed">10377201</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Yasui H., Inui N., Karayama M., et al. Correlation of the modified medical research council dyspnea scale with airway structure assessed by three-dimensional CT in patients with chronic obstructive pulmonary disease. Respir Med. 2019;146:76&#x2013;80. doi: 10.1016/j.rmed.2018.11.020.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/j.rmed.2018.11.020</ArticleId>
						<ArticleId IdType="pubmed">30665522</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Kendrick K.R., Baxi S.C., Smith R.M. Usefulness of the modified 0-10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma. J Emerg Nurs. 2000;26(3):216&#x2013;222. doi: 10.1016/s0099-1767(00)90093-x.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/s0099-1767(00)90093-x</ArticleId>
						<ArticleId IdType="pubmed">10839848</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Levis B., Benedetti A., Thombs B.D. DEPRESsion screening data (DEPRESSD) collaboration. accuracy of patient health questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. BMJ. 2019;365:l1476. doi: 10.1136/bmj.l1476.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1136/bmj.l1476</ArticleId>
						<ArticleId IdType="pmc">PMC6454318</ArticleId>
						<ArticleId IdType="pubmed">30967483</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606&#x2013;613. doi: 10.1046/j.1525-1497.2001.016009606.x.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1046/j.1525-1497.2001.016009606.x</ArticleId>
						<ArticleId IdType="pmc">PMC1495268</ArticleId>
						<ArticleId IdType="pubmed">11556941</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Desveaux L., Janaudis-Ferreira T., Goldstein R., Brooks D. An international comparison of pulmonary rehabilitation: a systematic review. COPD. 2015;12(2):144&#x2013;153. doi: 10.3109/15412555.2014.922066.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.3109/15412555.2014.922066</ArticleId>
						<ArticleId IdType="pubmed">24984085</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>World Health Organization. The Who Global Report on Traditional and Complementary Medicine 2019 Is Released. Published 2019. Accessed Oct 01, 2022. https://www.who.int/news/item/20-05-2019-the-who-global-report-on-traditional-and-complementary-medicine-2019-is-released.</Citation>
				</Reference>
				<Reference>
					<Citation>Ara&#xfa;jo Oliveira Ana Luisa, L&#xed;lia Andrade, Alda Marques. Minimal clinically important difference and predictive validity of the mMRC and mBorg in acute exacerbations of COPD[J] Eur Respiratory J. 2017;50(61) s.</Citation>
				</Reference>
				<Reference>
					<Citation>Jones P.W., Beeh K.M., Chapman K.R., et al. Minimal clinically important differences in pharmacological trials[J] Am J Respir Crit Care Med. 2014;189(3):250&#x2013;255.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">24383418</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Hu X.Y. Clinical efficacy of acupressure combined with traditional Chinese medicine application in the treatment of acute exacerbation of chronic obstructive pulmonary disease and its effect on inflammatory indexes. Chinese Folk Therapy. 2023;31(10):42&#x2013;45. doi: 10.19621/j.cnki.11-3555/r.2023.1014.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.19621/j.cnki.11-3555/r.2023.1014</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Jiang L.Y., Fang Y., Li Q. Clinical study of Xuanfei decoction combined with traditional Chinese medicine acupoint patch for the treatment of acute exacerbation of chronic obstructive pulmonary disease combined with respiratory failure. New Chinese Medicine. 2023;55(20):153&#x2013;157. doi: 10.13457/j.cnki.jncm.2023.20.031.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.13457/j.cnki.jncm.2023.20.031</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Hu J., Gao R., Wang Y., et al. Effect of Liuzijue on pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: study protocol for a multicenter, non-randomized, prospective study. BMC Complement Med Ther. 2022;22(1):296. doi: 10.1186/s12906-022-03789-6.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1186/s12906-022-03789-6</ArticleId>
						<ArticleId IdType="pmc">PMC9670448</ArticleId>
						<ArticleId IdType="pubmed">36397066</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>de Torres J.P., Pinto-Plata V., Ingenito E., et al. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest. 2002;121(4):1092&#x2013;1098. doi: 10.1378/chest.121.4.1092.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1378/chest.121.4.1092</ArticleId>
						<ArticleId IdType="pubmed">11948037</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Sunjaya A., Poulos L., Reddel H., Jenkins C. Qualitative validation of the modified Medical Research Council (mMRC) dyspnoea scale as a patient-reported measure of breathlessness severity. Respir Med. 2022;203 doi: 10.1016/j.rmed.2022.106984.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/j.rmed.2022.106984</ArticleId>
						<ArticleId IdType="pubmed">36179385</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Janssens J.P., Pache J.C., Nicod L.P. Physiological changes in respiratory func-tion associated with ageing. Eur Respir J. 1999;13(1):197&#x2013;205. doi: 10.1034/j.1399-3003.1999.13a36.x.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1034/j.1399-3003.1999.13a36.x</ArticleId>
						<ArticleId IdType="pubmed">10836348</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Lowery E.M., Brubaker A.L., Kuhlmann E., Kovacs E.J. The aging lung. Clin Interv Aging. 2013;8:1489&#x2013;1496. doi: 10.2147/CIA.S51152.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.2147/CIA.S51152</ArticleId>
						<ArticleId IdType="pmc">PMC3825547</ArticleId>
						<ArticleId IdType="pubmed">24235821</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Damayanthi H.D.W.T., Prabani K.I.P. Nutritional determinants and COVID-19 outcomes of older patients with COVID-19: a systematic review. Arch Gerontol Geriatr. 2021;95 doi: 10.1016/j.archger.2021.104411.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/j.archger.2021.104411</ArticleId>
						<ArticleId IdType="pmc">PMC8010373</ArticleId>
						<ArticleId IdType="pubmed">33836322</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Bencivenga L., Rengo G., Varricchi G. Elderly at time of COronaVIrus disease 2019 (COVID-19): possible role of immunosenescence and malnutrition. Geroscience. 2020;42(4):1089&#x2013;1092. doi: 10.1007/s11357-020-00218-9.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1007/s11357-020-00218-9</ArticleId>
						<ArticleId IdType="pmc">PMC7308600</ArticleId>
						<ArticleId IdType="pubmed">32578073</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Song W.J., Hui C.K.M., Hull J.H., et al. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir Med. 2021;9(5):533&#x2013;544. doi: 10.1016/S2213-2600(21)00125-9.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/S2213-2600(21)00125-9</ArticleId>
						<ArticleId IdType="pmc">PMC8041436</ArticleId>
						<ArticleId IdType="pubmed">33857435</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>World Health Organization. WHO Director-General's opening remarks at the media briefing. Accessed 17 February 2023. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing, 5-may-2023.</Citation>
				</Reference>
			</ReferenceList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
			<PMID Version="1">39372835</PMID>
			<DateRevised>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>08</Day>
			</DateRevised>
			<Article PubModel="Electronic-eCollection">
				<Journal>
					<ISSN IssnType="Electronic">2769-2558</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>3</Volume>
						<Issue>4</Issue>
						<PubDate>
							<Year>2024</Year>
							<Month>Dec</Month>
						</PubDate>
					</JournalIssue>
					<Title>PCN reports : psychiatry and clinical neurosciences</Title>
					<ISOAbbreviation>PCN Rep</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Comparing personality traits of healthcare workers with and without long COVID: Cross-sectional study.</ArticleTitle>
				<Pagination>
					<StartPage>e70017</StartPage>
					<MedlinePgn>e70017</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="pii" ValidYN="Y">e70017</ELocationID>
				<ELocationID EIdType="doi" ValidYN="Y">10.1002/pcn5.70017</ELocationID>
				<Abstract>
					<AbstractText Label="AIM" NlmCategory="UNASSIGNED">Pathological mechanisms of "long COVID" after recovery from the main symptoms of COVID-19 are unclear. We compared psychological differences between individuals with and without long COVID symptoms after initial COVID-19 infections.</AbstractText>
					<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This study includes medical workers with and without history of COVID-19. We assessed the degree of depression, health-related quality of life (HRQOL), the degree of anxiety and fear of COVID-19, and we used an original questionnaire. In the COVID-19 group, we also assessed personality traits and anxiety. The COVID-19 group was subclassified into those with and without long COVID to examine differences in circumstantial and psychological examinations.</AbstractText>
					<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Of 310 participants (141 men, 169 women, median age: 40 years), 167 had history of COVID-19 (83/84, 37 years) and 143 did not (58 men/85 women, 46 years). In the COVID-19 group, 26 had long COVID (12/14, 32 years) and 141 did not (58/85, 46 years). Fewer participants in the COVID-19 group had had COVID-19 vaccinations. The long COVID group had higher number of symptoms at the time of illness and higher NEO Five Factor Inventory Neuroticism scores than the non-long COVID group. They also had poorer mental health according to HRQOL than those without.</AbstractText>
					<AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Risk factors for long COVID may include the number of symptoms at the time of illness and neurotic tendency on NEO Five Factor Inventory. Participants with long COVID had poorer mental health according to HRQOL. People with long COVID might be especially sensitive to and pessimistic about the symptoms that interfere with their daily lives, resulting in certain cognitive and behavioral patterns. They may benefit from early psychiatric intervention.</AbstractText>
					<CopyrightInformation>&#xa9; 2024 The Author(s). Psychiatry and Clinical Neurosciences Reports published by John Wiley &amp; Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.</CopyrightInformation>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Sakai</LastName>
						<ForeName>Keiko</ForeName>
						<Initials>K</Initials>
						<Identifier Source="ORCID">0009-0005-8594-678X</Identifier>
						<AffiliationInfo>
							<Affiliation>Department of Rehabilitation Osaka Kawasaki Rehabilitation University Kaizuka Osaka Japan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Tarutani</LastName>
						<ForeName>Seiichiro</ForeName>
						<Initials>S</Initials>
						<AffiliationInfo>
							<Affiliation>Osaka Institute of Clinical Psychiatry Shin-Abuyama Hospital Takatsuki Osaka Japan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Okamura</LastName>
						<ForeName>Takehiko</ForeName>
						<Initials>T</Initials>
						<AffiliationInfo>
							<Affiliation>Osaka Institute of Clinical Psychiatry Shin-Abuyama Hospital Takatsuki Osaka Japan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Yoneda</LastName>
						<ForeName>Hiroshi</ForeName>
						<Initials>H</Initials>
						<AffiliationInfo>
							<Affiliation>Osaka Institute of Clinical Psychiatry Shin-Abuyama Hospital Takatsuki Osaka Japan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Kawasaki</LastName>
						<ForeName>Tatsuhito</ForeName>
						<Initials>T</Initials>
						<AffiliationInfo>
							<Affiliation>Mizuma Hospital Kaizuka Osaka Japan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Takeda</LastName>
						<ForeName>Masatoshi</ForeName>
						<Initials>M</Initials>
						<AffiliationInfo>
							<Affiliation>Department of Rehabilitation Osaka Kawasaki Rehabilitation University Kaizuka Osaka Japan.</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>05</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>Australia</Country>
				<MedlineTA>PCN Rep</MedlineTA>
				<NlmUniqueID>9918451287106676</NlmUniqueID>
				<ISSNLinking>2769-2558</ISSNLinking>
			</MedlineJournalInfo>
			<KeywordList Owner="NOTNLM">
				<Keyword MajorTopicYN="N">COVID&#x2010;19</Keyword>
				<Keyword MajorTopicYN="N">healthcare workers</Keyword>
				<Keyword MajorTopicYN="N">long COVID</Keyword>
				<Keyword MajorTopicYN="N">mental health</Keyword>
				<Keyword MajorTopicYN="N">personality traits</Keyword>
			</KeywordList>
			<CoiStatement>The authors declare no conflict of interest.</CoiStatement>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="received">
					<Year>2024</Year>
					<Month>5</Month>
					<Day>8</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="revised">
					<Year>2024</Year>
					<Month>8</Month>
					<Day>28</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="accepted">
					<Year>2024</Year>
					<Month>9</Month>
					<Day>14</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>7</Day>
					<Hour>16</Hour>
					<Minute>24</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>7</Day>
					<Hour>16</Hour>
					<Minute>23</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>7</Day>
					<Hour>6</Hour>
					<Minute>8</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pmc-release">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>5</Day>
				</PubMedPubDate>
			</History>
			<PublicationStatus>epublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pubmed">39372835</ArticleId>
				<ArticleId IdType="pmc">PMC11452823</ArticleId>
				<ArticleId IdType="doi">10.1002/pcn5.70017</ArticleId>
				<ArticleId IdType="pii">PCN570017</ArticleId>
			</ArticleIdList>
			<ReferenceList>
				<Reference>
					<Citation>
World Health Organization (WHO)
. Coronavirus disease (COVID&#x2010;19) pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (2019). Accessed 26 Dec 2023.</Citation>
				</Reference>
				<Reference>
					<Citation>
World Health Organization (WHO)
. COVID&#x2010;19 epidemiological update&#x2014;22 December 2023. https://www.who.int/publications/m/item/covid-19-epidemiological-update---22-december-2023 (2023). Accessed 26 Dec 2023.</Citation>
				</Reference>
				<Reference>
					<Citation>Alimoradi Z, Brostr&#xf6;m A, Potenza MN, Lin C&#x2010;Y, Pakpour AH. Associations between behavioral addictions and mental health concerns during the COVID&#x2010;19 pandemic: a systematic review and meta&#x2010;analysis. Curr Addict Rep. 2024;11(3):565&#x2013;587. 10.1007/s40429-024-00555-1</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1007/s40429-024-00555-1</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Kar B, Kar N, Panda MC. Social trust and COVID&#x2010;appropriate behavior: learning from the pandemic. Asian J Soc Health Behav. 2023;6(3):93&#x2013;104.</Citation>
				</Reference>
				<Reference>
					<Citation>Lopez&#x2010;Leon S, Wegman&#x2010;Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long&#x2010;term effects of COVID&#x2010;19: a systematic review and meta&#x2010;analysis. Sci Rep. 2021;11(1):16144. 10.1038/s41598-021-95565-8</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId>
						<ArticleId IdType="pmc">PMC8352980</ArticleId>
						<ArticleId IdType="pubmed">34373540</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>
World Health Organization (WHO)
. Post COVID&#x2010;19 condition (Long COVID). https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition (2022). Accessed 1 Feb 2024.</Citation>
				</Reference>
				<Reference>
					<Citation>Starcevic V, Janca A. Personality dimensions and disorders and coping with the COVID&#x2010;19 pandemic. Curr Opin Psychiatry. 2022;35(1):73&#x2013;77. 10.1097/YCO.0000000000000755</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1097/YCO.0000000000000755</ArticleId>
						<ArticleId IdType="pmc">PMC8654116</ArticleId>
						<ArticleId IdType="pubmed">34855697</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Radloff LS. The CES&#x2010;D Scale: a self&#x2010;report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385&#x2013;401.</Citation>
				</Reference>
				<Reference>
					<Citation>Shima S, Shikano T, Kitamura T, Asai M. New self&#x2010;rating scales for depression. Clin Psychiatry. 1985;27:717&#x2013;723. (in Japanese).</Citation>
				</Reference>
				<Reference>
					<Citation>Sugawara N, Kaneda A, Takahashi I, Nakaji S, Yasui&#x2010;Furukori N. Application of a stratum&#x2010;specific likelihood ratio analysis in a screen for depression among a community&#x2010;dwelling population in Japan. Neuropsychiatr Dis Treat. 2017;13:2369&#x2013;2374. 10.2147/NDT.S142517</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.2147/NDT.S142517</ArticleId>
						<ArticleId IdType="pmc">PMC5602451</ArticleId>
						<ArticleId IdType="pubmed">28979124</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Ware JE Jr., Kosinski M, Keller SD. A 12&#x2010;Item Short&#x2010;Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220&#x2013;233.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">8628042</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Fukuhara S, Suzukamo Y. Manual of SF&#x2010;36v2 Japanese version. Kyoto: Qualitest Inc.; 2004; (in Japanese).</Citation>
				</Reference>
				<Reference>
					<Citation>Fukuhara S, Ware JE Jr., Kosinski M, Wada S, Gandek B. Psychometric and clinical tests of validity of the Japanese SF&#x2010;36 Health Survey. J Clin Epidemiol. 1998;51(11):1045&#x2013;1053. 10.1016/s0895-4356(98)00096-1</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/s0895-4356(98)00096-1</ArticleId>
						<ArticleId IdType="pubmed">9817122</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Ahorsu DK, Lin C&#x2010;Y, Imani V, Saffari M, Griffiths MD, Pakpour AH. The fear of COVID&#x2010;19 scale: development and initial validation. Int J Ment Health Addict. 2022;20:1537&#x2013;1545. 10.1007/s11469-020-00270-8</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1007/s11469-020-00270-8</ArticleId>
						<ArticleId IdType="pmc">PMC7100496</ArticleId>
						<ArticleId IdType="pubmed">32226353</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Lin C&#x2010;Y, Hou W&#x2010;L, Mamun MA, Aparecido da Silva J, Broche&#x2010;P&#xe9;rez Y, Ullah I, et al. Fear of COVID&#x2010;19 Scale (FCV&#x2010;19S) across countries: measurement invariance issues. Nurs Open. 2021;8(4):1892&#x2013;1908. 10.1002/nop2.855</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1002/nop2.855</ArticleId>
						<ArticleId IdType="pmc">PMC8186712</ArticleId>
						<ArticleId IdType="pubmed">33745219</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Wakashima K, Asai K, Kobayashi D, Koiwa K, Kamoshida S, Sakuraba M. The Japanese version of the Fear of COVID&#x2010;19 scale: reliability, validity, and relation to coping behavior. PLoS One. 2020;15:e024. 10.1371/journal.pone.0241958</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1371/journal.pone.0241958</ArticleId>
						<ArticleId IdType="pmc">PMC7644080</ArticleId>
						<ArticleId IdType="pubmed">33152038</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Koiwa K, Wakashima K, Ikuta M, Asai K, Takagi G. Fear of COVID&#x2010;19 infection and related factors in Japan: a comparison of college students, pregnant women, hospital nurses and the general public. PLoS One. 2022;17(7):e0271176. 10.1371/journal.pone.0271176</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1371/journal.pone.0271176</ArticleId>
						<ArticleId IdType="pmc">PMC9278735</ArticleId>
						<ArticleId IdType="pubmed">35830424</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Costa PT Jr., McCrae RR. Revised NEO Personality Inventory (NEO PI&#x2010;R) and NEO Five&#x2010;Factor Inventory (NEO&#x2010;FFI). Florida: Psychological Assessment Resources, Inc; 1992.</Citation>
				</Reference>
				<Reference>
					<Citation>Shimonaka Y, Nakazato K, Gondo Y, Takayama M. NEO&#x2010;PI&#x2010;R, NEO&#x2010;FFI Manual for the Japanese version Revised and enlarged edition. Tokyo: Tokyo Shinri, Inc; 2011. (in Japanese).</Citation>
				</Reference>
				<Reference>
					<Citation>Narumoto J, Nakamura K, Kitabayashi Y, Shibata K, Nakamae T, Fukui K. Relationships among burnout, coping style and personality: study of Japanese professional caregivers for elderly. Psychiatry Clin Neurosci. 2008;62(2):174&#x2013;176. 10.1111/j.1440-1819.2008.01751.x</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1111/j.1440-1819.2008.01751.x</ArticleId>
						<ArticleId IdType="pubmed">18412839</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Spielberger CD. Manual for the State&#x2010;Trait Anxiety Inventory, STAI&#x2010;form Y. Palto Alto, CA: Consulting Psychologists Press; 1983.</Citation>
				</Reference>
				<Reference>
					<Citation>Hidano N, Fukuhara M, Iwawaki S, Soga S, Spielberger CD. Manual of State&#x2010;Trait Anxiety Inventory&#x2010;Form JYZ. Tokyo: Jitsumu Kyoiku&#x2010;Shuppan; 2022. (in Japanese).</Citation>
				</Reference>
				<Reference>
					<Citation>Iwata N, Mishima N, Shimizu T, Mizoue T, Fukuhara M, Hidano T, et al. The Japanese adaptation of the STAI Form Y in Japanese working adults&#x2014;the presence or absence of anxiety. Ind Health. 1998;36:8&#x2013;13.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">9473852</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>
Ministry of Health, Labour and Welfare
. The domestic occurrence status of novel coronavirus infection in Japan. (2023). https://www.mhlw.go.jp/stf/covid-19/kokunainohasseijoukyou.html. Accessed 25 Mar 2024.</Citation>
				</Reference>
				<Reference>
					<Citation>
National Institute of Infectious Diseases
. Current Situation of Infection, January 11, 2023. https://www.niid.go.jp/niid/en/2019-ncov-e/11761-covid19-ab113th-en.html (2023). Accessed 25 Mar 2024.</Citation>
				</Reference>
				<Reference>
					<Citation>Guedes AR, Oliveira MS, Tavares BM, Luna&#x2010;Muschi A, Lazari CS, Montal AC, et al. Reinfection rate in a cohort of healthcare workers over 2 years of the COVID&#x2010;19 pandemic. Sci Rep. 2023;13(1):712. 10.1038/s41598-022-25908-6</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1038/s41598-022-25908-6</ArticleId>
						<ArticleId IdType="pmc">PMC9837751</ArticleId>
						<ArticleId IdType="pubmed">36639411</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA&#x2010;1273 SARS&#x2010;CoV&#x2010;2 Vaccine. N Engl J Med. 2021;384(5):403&#x2013;416. 10.1056/NEJMoa2035389</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1056/NEJMoa2035389</ArticleId>
						<ArticleId IdType="pmc">PMC7787219</ArticleId>
						<ArticleId IdType="pubmed">33378609</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Lin C&#x2010;Y, Fan C&#x2010;W, Ahorsu DK, Lin YC, Weng H&#x2010;C, Griffiths MD. Associations between vaccination and quality of life among Taiwan general population: a comparison between COVID&#x2010;19 vaccines and flu vaccines. Hum Vaccines Immunother. 2022;18(5):2079344. 10.1080/21645515.2022.2079344</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1080/21645515.2022.2079344</ArticleId>
						<ArticleId IdType="pmc">PMC9621022</ArticleId>
						<ArticleId IdType="pubmed">35679589</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;146. 10.1038/s41579-022-00846-2</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId>
						<ArticleId IdType="pmc">PMC9839201</ArticleId>
						<ArticleId IdType="pubmed">36639608</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Renaud&#x2010;Charest O, Lui LMW, Eskander S, Ceban F, Ho R, Di Vincenzo JD, et al. Onset and frequency of depression in post&#x2010;COVID&#x2010;19 syndrome: a systematic review. J Psychiatr Res. 2021;144:129&#x2013;137. 10.1016/j.jpsychires.2021.09.054</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/j.jpsychires.2021.09.054</ArticleId>
						<ArticleId IdType="pmc">PMC8482840</ArticleId>
						<ArticleId IdType="pubmed">34619491</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Rass V, Beer R, Schiefecker AJ, Kofler M, Lindner A, Mahlknecht P, et al. Neurological outcome and quality of life 3 months after COVID&#x2010;19: a prospective observational cohort study. Eur J Neurol. 2021;28(10):3348&#x2013;3359. 10.1111/ene.14803</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1111/ene.14803</ArticleId>
						<ArticleId IdType="pmc">PMC8250725</ArticleId>
						<ArticleId IdType="pubmed">33682276</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Takao M, Ohira M. Neurological post&#x2010;acute sequelae of SARS&#x2010;CoV&#x2010;2 infection. Psychiatry Clin Neurosci. 2023;77(2):72&#x2013;83. 10.1111/pcn.13481</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1111/pcn.13481</ArticleId>
						<ArticleId IdType="pmc">PMC9538807</ArticleId>
						<ArticleId IdType="pubmed">36148558</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Yong SJ. Long COVID or post&#x2010;COVID&#x2010;19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis. 2021;53(10):737&#x2013;754. 10.1080/23744235.2021.1924397</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId>
						<ArticleId IdType="pmc">PMC8146298</ArticleId>
						<ArticleId IdType="pubmed">34024217</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Watanabe A, Iwagami M, Yasuhara J, Takagi H, Kuno T. Protective effect of COVID&#x2010;19 vaccination against long COVID syndrome: a systematic review and meta&#x2010;analysis. Vaccine. 2023;41(11):1783&#x2013;1790. 10.1016/j.vaccine.2023.02.008</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/j.vaccine.2023.02.008</ArticleId>
						<ArticleId IdType="pmc">PMC9905096</ArticleId>
						<ArticleId IdType="pubmed">36774332</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Fergusson DM, Horwood LJ, Lawton JM. The relationships between neuroticism and depressive symptoms. Soc Psychiatry Psychiatr Epidemiol. 1989;24(6):275&#x2013;281. 10.1007/BF01788029</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1007/BF01788029</ArticleId>
						<ArticleId IdType="pubmed">2512644</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Sado M, Yamauchi K, Kawakami N, Ono Y, Furukawa TA, Tsuchiya M, et al. Cost of depression among adults in Japan in 2005. Psychiatry Clin Neurosci. 2011;65(5):442&#x2013;450. 10.1111/j.1440-1819.2011.02237.x</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1111/j.1440-1819.2011.02237.x</ArticleId>
						<ArticleId IdType="pubmed">21851453</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>
Ministry of Health, Labour and Welfare
. It's turned to the analysis of labor economy&#x2010;continuous pay raise. 2023. https://www.mhlw.go.jp/wp/hakusyo/roudou/23/dl/23-1.pdf. Accessed 26 Sep 2024.</Citation>
				</Reference>
				<Reference>
					<Citation>
Ministry of Health, Labour and Welfare
. Suicide Prevention Whitepaper. 2020. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hukushi_kaigo/seikatsuhogo/jisatsutoukei-jisatsusyasu.html. Accessed 15 Jan 2024.</Citation>
				</Reference>
				<Reference>
					<Citation>Dragioti E, Tsartsalis D, Mentis M, Mantzoukas S, Gouva M. Impact of the COVID&#x2010;19 pandemic on the mental health of hospital staff: an umbrella review of 44 meta&#x2010;analyses. Int J Nurs Stud. 2022;131:104272. 10.1016/j.ijnurstu.2022.104272</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/j.ijnurstu.2022.104272</ArticleId>
						<ArticleId IdType="pmc">PMC9045868</ArticleId>
						<ArticleId IdType="pubmed">35576637</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Andhavarapu S, Yardi I, Bzhilyanskaya V, Lurie T, Bhinder M, Patel P, et al. Post&#x2010;traumatic stress in healthcare workers during the COVID&#x2010;19 pandemic: a systematic review and meta&#x2010;analysis. Psychiatry Res. 2022;317:114890. 10.1016/j.psychres.2022.114890</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/j.psychres.2022.114890</ArticleId>
						<ArticleId IdType="pmc">PMC9573911</ArticleId>
						<ArticleId IdType="pubmed">36260970</ArticleId>
					</ArticleIdList>
				</Reference>
			</ReferenceList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
			<PMID Version="1">39369845</PMID>
			<DateCompleted>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>17</Day>
			</DateCompleted>
			<DateRevised>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>17</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1879-0631</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>357</Volume>
						<PubDate>
							<Year>2024</Year>
							<Month>Nov</Month>
							<Day>15</Day>
						</PubDate>
					</JournalIssue>
					<Title>Life sciences</Title>
					<ISOAbbreviation>Life Sci</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Exploring the characteristics and antecedents of clinically significant long COVID: A longitudinal cohort study.</ArticleTitle>
				<Pagination>
					<StartPage>123114</StartPage>
					<MedlinePgn>123114</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.lfs.2024.123114</ELocationID>
				<ELocationID EIdType="pii" ValidYN="Y">S0024-3205(24)00704-5</ELocationID>
				<Abstract>
					<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A significant number of coronavirus disease 2019 (COVID-19) survivors are experiencing long COVID, with symptoms lasting beyond three months. While diverse long COVID symptoms are established, there are gaps in understanding its long-term trends, intensity, and risk factors, requiring further investigation.</AbstractText>
					<AbstractText Label="AIMS" NlmCategory="OBJECTIVE">This study aimed to investigate the long COVID characteristics and associated factors by following COVID-19 survivors for one year post-infection and comparing them with healthy counterparts.</AbstractText>
					<AbstractText Label="MAIN METHODS" NlmCategory="METHODS">In this longitudinal, correlational study, COVID-19 survivors diagnosed between November 2021 and February 2023 were monitored every three months for a year. Participants aged &#x2265;18&#xa0;years who had reported a positive COVID-19 test were recruited via social media and healthcare provider referrals.</AbstractText>
					<AbstractText Label="KEY FINDINGS" NlmCategory="RESULTS">Out of 182 survivors who initially agreed to participate, 176 completed the study. The mean age was 47.56&#xa0;years (SD&#xa0;=&#xa0;16.2), and 51.1&#xa0;% were female. There was a clinically significant decline in cognitive function and health-related quality of life over time, with symptoms like shortness of breath, reduced physical fitness, and increased health concerns. Those with severe acute COVID-19 symptoms experienced greater cognitive and physical declines and more shortness of breath a year later. Lower financial status was linked to poorer health-related quality of life and increased health concerns.</AbstractText>
					<AbstractText Label="SIGNIFICANCE" NlmCategory="CONCLUSIONS">A year post-infection, COVID-19's impact on cognitive function and health-related quality of life remains significant, affecting individuals and communities. Survivors with severe initial symptoms and economic disadvantages need more attention. Future research should identify additional predictors of severe long COVID.</AbstractText>
					<CopyrightInformation>Copyright &#xa9; 2024. Published by Elsevier Inc.</CopyrightInformation>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Tang</LastName>
						<ForeName>Chia-Chun</ForeName>
						<Initials>CC</Initials>
						<AffiliationInfo>
							<Affiliation>School of Nursing, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Nursing, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Chang</LastName>
						<ForeName>Jung Chen</ForeName>
						<Initials>JC</Initials>
						<AffiliationInfo>
							<Affiliation>School of Nursing, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Nursing, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Ho</LastName>
						<ForeName>Sung-Jung</ForeName>
						<Initials>SJ</Initials>
						<AffiliationInfo>
							<Affiliation>Division of Chest Medicine, Department of Internal Medicine, Min-Sheng General Hospital, Taoyuan, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Liu</LastName>
						<ForeName>Wang-Da</ForeName>
						<Initials>WD</Initials>
						<AffiliationInfo>
							<Affiliation>Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Department of Internal Medicine, College of Medicine, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Pan</LastName>
						<ForeName>Mei-Yan</ForeName>
						<Initials>MY</Initials>
						<AffiliationInfo>
							<Affiliation>Department of Nursing, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Chang</LastName>
						<ForeName>Shih-Chieh</ForeName>
						<Initials>SC</Initials>
						<AffiliationInfo>
							<Affiliation>Division of Chest Medicine, Department of Internal Medicine, National Yang Ming Chiao Tung University Hospital, Yilan, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Wang</LastName>
						<ForeName>Wei-Shin</ForeName>
						<Initials>WS</Initials>
						<AffiliationInfo>
							<Affiliation>School of Nursing, College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Yeh</LastName>
						<ForeName>Yi-Chen</ForeName>
						<Initials>YC</Initials>
						<AffiliationInfo>
							<Affiliation>Department of Nursing, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Chen</LastName>
						<ForeName>Cheng-Hsuan</ForeName>
						<Initials>CH</Initials>
						<AffiliationInfo>
							<Affiliation>Department of Nursing, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Wu</LastName>
						<ForeName>Wei-Wen</ForeName>
						<Initials>WW</Initials>
						<AffiliationInfo>
							<Affiliation>School of Nursing, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Nursing, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: weiwen@ntu.edu.tw.</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>04</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>Netherlands</Country>
				<MedlineTA>Life Sci</MedlineTA>
				<NlmUniqueID>0375521</NlmUniqueID>
				<ISSNLinking>0024-3205</ISSNLinking>
			</MedlineJournalInfo>
			<CitationSubset>IM</CitationSubset>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
					<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
					<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D017741" MajorTopicYN="Y">Survivors</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName>
					<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
				</MeshHeading>
			</MeshHeadingList>
			<KeywordList Owner="NOTNLM">
				<Keyword MajorTopicYN="N">Long COVID</Keyword>
				<Keyword MajorTopicYN="N">Longitudinal study</Keyword>
				<Keyword MajorTopicYN="N">Post-COVID condition</Keyword>
				<Keyword MajorTopicYN="N">Symptom assessment</Keyword>
			</KeywordList>
			<CoiStatement>Declaration of competing interest None to declare.</CoiStatement>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="received">
					<Year>2024</Year>
					<Month>6</Month>
					<Day>3</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="revised">
					<Year>2024</Year>
					<Month>9</Month>
					<Day>24</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="accepted">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>3</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>18</Day>
					<Hour>10</Hour>
					<Minute>18</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>7</Day>
					<Hour>4</Hour>
					<Minute>17</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>6</Day>
					<Hour>19</Hour>
					<Minute>18</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pubmed">39369845</ArticleId>
				<ArticleId IdType="doi">10.1016/j.lfs.2024.123114</ArticleId>
				<ArticleId IdType="pii">S0024-3205(24)00704-5</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
			<PMID Version="1">39357795</PMID>
			<DateCompleted>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>17</Day>
			</DateCompleted>
			<DateRevised>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>17</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1879-0631</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>357</Volume>
						<PubDate>
							<Year>2024</Year>
							<Month>Nov</Month>
							<Day>15</Day>
						</PubDate>
					</JournalIssue>
					<Title>Life sciences</Title>
					<ISOAbbreviation>Life Sci</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Gastrointestinal manifestations of long COVID.</ArticleTitle>
				<Pagination>
					<StartPage>123100</StartPage>
					<MedlinePgn>123100</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.lfs.2024.123100</ELocationID>
				<ELocationID EIdType="pii" ValidYN="Y">S0024-3205(24)00690-8</ELocationID>
				<Abstract>
					<AbstractText>Long COVID is estimated to have affected 6.9&#xa0;% of US adults, 17.8 million people in the US alone, as of early 2023. While SARS-CoV-2 is primarily considered a respiratory virus, gastrointestinal (GI) symptoms are also frequent in patients with coronavirus disease 2019 (COVID-19) and in patients with Long COVID. The risk of developing GI symptoms is increased with increasing severity of COVID-19, the presence of GI symptoms in the acute infection, and psychological distress both before and after COVID-19. Persistence of the virus in the GI tract, ensuing inflammation, and alteration of the microbiome are all likely mediators of the effects of SARS Co-V-2 virus on the gut. These factors may all increase intestinal permeability and systemic inflammation. GI inflammation and dysbiosis can change the absorption and metabolism of tryptophan, an important neurotransmitter. Long COVID GI symptoms resemble a Disorder of Gut Brain Interaction (DGBI) such as post infection Irritable Bowel Syndrome (IBS). Current standards of treatment for IBS can guide our treatment of Long COVID patients. Dysautonomia, a frequent Long COVID condition affecting the autonomic nervous system, can also affect the GI tract, and must be considered in Long COVID patients with GI symptoms. Long COVID symptoms fall within the broader category of Infection Associated Chronic Conditions (IACCs). Research into the GI symptoms of Long COVID may further our understanding of other post infection chronic GI conditions, and elucidate the roles of therapeutic options including antivirals, probiotics, neuromodulators, and treatments of dysautonomia.</AbstractText>
					<CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>King</LastName>
						<ForeName>Louise R</ForeName>
						<Initials>LR</Initials>
						<AffiliationInfo>
							<Affiliation>University of North Carolina School of Medicine, Department of Medicine, Division of General Medicine and Clinical Epidemiology, 5034 Old Clinic Building, 101 Manning Drive, Chapel Hill, NC 27599, United States of America. Electronic address: louise_king@med.unc.edu.</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
					<PublicationType UI="D016454">Review</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2024</Year>
					<Month>09</Month>
					<Day>30</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>Netherlands</Country>
				<MedlineTA>Life Sci</MedlineTA>
				<NlmUniqueID>0375521</NlmUniqueID>
				<ISSNLinking>0024-3205</ISSNLinking>
			</MedlineJournalInfo>
			<CitationSubset>IM</CitationSubset>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
					<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D005767" MajorTopicYN="Y">Gastrointestinal Diseases</DescriptorName>
					<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
					<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
					<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName>
					<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D041981" MajorTopicYN="N">Gastrointestinal Tract</DescriptorName>
					<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
					<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D043183" MajorTopicYN="N">Irritable Bowel Syndrome</DescriptorName>
					<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
					<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
					<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
				</MeshHeading>
			</MeshHeadingList>
			<KeywordList Owner="NOTNLM">
				<Keyword MajorTopicYN="N">COVID-19</Keyword>
				<Keyword MajorTopicYN="N">Clinical</Keyword>
				<Keyword MajorTopicYN="N">Gastrointestinal</Keyword>
				<Keyword MajorTopicYN="N">Long COVID</Keyword>
				<Keyword MajorTopicYN="N">Microbiome</Keyword>
				<Keyword MajorTopicYN="N">Post COVID</Keyword>
			</KeywordList>
			<CoiStatement>Declaration of competing interest No competing interests.</CoiStatement>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="received">
					<Year>2024</Year>
					<Month>6</Month>
					<Day>30</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="revised">
					<Year>2024</Year>
					<Month>9</Month>
					<Day>15</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="accepted">
					<Year>2024</Year>
					<Month>9</Month>
					<Day>28</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>18</Day>
					<Hour>0</Hour>
					<Minute>30</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>3</Day>
					<Hour>4</Hour>
					<Minute>22</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>2</Day>
					<Hour>19</Hour>
					<Minute>18</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pubmed">39357795</ArticleId>
				<ArticleId IdType="doi">10.1016/j.lfs.2024.123100</ArticleId>
				<ArticleId IdType="pii">S0024-3205(24)00690-8</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
</PubmedArticleSet>`
const pubmedData2 = `<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
	<PubmedArticle>
		<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
			<PMID Version="1">39469291</PMID>
			<DateRevised>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>30</Day>
			</DateRevised>
			<Article PubModel="Electronic-eCollection">
				<Journal>
					<ISSN IssnType="Print">1178-2390</ISSN>
					<JournalIssue CitedMedium="Print">
						<Volume>17</Volume>
						<PubDate>
							<Year>2024</Year>
						</PubDate>
					</JournalIssue>
					<Title>Journal of multidisciplinary healthcare</Title>
					<ISOAbbreviation>J Multidiscip Healthc</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Trends and Hotspots in the Health Economics Evaluation of Chronic Fatigue Syndrome.</ArticleTitle>
				<Pagination>
					<StartPage>4877</StartPage>
					<EndPage>4892</EndPage>
					<MedlinePgn>4877-4892</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.2147/JMDH.S482100</ELocationID>
				<Abstract>
					<AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To explore the research trends and hotspots of health economics evaluations of patients with chronic fatigue syndrome.</AbstractText>
					<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">To explore the research trends and hotspots of health economics evaluations of chronic fatigue syndrome, 180 articles published between 1991 and 2024 were visualized and analyzed via CiteSpace 6.3 software. R3 and VOSviewer1.6.20 and R4.3.3. The content includes annual publication volume, journal distribution, author country, publishing organization, author collaboration, citation analysis, and keyword analysis in 7 aspects.</AbstractText>
					<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Fewer studies have evaluated the health economics of individuals with chronic fatigue syndrome in China and abroad, Chinese studies are especially rare, and research results in the UK are mostly found in other countries. Moreover, cooperation and linkages between institutions, as well as between authors, are not yet strong.</AbstractText>
					<AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The hotspot of health economics evaluation methods in this field is cost-effectiveness analysis, and the hotspot of diagnosis and treatment methods is cognitive&#x2012;behavioral therapy. We also found that chronic fatigue syndrome may also have a strong potential association with depression from the perspective of health economics. Health economic evaluations of multiple treatments should be conducted simultaneously to increase attention to this field and provide a reference basis for low-cost and high-quality diagnostic and treatment programs.</AbstractText>
					<CopyrightInformation>&#xa9; 2024 Wan et al.</CopyrightInformation>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y" EqualContrib="Y">
						<LastName>Wan</LastName>
						<ForeName>Hejia</ForeName>
						<Initials>H</Initials>
						<Identifier Source="ORCID">0009-0003-3900-1967</Identifier>
						<AffiliationInfo>
							<Affiliation>School of Nursing, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y" EqualContrib="Y">
						<LastName>Wei</LastName>
						<ForeName>Bingqi</ForeName>
						<Initials>B</Initials>
						<AffiliationInfo>
							<Affiliation>School of Traditional Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Qian</LastName>
						<ForeName>Wenli</ForeName>
						<Initials>W</Initials>
						<AffiliationInfo>
							<Affiliation>School of Management, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Zhang</LastName>
						<ForeName>Jing</ForeName>
						<Initials>J</Initials>
						<AffiliationInfo>
							<Affiliation>School of Nursing, Henan University of Chinese Medicine, Zhengzhou, People's Republic of China.</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
					<PublicationType UI="D016454">Review</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>24</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>New Zealand</Country>
				<MedlineTA>J Multidiscip Healthc</MedlineTA>
				<NlmUniqueID>101512691</NlmUniqueID>
				<ISSNLinking>1178-2390</ISSNLinking>
			</MedlineJournalInfo>
			<KeywordList Owner="NOTNLM">
				<Keyword MajorTopicYN="N">CiteSpace</Keyword>
				<Keyword MajorTopicYN="N">bibliometrics</Keyword>
				<Keyword MajorTopicYN="N">chronic fatigue syndrome</Keyword>
				<Keyword MajorTopicYN="N">health economics</Keyword>
				<Keyword MajorTopicYN="N">myalgic encephalomyelitis</Keyword>
				<Keyword MajorTopicYN="N">visual analysis</Keyword>
			</KeywordList>
			<CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="received">
					<Year>2024</Year>
					<Month>6</Month>
					<Day>14</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="accepted">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>15</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>29</Day>
					<Hour>10</Hour>
					<Minute>56</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>29</Day>
					<Hour>10</Hour>
					<Minute>55</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>29</Day>
					<Hour>4</Hour>
					<Minute>39</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pmc-release">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>24</Day>
				</PubMedPubDate>
			</History>
			<PublicationStatus>epublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pubmed">39469291</ArticleId>
				<ArticleId IdType="pmc">PMC11514696</ArticleId>
				<ArticleId IdType="doi">10.2147/JMDH.S482100</ArticleId>
				<ArticleId IdType="pii">482100</ArticleId>
			</ArticleIdList>
			<ReferenceList>
				<Reference>
					<Citation>Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Internal Med. 1994;121(12):953&#x2013;959. doi:10.7326/0003-4819-121-12-199412150-00009</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.7326/0003-4819-121-12-199412150-00009</ArticleId>
						<ArticleId IdType="pubmed">7978722</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Helliwell AM, Stockwell PA, Edgar CD, Chatterjee A, Tate WP. Dynamic epigenetic changes during a relapse and recovery cycle in myalgic encephalomyelitis/chronic fatigue syndrome. Int J Mol Sci. 2022;23(19):11852. doi:10.3390/ijms231911852</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.3390/ijms231911852</ArticleId>
						<ArticleId IdType="pmc">PMC9570248</ArticleId>
						<ArticleId IdType="pubmed">36233152</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Reynolds KJ, Vernon SD, Bouchery E, Reeves WC. The economic impact of chronic fatigue syndrome. Cost Eff Resour Alloc. 2004;2(1):4. doi:10.1186/1478-7547-2-4</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1186/1478-7547-2-4</ArticleId>
						<ArticleId IdType="pmc">PMC449736</ArticleId>
						<ArticleId IdType="pubmed">15210053</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Nacul L, Authier FJ, Scheibenbogen C, et al. European network on myalgic encephalomyelitis/chronic fatigue syndrome (EUROMENE): expert consensus on the diagnosis, service provision, and care of people with ME/CFS in Europe. Medicina. 2021;57(5):510. doi:10.3390/medicina57050510</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.3390/medicina57050510</ArticleId>
						<ArticleId IdType="pmc">PMC8161074</ArticleId>
						<ArticleId IdType="pubmed">34069603</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Manu P, Lane TJ, Matthews DA. Chronic fatigue and chronic fatigue syndrome: clinical epidemiology and aetiological classification. Ciba Found Symp. 1993;173:23&#x2013;31. doi:10.1002/9780470514382.ch3.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1002/9780470514382.ch3</ArticleId>
						<ArticleId IdType="pubmed">8491100</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Bearn J, Wessely S. Neurobiological aspects of the chronic fatigue syndrome. Eur J Clin Invest. 1994;24(2):79&#x2013;90. doi:10.1111/j.1365-2362.1994.tb00971.x</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1111/j.1365-2362.1994.tb00971.x</ArticleId>
						<ArticleId IdType="pubmed">8206084</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Fischer A, Threlfall A, Cookson R, Meah S, Rutter H, Kelly MP. The appraisal of public health interventions. Lancet. 2012;380:S17&#x2013;S17. doi:10.1016/s0140-6736(13)60373-6</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/s0140-6736(13)60373-6</ArticleId>
						<ArticleId IdType="pubmed">23995712</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Trueman P, Anokye NK. Applying economic evaluation to public health interventions: the case of interventions to promote physical activity. J Public Health. 2013;35(1):32&#x2013;39. doi:10.1093/pubmed/fds050</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1093/pubmed/fds050</ArticleId>
						<ArticleId IdType="pmc">PMC3580051</ArticleId>
						<ArticleId IdType="pubmed">22753453</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Bombardier CH, Buchwald D. Chronic fatigue, chronic fatigue syndrome, and fibromyalgia. Disability and health-care use. Med Care. 1996;34(9):924&#x2013;930. doi:10.1097/00005650-199609000-00005</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1097/00005650-199609000-00005</ArticleId>
						<ArticleId IdType="pubmed">8792781</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Thomas PW, Thomas S, Kersten P, et al. Multi-centre parallel arm randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based cognitive behavioural approach to managing fatigue in people with multiple sclerosis. BMC Neurol. 2010;10:43. doi:10.1186/1471-2377-10-43</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1186/1471-2377-10-43</ArticleId>
						<ArticleId IdType="pmc">PMC2905353</ArticleId>
						<ArticleId IdType="pubmed">20553617</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Du Z, Wang Z, Guo F, Wang T. Dynamic structures and emerging trends in the management of major trauma: a bibliometric analysis of publications between 2012 and 2021. Front Public Health. 2022;10:1017817. doi:10.3389/fpubh.2022.1017817</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.3389/fpubh.2022.1017817</ArticleId>
						<ArticleId IdType="pmc">PMC9663840</ArticleId>
						<ArticleId IdType="pubmed">36388390</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Wei N, Xu Y, Li Y, et al. A bibliometric analysis of T cell and atherosclerosis. Front Immunol. 2022;13:948314. doi:10.3389/fimmu.2022.948314</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.3389/fimmu.2022.948314</ArticleId>
						<ArticleId IdType="pmc">PMC9606647</ArticleId>
						<ArticleId IdType="pubmed">36311729</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Ma D, Guan B, Song L, et al. A bibliometric analysis of exosomes in cardiovascular diseases from 2001 to 2021. Front Cardiovasc Med. 2021;8:734514. doi:10.3389/fcvm.2021.734514</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.3389/fcvm.2021.734514</ArticleId>
						<ArticleId IdType="pmc">PMC8424118</ArticleId>
						<ArticleId IdType="pubmed">34513962</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Vilker Zucolotto Pessin L, Harue yamane L, Ribeiro Siman R. Smart bibliometrics: an integrated method of science mapping and bibliometric analysis. Scientometrics. 2022;127:3695&#x2013;3718. doi:10.1007/s11192-022-04406-6</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1007/s11192-022-04406-6</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>PubMed. National Library of Medicine, U.S. National Library of Medicine. https://pubmed.ncbi.nlm.nih.gov/. Accessed October
21, 2024.</Citation>
				</Reference>
				<Reference>
					<Citation>Rons N. Bibliometric approximation of a scientific specialty by combining key sources, title words, authors and references. J Informetrics. 2018;12:113&#x2013;132. doi:10.1016/j.joi.2017.12.003</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/j.joi.2017.12.003</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Cao Y, Xiong F, Xia X, et al. Economic impact of powered stapler in video-assisted thoracic surgery lobectomy for lung cancer in a Chinese tertiary hospital: a cost-minimization analysis. Health Econ Rev. 2022;12(1):12. doi:10.1186/s13561-022-00359-x</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1186/s13561-022-00359-x</ArticleId>
						<ArticleId IdType="pmc">PMC8830080</ArticleId>
						<ArticleId IdType="pubmed">35141818</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Greenberg B, Hall S, Grabner M, Balu S, Zhang X, Kantor D. Multiple sclerosis relapse rates and healthcare costs of two versions of glatiramer acetate. Curr Med Res Opin. 2020;36(7):1167&#x2013;1175. doi:10.1080/03007995.2020.1760808</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1080/03007995.2020.1760808</ArticleId>
						<ArticleId IdType="pubmed">32329362</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Seixas BV, Dionne F, Mitton C. Practices of decision making in priority setting and resource allocation: a scoping review and narrative synthesis of existing frameworks. Health Econ Rev. 2021;11(1):2. doi:10.1186/s13561-020-00300-0</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1186/s13561-020-00300-0</ArticleId>
						<ArticleId IdType="pmc">PMC7789400</ArticleId>
						<ArticleId IdType="pubmed">33411161</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Giorgi MA, Caroli C, Giglio ND, et al. Estimation of the cost-effectiveness of apixaban versus vitamin K antagonists in the management of atrial fibrillation in Argentina. Health Econ Rev. 2015;5(1):52. doi:10.1186/s13561-015-0052-8</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1186/s13561-015-0052-8</ArticleId>
						<ArticleId IdType="pmc">PMC4480270</ArticleId>
						<ArticleId IdType="pubmed">26112219</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Garc&#xed;a-Ruiz AJ, P&#xe9;rez-Costillas L, Montesinos AC, Alcalde J, Oyag&#xfc;ez I, Casado MA. Cost-effectiveness analysis of antipsychotics in reducing schizophrenia relapses. Health Econ Rev. 2012;2(1):8. doi:10.1186/2191-1991-2-8</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1186/2191-1991-2-8</ArticleId>
						<ArticleId IdType="pmc">PMC3402933</ArticleId>
						<ArticleId IdType="pubmed">22828390</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>McCrone P, Sharpe M, Chalder T, et al. Adaptive pacing, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome: a cost-effectiveness analysis. PLoS One. 2012;7(8):e40808. doi:10.1371/journal.pone.0040808</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1371/journal.pone.0040808</ArticleId>
						<ArticleId IdType="pmc">PMC3411573</ArticleId>
						<ArticleId IdType="pubmed">22870204</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Vos-Vromans D, Evers S, Huijnen I, et al. Economic evaluation of multidisciplinary rehabilitation treatment versus cognitive behavioural therapy for patients with chronic fatigue syndrome: a randomized controlled trial. PLoS One. 2017;12(6):e0177260. doi:10.1371/journal.pone.0177260</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1371/journal.pone.0177260</ArticleId>
						<ArticleId IdType="pmc">PMC5456034</ArticleId>
						<ArticleId IdType="pubmed">28574985</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Meng H, Friedberg F. Cost-utility of home-based fatigue self-management versus usual care for the treatment of chronic fatigue syndrome. Fatigue. 2017;5(4):202&#x2013;214. doi:10.1080/21641846.2017.1343171</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1080/21641846.2017.1343171</ArticleId>
						<ArticleId IdType="pmc">PMC6438387</ArticleId>
						<ArticleId IdType="pubmed">30931176</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Jacob L, Haro JM, Kostev K. Associations of physical and psychiatric conditions with chronic fatigue syndrome in Germany: an exploratory case-control study. Psychol Med. 2022;52(4):780&#x2013;786. doi:10.1017/S0033291720002470</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1017/S0033291720002470</ArticleId>
						<ArticleId IdType="pubmed">32686638</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Lee SH, Shin HS, Park HY, et al. Depression as a mediator of chronic fatigue and post-traumatic stress symptoms in middle east respiratory syndrome survivors. Psychiatry Invest. 2019;16(1):59&#x2013;64. doi:10.30773/pi.2018.10.22.3</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.30773/pi.2018.10.22.3</ArticleId>
						<ArticleId IdType="pmc">PMC6354037</ArticleId>
						<ArticleId IdType="pubmed">30605995</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Castro-Marrero J, Faro M, Zaragoz&#xe1; MC, Aliste L, de Sevilla TF, Alegre J. Unemployment and work disability in individuals with chronic fatigue syndrome/myalgic encephalomyelitis: a community-based cross-sectional study from Spain. BMC Public Health. 2019;19(1):840. doi:10.1186/s12889-019-7225-z</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1186/s12889-019-7225-z</ArticleId>
						<ArticleId IdType="pmc">PMC6599355</ArticleId>
						<ArticleId IdType="pubmed">31253111</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Cochrane M, Mitchell E, Hollingworth W, Crawley E, Tr&#xe9;pel D. Cost-effectiveness of interventions for chronic fatigue syndrome or myalgic encephalomyelitis: a systematic review of economic evaluations. Appl Health Econ Health Policy. 2021;19(4):473&#x2013;486. doi:10.1007/s40258-021-00635-7</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1007/s40258-021-00635-7</ArticleId>
						<ArticleId IdType="pmc">PMC7917957</ArticleId>
						<ArticleId IdType="pubmed">33646528</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Janse A, Bleijenberg G, Knoop H. Prediction of long-term outcome after cognitive behavioral therapy for chronic fatigue syndrome. J Psychosom Res. 2019;121:93&#x2013;99. doi:10.1016/j.jpsychores.2019.03.017</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/j.jpsychores.2019.03.017</ArticleId>
						<ArticleId IdType="pubmed">31006534</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Heald A, Barber L, Jones HL, Farman S, Walther A. Service based comparison of group cognitive behavior therapy to waiting list control for chronic fatigue syndrome with regard to symptom reduction and positive psychological dimensions. Medicine. 2019;98(39):e16720. doi:10.1097/MD.0000000000016720</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1097/MD.0000000000016720</ArticleId>
						<ArticleId IdType="pmc">PMC6775347</ArticleId>
						<ArticleId IdType="pubmed">31574792</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>O&#x2019;Dowd H, Beasant L, Ingram J, et al. The feasibility and acceptability of an early intervention in primary care to prevent chronic fatigue syndrome (CFS) in adults: randomised controlled trial. Pilot Feasibility Stud. 2020;6:65. doi:10.1186/s40814-020-00595-0</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1186/s40814-020-00595-0</ArticleId>
						<ArticleId IdType="pmc">PMC7216523</ArticleId>
						<ArticleId IdType="pubmed">32426159</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Leach H, Eccles A, Chew-Graham CA, Atherton H. Patient experiences of remote consulting with chronic fatigue syndrome/myalgic encephalomyelitis and fibromyalgia: a qualitative study. BJGP Open. 2024;27:BJGPO.2024.0079. doi:10.3399/BJGPO.2024.0079</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.3399/BJGPO.2024.0079</ArticleId>
						<ArticleId IdType="pubmed">39191480</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Carrasco-Querol N, Gonz&#xe1;lez Serra G, Bueno Hern&#xe1;ndez N, et al. Effectiveness and health benefits of a nutritional, chronobiological and physical exercise primary care intervention in fibromyalgia and chronic fatigue syndrome: SYNCHRONIZE + mixed-methods study protocol. Medicine. 2023;102(17):e33637. doi:10.1097/MD.0000000000033637</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1097/MD.0000000000033637</ArticleId>
						<ArticleId IdType="pmc">PMC10145802</ArticleId>
						<ArticleId IdType="pubmed">37115043</ArticleId>
					</ArticleIdList>
				</Reference>
			</ReferenceList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Status="Publisher" Owner="NLM">
			<PMID Version="1">39449566</PMID>
			<DateRevised>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>25</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1461-7277</ISSN>
					<JournalIssue CitedMedium="Internet">
						<PubDate>
							<Year>2024</Year>
							<Month>Oct</Month>
							<Day>25</Day>
						</PubDate>
					</JournalIssue>
					<Title>Journal of health psychology</Title>
					<ISOAbbreviation>J Health Psychol</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Much more than a biological phenomenon: A qualitative study of women's experiences of brain fog across their reproductive journey.</ArticleTitle>
				<Pagination>
					<StartPage>13591053241290656</StartPage>
					<MedlinePgn>13591053241290656</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1177/13591053241290656</ELocationID>
				<Abstract>
					<AbstractText>Whilst 'brain fog' is mostly considered a biological problem little is understood about an individual's experience. This qualitative study explored women's experiences of brain fog focusing on those at the start (aged 18-25; 
						<i>n</i>&#x2009;=&#x2009;10) and end (aged 45-60; 
						<i>n</i>&#x2009;=&#x2009;10) of their reproductive journey. Descriptive thematic analysis described three themes: (i) 'daily disruptions' describing cognitive dysfunctions and the main triggers; (ii) 'the cycle of impact' with a focus on women's emotional experiences and how these can exacerbate brain fog; (iii) 'taking control' highlighting the use of self-care, physical prompts and Hormonal Replacement Therapy (HRT) to manage brain fog. Transcending these themes was the notion of 'crisis of identity' illustrating the negative impact of brain fog on the women's sense of self with some older women describing acceptance and finding it less challenging. Brain fog is much more than a biological phenomenon and has broader implications for a woman's sense of self.
					</AbstractText>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Johnson</LastName>
						<ForeName>Hannah</ForeName>
						<Initials>H</Initials>
						<AffiliationInfo>
							<Affiliation>University of Surrey, UK.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Ogden</LastName>
						<ForeName>Jane</ForeName>
						<Initials>J</Initials>
						<Identifier Source="ORCID">0000-0003-4271-5621</Identifier>
						<AffiliationInfo>
							<Affiliation>University of Surrey, UK.</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>25</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>England</Country>
				<MedlineTA>J Health Psychol</MedlineTA>
				<NlmUniqueID>9703616</NlmUniqueID>
				<ISSNLinking>1359-1053</ISSNLinking>
			</MedlineJournalInfo>
			<CitationSubset>IM</CitationSubset>
			<KeywordList Owner="NOTNLM">
				<Keyword MajorTopicYN="N">brain fog</Keyword>
				<Keyword MajorTopicYN="N">experiences</Keyword>
				<Keyword MajorTopicYN="N">hormones</Keyword>
				<Keyword MajorTopicYN="N">identity</Keyword>
				<Keyword MajorTopicYN="N">reproductive journey</Keyword>
			</KeywordList>
			<CoiStatement>Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="medline">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>25</Day>
					<Hour>6</Hour>
					<Minute>23</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>25</Day>
					<Hour>6</Hour>
					<Minute>23</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>25</Day>
					<Hour>3</Hour>
					<Minute>22</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>aheadofprint</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pubmed">39449566</ArticleId>
				<ArticleId IdType="doi">10.1177/13591053241290656</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Status="Publisher" Owner="NLM">
			<PMID Version="1">39442002</PMID>
			<DateRevised>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>23</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1550-9109</ISSN>
					<JournalIssue CitedMedium="Internet">
						<PubDate>
							<Year>2024</Year>
							<Month>Oct</Month>
							<Day>23</Day>
						</PubDate>
					</JournalIssue>
					<Title>Sleep</Title>
					<ISOAbbreviation>Sleep</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Genetic variants associated with chronic fatigue syndrome predict population-level fatigue severity and actigraphic measurements.</ArticleTitle>
				<ELocationID EIdType="pii" ValidYN="Y">zsae243</ELocationID>
				<ELocationID EIdType="doi" ValidYN="Y">10.1093/sleep/zsae243</ELocationID>
				<Abstract>
					<AbstractText Label="STUDY OBJECTIVES" NlmCategory="OBJECTIVE">The diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome (CFS) is based on a constellation of symptoms which center around fatigue. However, fatigue is commonly reported in the general population by people without CFS. Does the biology underlying fatigue in patients with CFS also drive fatigue experienced by individuals without CFS?</AbstractText>
					<AbstractText Label="METHODS" NlmCategory="METHODS">We used UK Biobank actigraphy data to characterize differences in physical activity patterns and daily temperature rhythms between participants diagnosed with CFS compared to controls. We then tested if single nucleotide variants (SNVs) previously associated with CFS are also associated with the variation of these actigraphic CFS correlates and/or subjective fatigue symptoms in the general population.</AbstractText>
					<AbstractText Label="RESULTS" NlmCategory="RESULTS">Participants diagnosed with CFS (n = 295) had significantly decreased overall movement (Cohen's d = 0.220, 95% CI of -0.335 to -0.106, p-value = 2.42x10-15), lower activity amplitudes (Cohen's d = -0.377, 95% CI of -0.492 to -0.262, p-value = 1.74x10-6), and lower wrist temperature amplitudes (Cohen's d = -0.173, 95% CI of -0.288 -0.059, p-value = 0.002) compared to controls (n = 63,133). Of 30 tested SNVs associated in the literature with CFS, one was associated in the control population with subjective fatigue and one with actigraphic measurements (FDR &lt; 0.05).</AbstractText>
					<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The genetic overlap of CFS risk with actigraphy and subjective fatigue phenotypes suggests that some biological mechanisms underlying pathologic fatigue in CFS patients also underlie fatigue symptoms at a broader population level. Therefore, understanding the biology of fatigue in general may inform our understanding of CFS pathophysiology.</AbstractText>
					<CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press on behalf of Sleep Research Society. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site&#x2014;for further information please contact journals.permissions@oup.com.</CopyrightInformation>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Liu</LastName>
						<ForeName>Patrick Z</ForeName>
						<Initials>PZ</Initials>
						<Identifier Source="ORCID">0000-0001-9663-8233</Identifier>
						<AffiliationInfo>
							<Affiliation>Chronobiology and Sleep Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Raizen</LastName>
						<ForeName>David M</ForeName>
						<Initials>DM</Initials>
						<Identifier Source="ORCID">0000-0001-5935-0476</Identifier>
						<AffiliationInfo>
							<Affiliation>Chronobiology and Sleep Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation>
						</AffiliationInfo>
						<AffiliationInfo>
							<Affiliation>Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Skarke</LastName>
						<ForeName>Carsten</ForeName>
						<Initials>C</Initials>
						<AffiliationInfo>
							<Affiliation>Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation>
						</AffiliationInfo>
						<AffiliationInfo>
							<Affiliation>Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Brooks</LastName>
						<ForeName>Thomas G</ForeName>
						<Initials>TG</Initials>
						<Identifier Source="ORCID">0000-0002-6980-0079</Identifier>
						<AffiliationInfo>
							<Affiliation>Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Anafi</LastName>
						<ForeName>Ron C</ForeName>
						<Initials>RC</Initials>
						<AffiliationInfo>
							<Affiliation>Chronobiology and Sleep Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation>
						</AffiliationInfo>
						<AffiliationInfo>
							<Affiliation>Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>23</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>United States</Country>
				<MedlineTA>Sleep</MedlineTA>
				<NlmUniqueID>7809084</NlmUniqueID>
				<ISSNLinking>0161-8105</ISSNLinking>
			</MedlineJournalInfo>
			<CitationSubset>IM</CitationSubset>
			<KeywordList Owner="NOTNLM">
				<Keyword MajorTopicYN="N">SNVs</Keyword>
				<Keyword MajorTopicYN="N">UK Biobank</Keyword>
				<Keyword MajorTopicYN="N">actigraphy</Keyword>
				<Keyword MajorTopicYN="N">dysautonomia</Keyword>
				<Keyword MajorTopicYN="N">fatigue</Keyword>
				<Keyword MajorTopicYN="N">myalgic encephalomyelitis/chronic fatigue syndrome</Keyword>
			</KeywordList>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="received">
					<Year>2024</Year>
					<Month>4</Month>
					<Day>7</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>23</Day>
					<Hour>22</Hour>
					<Minute>28</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>23</Day>
					<Hour>22</Hour>
					<Minute>28</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>23</Day>
					<Hour>15</Hour>
					<Minute>13</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>aheadofprint</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pubmed">39442002</ArticleId>
				<ArticleId IdType="doi">10.1093/sleep/zsae243</ArticleId>
				<ArticleId IdType="pii">7833455</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
			<PMID Version="1">39434583</PMID>
			<DateCompleted>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>29</Day>
			</DateCompleted>
			<DateRevised>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>29</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1746-1561</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>94</Volume>
						<Issue>11</Issue>
						<PubDate>
							<Year>2024</Year>
							<Month>Nov</Month>
						</PubDate>
					</JournalIssue>
					<Title>The Journal of school health</Title>
					<ISOAbbreviation>J Sch Health</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Planning for Long-Term Recovery: The Impact of COVID-19 on Educators Working With Children From Seasonal and Migrant Farmworker Families.</ArticleTitle>
				<Pagination>
					<StartPage>1049</StartPage>
					<EndPage>1057</EndPage>
					<MedlinePgn>1049-1057</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1111/josh.13514</ELocationID>
				<Abstract>
					<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Education faced challenges during the COVID-19 pandemic. Although the United States has declared an end to the public health emergency, schools continue to be impacted. While considerable research has focused on the impact of the pandemic on students, fewer studies have focused on educators, and even less on educators who specialize in working with marginalized student populations.</AbstractText>
					<AbstractText Label="METHODS" NlmCategory="METHODS">This study measured the impact of the pandemic impact on educators working with students from seasonal and migrant farmworker families to understand what supports educators need as schools plan for long-term recovery. A total of 1024 educators including early childhood education and K-12 teachers, as well as administrators, completed a COVID-19 questionnaire between October 2020 and January 2021, measuring their experiences as well as personal and work-related stressors during the pandemic.</AbstractText>
					<AbstractText Label="RESULTS" NlmCategory="RESULTS">Educators underwent difficult COVID-19 experiences and faced several factors contributing to personal and work-related stress. Personal stress factors included concerns about they themselves, or family members, becoming ill, concerns about the emotional/mental health of their family, and fear of loss/reduction in employment. Work-related stress factors included concerns about the emotional and mental health of co-workers.</AbstractText>
					<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Educators working with migrant children need additional supports-including support from administrators, psychological services, and opportunities to give/receive colleague/peer support.</AbstractText>
					<CopyrightInformation>&#xa9; 2024 American School Health Association.</CopyrightInformation>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Rosado</LastName>
						<ForeName>Javier I</ForeName>
						<Initials>JI</Initials>
						<Identifier Source="ORCID">0000-0002-0210-2743</Identifier>
						<AffiliationInfo>
							<Affiliation>Florida State University College of Medicine, Isabel Collier Read Medical Campus, Immokalee, FL.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Torres-Aponte</LastName>
						<ForeName>Lisandra</ForeName>
						<Initials>L</Initials>
						<Identifier Source="ORCID">0009-0000-5019-9351</Identifier>
						<AffiliationInfo>
							<Affiliation>Florida State University College of Medicine, Isabel Collier Read Medical Campus, Immokalee, FL.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Wang</LastName>
						<ForeName>Yuxia</ForeName>
						<Initials>Y</Initials>
						<AffiliationInfo>
							<Affiliation>Florida State University College of Medicine, Tallahassee, FL.</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>22</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>United States</Country>
				<MedlineTA>J Sch Health</MedlineTA>
				<NlmUniqueID>0376370</NlmUniqueID>
				<ISSNLinking>0022-4391</ISSNLinking>
			</MedlineJournalInfo>
			<CitationSubset>IM</CitationSubset>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
					<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D014171" MajorTopicYN="Y">Transients and Migrants</DescriptorName>
					<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
					<QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000070777" MajorTopicYN="Y">School Teachers</DescriptorName>
					<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
					<QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000067565" MajorTopicYN="Y">Farmers</DescriptorName>
					<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
					<QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D013334" MajorTopicYN="N">Students</DescriptorName>
					<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
					<QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
				</MeshHeading>
			</MeshHeadingList>
			<KeywordList Owner="NOTNLM">
				<Keyword MajorTopicYN="N">COVID&#x2010;19</Keyword>
				<Keyword MajorTopicYN="N">educator wellbeing</Keyword>
				<Keyword MajorTopicYN="N">migrant education</Keyword>
			</KeywordList>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="revised">
					<Year>2024</Year>
					<Month>8</Month>
					<Day>16</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="received">
					<Year>2023</Year>
					<Month>12</Month>
					<Day>1</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="accepted">
					<Year>2024</Year>
					<Month>8</Month>
					<Day>28</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>29</Day>
					<Hour>12</Hour>
					<Minute>28</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>22</Day>
					<Hour>6</Hour>
					<Minute>28</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>22</Day>
					<Hour>3</Hour>
					<Minute>13</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pubmed">39434583</ArticleId>
				<ArticleId IdType="doi">10.1111/josh.13514</ArticleId>
			</ArticleIdList>
			<ReferenceList>
				<Title>REFERENCES</Title>
				<Reference>
					<Citation>Atiles JT, Almod&#xf3;var M, Chavarr&#xed;a Vargas A, Dias MJA, Z&#xfa;&#xf1;iga Le&#xf3;n IM. International responses to COVID&#x2010;19: challenges faced by early childhood professionals. Eur Early Child Educ Res J. 2021;29(1):66&#x2010;78. https://doi.org/10.1080/1350293x.2021.1872674.</Citation>
				</Reference>
				<Reference>
					<Citation>Brainard J. &#x201c;COVID&#x2010;ization&#x201d; of research levels off. Science. 2022;376(6595):782&#x2010;783. https://doi.org/10.1126/science.add0532.</Citation>
				</Reference>
				<Reference>
					<Citation>Pokhrel S, Chhetri R. A literature review on impact of COVID&#x2010;19 pandemic on teaching and learning. High Educ Future. 2021;8(1):133&#x2010;141. https://doi.org/10.1177/2347631120983481.</Citation>
				</Reference>
				<Reference>
					<Citation>Quandt SA, LaMonto NJ, Mora DC, Talton JW, Laurienti PJ, Arcury TA. COVID&#x2010;19 pandemic among immigrant Latinx farmworker and non&#x2010;farmworker families: a rural&#x2010;urban comparison of economic, educational, healthcare, and immigration concerns. New Solut. 2021;31(1):30&#x2010;47. https://doi.org/10.1177/1048291121992468.</Citation>
				</Reference>
				<Reference>
					<Citation>Habib RR, El Khayat M, Ghanawi J, Katrib RS, Hneiny L, Halwani DA. Child labor and associated risk factors in the wake of the COVID&#x2010;19 pandemic: a scoping review. Front Public Health. 2024;11:1240988. https://doi.org/10.3389/fpubh.2023.1240988.</Citation>
				</Reference>
				<Reference>
					<Citation>Daumiller M, Rinas R, Schoon I, L&#xfc;ftenegger M. How did COVID&#x2010;19 affect education and what can Be learned moving forward? Z Psychol. 2023;231(3):177&#x2010;191. https://doi.org/10.1027/2151&#x2010;2604/a000527.</Citation>
				</Reference>
				<Reference>
					<Citation>Oducado RM, Rabacal J, Moralista R, Tamdang K. Perceived stress due COVID&#x2010;19 pandemic among employed professional teachers. Int J Educ Res Innov. 2020;15(15):305&#x2010;316. https://doi.org/10.46661/ijeri.5284.</Citation>
				</Reference>
				<Reference>
					<Citation>Klapproth F, Federkeil L, Heinschke F, Jungmann T. Teachers experiences of stress and their coping strategies during COVID &#x2010; 19 induced distance teaching. J Pedagogic Res. 2020;4(4):444&#x2010;452. https://doi.org/10.33902/jpr.2020062805.</Citation>
				</Reference>
				<Reference>
					<Citation>Natale R, Davidson B, Woody M, et al. A model of care for delivering supports to childcare providers during the COVID&#x2010;19 pandemic. Res Sq. 2020:1:1. https://doi.org/10.21203/rs.3.rs&#x2010;39115/v1.</Citation>
				</Reference>
				<Reference>
					<Citation>Rosado J, Torres Aponte L, Velazques J, Wang Y. COVID&#x2010;19 Impact on Migrant Education Teachers &amp; Staff. Presented at: Poster presentation at the American Psychological Association Annual Convention, American Psychological Association, Virtual (National); 2021.</Citation>
				</Reference>
				<Reference>
					<Citation>Chitra A. Study on impact of occupational stress on job satisfaction of teachers during Covid&#x2010;19 pandemic period. Glob Develop Rev. 2020;4(2):52&#x2010;62.</Citation>
				</Reference>
				<Reference>
					<Citation>Ko&#x161;ir K, Dugonik &#x160;, Huski&#x107; A, Gra&#x10d;ner J, Kokol Z, Krajnc &#x17d;. Predictors of perceived teachers' and school counsellors' work stress in the transition period of online education in schools during the COVID&#x2010;19 pandemic. Educ Stud. 2022;48(6):844&#x2010;848. https://doi.org/10.1080/03055698.2020.1833840.</Citation>
				</Reference>
				<Reference>
					<Citation>MacDonald M, Hill C. The educational impact of the Covid&#x2010;19 rapid response on teachers, students, and families: insights from British Columbia, Canada. Prospects. 2021;51:627&#x2010;641. https://doi.org/10.1007/s11125&#x2010;020&#x2010;09527&#x2010;5.</Citation>
				</Reference>
				<Reference>
					<Citation>Mulvihill T, Martin L. Voices in education: the social&#x2013;emotional impact on teachers in a COVID&#x2010;19 world: how can teacher education lend a hand? Teach Educ. 2022;57(3):239&#x2010;248. https://doi.org/10.1080/08878730.2022.2076389.</Citation>
				</Reference>
				<Reference>
					<Citation>Regional Terrorism and Disaster Coalitions for Child and Family Resilience. COVID&#x2010;19 Survey for Pre&#x2010;k to 12 Teachers and School Staff. Montclaire, NJ: Montclair State University; 2020.</Citation>
				</Reference>
				<Reference>
					<Citation>Grasso DJ, Briggs&#x2010;Gowan MJ, Carter AS, Goldstein BL, Ford JD. Profiling COVID&#x2010;related experiences in the United States with the epidemic&#x2010;pandemic impacts inventory: linkages to psychosocial functioning. Brain Behav. 2021;11(8):e02197. https://doi.org/10.1002/brb3.2197.</Citation>
				</Reference>
				<Reference>
					<Citation>Montiel Ishino FA, McNab P, Villalobos K, Cohen JH, N&#xe1;poles AM, Williams F. Hispanic/Latino acculturation profiles and telomere length: latent class analysis on a nationally representative sample. Front Public Health. 2021;9:640226.</Citation>
				</Reference>
				<Reference>
					<Citation>Susilaningsih F, Komariah M, Mediawati A, Lumbantobing V. Quality of work&#x2010;life among lecturers during online learning in COVID&#x2010;19 pandemic period: a scoping review. Malaysian J Med Health Sci. 2021;17(Suppl 4):2636&#x2010;9346.</Citation>
				</Reference>
				<Reference>
					<Citation>Bottiani JH, Duran CAK, Pas ET, Bradshaw CP. Teacher stress and burnout in urban middle schools: associations with job demands, resources, and effective classroom practices. J Sch Psychol. 2019;77:36&#x2010;51. https://doi.org/10.1016/j.jsp.2019.10.002.</Citation>
				</Reference>
				<Reference>
					<Citation>Skaalvik EM, Skaalvik S. Job demands and job resources as predictors of teacher motivation and well&#x2010;being. Soc Psychol Educ. 2018;21(5):1251&#x2010;1275. https://doi.org/10.1007/s11218&#x2010;018&#x2010;9464&#x2010;8.</Citation>
				</Reference>
				<Reference>
					<Citation>Walsh C. Developing Teacher Capacity and Resilience to Support Vulnerable High School Learners. The Organizational Improvement Plan at Western University. London, Canada: Western University; 2022:271. https://ir.lib.uwo.ca/oip/271/.</Citation>
				</Reference>
				<Reference>
					<Citation>Ortega L, Thompson I, Daniels H. School staff advice&#x2010;seeking patterns regarding support for vulnerable students. J Educ Adm. 2019;58(2):151&#x2010;170. https://doi.org/10.1108/jea&#x2010;12&#x2010;2018&#x2010;0236.</Citation>
				</Reference>
				<Reference>
					<Citation>Madrid JE. Title I's migrant education program: the challenges of addressing migrant students' educational needs in the 21st century. Georgetown J Law Modern Critical Race Perspect. 2019;11(1):67&#x2010;98.</Citation>
				</Reference>
				<Reference>
					<Citation>Zheng M, Asif M, Tufail MS, et al. COVID academic pandemic: techno stress faced by teaching staff for online academic activities. Front Psychol. 2022;13:895371. https://doi.org/10.3389/fpsyg.2022.895371.</Citation>
				</Reference>
				<Reference>
					<Citation>Daumiller M, Rinas R, Hein J, Janke S, Dickh&#xe4;user O, Dresel M. Shifting from face&#x2010;to&#x2010;face to online teaching during COVID&#x2010;19: the role of university faculty achievement goals for attitudes towards this sudden change, and their relevance for burnout/engagement and student evaluations of teaching quality. Comput Hum Behav. 2021;118:1&#x2010;20. https://doi.org/10.1016/j.chb.2020.106677.</Citation>
				</Reference>
				<Reference>
					<Citation>Kakepotoa I, Talpur Q, Memon IA, Halepoto IA, Jalbani KB. Pedagogical shift: faculty insights about E&#x2010;teaching barriers during COVID pandemic. Int J Innov Creativity Change. 2024;15(6):1147&#x2010;1160.</Citation>
				</Reference>
				<Reference>
					<Citation>Robinson LE, Valido A, Drescher A, et al. Teachers, stress, and the COVID&#x2010;19 pandemic: a qualitative analysis. Sch Ment Heal. 2023;15:78&#x2010;89. https://doi.org/10.1007/s12310&#x2010;022&#x2010;09533&#x2010;2.</Citation>
				</Reference>
				<Reference>
					<Citation>U.S. Health and Human Services. COVID&#x2010;19 Public Health Emergency (PHE); 2023. https://www.hhs.gov/coronavirus/covid&#x2010;19&#x2010;public&#x2010;health&#x2010;emergency/index.html. Accessed May 8, 2020.</Citation>
				</Reference>
				<Reference>
					<Citation>Mucci GA, Collins E, Pearce E, et al. The lost years: an integrative review of the mental health, educational, and social impact of the pandemic on children and adolescents from 2019 to 2022. J Pediatr Neuropsychol. 2024;10:49&#x2010;90. https://doi.org/10.1007/s40817&#x2010;024&#x2010;00160&#x2010;0.</Citation>
				</Reference>
				<Reference>
					<Citation>Zimmerman KO, Benjamin DK. Lessons learned from the COVID&#x2010;19 pandemic in K&#x2010;12 education. Pediatrics. 2023;152(Supp 1):e2023060352O.</Citation>
				</Reference>
				<Reference>
					<Citation>Betth&#xe4;user BA, Bach&#x2010;Mortensen AM, Engzell P. A systematic review and meta&#x2010;analysis of the evidence on learning during the COVID&#x2010;19 pandemic. Nat Hum Behav. 2023;7(3):375&#x2010;385. https://doi.org/10.1038/s41562&#x2010;022&#x2010;01506&#x2010;4.</Citation>
				</Reference>
				<Reference>
					<Citation>Namkung JM, Goodrich JM, Hebert M, Koziol N. Impacts of the COVID&#x2010;19 pandemic on student learning and opportunity gaps across the 2020&#x2013;2021 school year: a National Survey of teachers. Front Educ. 2022;7:921497. https://doi.org/10.3389/feduc.2022.921497.</Citation>
				</Reference>
				<Reference>
					<Citation>Hesham Abdou Ahmed G. Special education teachers' mental health after reopening schools during Covid&#x2010;19. PLoS One. 2023;18(5):E0284870. https://doi.org/10.1371/journal.pone.0284870.</Citation>
				</Reference>
				<Reference>
					<Citation>Smith P, Oudyk J, Cedillo L, Inouye K, Potter G, Mustard C. The psychosocial work environment among educators during the COVID&#x2010;19 pandemic. Occup Med (Lond). 2022;72(7):439&#x2010;445. https://doi.org/10.1093/occmed/kqac050.</Citation>
				</Reference>
				<Reference>
					<Citation>Buskila Y, Chen&#x2010;Levi T. The role of authentic school leaders in promoting teachers' well&#x2010;being: perceptions of Israeli teachers. Athens J Educ. 2021;8(2):161&#x2010;180. https://doi.org/10.30958/aje.8&#x2010;2&#x2010;3.</Citation>
				</Reference>
				<Reference>
					<Citation>Dosil Santamar&#xed;a M, Idoiaga Mondragon N, Berasategi Santxo N, Ozamiz&#x2010;Etxebarria N. Teacher stress, anxiety and depression at the beginning of the academic year during the COVID&#x2010;19 pandemic. Glob Mental Health (Camb). 2021;8(14):1&#x2010;8. https://doi.org/10.1017/gmh.2021.14.</Citation>
				</Reference>
				<Reference>
					<Citation>Fan X. Study on stress management of college teachers based on employee assistance program. J Educ. 2023;203(4):812&#x2010;817. https://doi.org/10.1177/0022057421996255.</Citation>
				</Reference>
				<Reference>
					<Citation>Kim LE, Oxley L, Asbury K. &#x201c;My brain feels like a browser with 100 tabs open&#x201d;: a longitudinal study of teachers' mental health and well&#x2010;being during the COVID&#x2010;19 pandemic. Br J Educ Psychol. 2022;92(1):299&#x2010;318. https://doi.org/10.1111/bjep.12450.</Citation>
				</Reference>
				<Reference>
					<Citation>Nawaz K, Saeed H, Sajeel T. Covid&#x2010;19 and the state of research from the perspective of psychology. Int J Bus Psychol. 2020;2:35&#x2010;44.</Citation>
				</Reference>
				<Reference>
					<Citation>Codding RS, Collier&#x2010;Meek M, Jimerson S, Klingbeil DA, Mayer MJ, Miller F. School psychology reflections on COVID&#x2010;19, antiracism, and gender and racial disparities in publishing. Sch Psychol. 2020;35(4):227&#x2010;232. https://doi.org/10.1037/spq0000399.</Citation>
				</Reference>
			</ReferenceList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
			<PMID Version="1">39425035</PMID>
			<DateCompleted>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>18</Day>
			</DateCompleted>
			<DateRevised>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>21</Day>
			</DateRevised>
			<Article PubModel="Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1471-2377</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>24</Volume>
						<Issue>1</Issue>
						<PubDate>
							<Year>2024</Year>
							<Month>Oct</Month>
							<Day>18</Day>
						</PubDate>
					</JournalIssue>
					<Title>BMC neurology</Title>
					<ISOAbbreviation>BMC Neurol</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Chronic Overlapping Pain Conditions in people with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a sample from the Multi-site Clinical Assessment of ME/CFS (MCAM) study.</ArticleTitle>
				<Pagination>
					<StartPage>399</StartPage>
					<MedlinePgn>399</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="pii" ValidYN="Y">399</ELocationID>
				<ELocationID EIdType="doi" ValidYN="Y">10.1186/s12883-024-03872-0</ELocationID>
				<Abstract>
					<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Chronic overlapping pain conditions (COPCs), pain-related conditions that frequently occur together, may occur in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and could impact illness severity. This study aimed to identify comorbid COPCs in patients with ME/CFS and evaluate their&#xa0;impact on illness severity.</AbstractText>
					<AbstractText Label="METHODS" NlmCategory="METHODS">We used data from 923 participants in the Multi-Site Clinical Assessment of ME/CFS study, conducted in seven U.S. specialty clinics between 2012 and 2020, who completed the baseline assessment (595 ME/CFS and 328 healthy controls (HC)). COPCs included chronic low back pain (cLBP), chronic migraine/headache (cMHA), fibromyalgia (FM), interstitial cystitis/irritable bladder (IC/IB), irritable bowel syndrome (IBS), temporomandibular disorder (TMD). Illness severity was assessed through questionnaires measuring symptoms and functioning. Multivariate analysis of variance and analysis of covariance models were used for analyses. Log-binomial regression analyses were used to compute prevalence of COPCs and prevalence ratios (PR) between groups with 95% confidence intervals. Both unadjusted and adjusted results with age and sex are presented.</AbstractText>
					<AbstractText Label="RESULTS" NlmCategory="RESULTS">76% of participants with ME/CFS had at least one COPCs compared to 17.4% of HC. Among ME/CFS participants, cMHA was most prevalent (48.1%), followed by FM (45.0%), cLBP (33.1%), and IBS (31.6%). All individual COPCs, except TMD, were significantly more frequent in females than males. The unadjusted PR (ME/CFS compared to HC) was highest for FM [147.74 (95% confidence interval (CI)&#x2009;=&#x2009;20.83-1047.75], followed by cLBP [39.45 (12.73-122.27)], and IC/IB [13.78 (1.88-101.24)]. The significance and order did not change after age and sex adjustment. The COPC comorbidities of cLBP and FM each had a significant impact on most health measures, particularly in pain attributes (Cohen's d effect size 0.8 or larger). While the impact of COPC comorbidities on non-pain attributes and quality of life measures was less pronounced than that&#xa0;on pain, statistically significant differences between ME/CFS participants with and without COPCs were still evident.</AbstractText>
					<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">More than 75% of ME/CFS participants had one or more COPCs. Multiple COPCs further exacerbated illness severity, especially among females with ME/CFS. Assessment and management of COPCs may help improve the health and quality of life for patients with ME/CFS.</AbstractText>
					<CopyrightInformation>&#xa9; 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.</CopyrightInformation>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y" EqualContrib="Y">
						<LastName>Fall</LastName>
						<ForeName>Elizabeth A</ForeName>
						<Initials>EA</Initials>
						<AffiliationInfo>
							<Affiliation>Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. oki4@cdc.gov.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y" EqualContrib="Y">
						<LastName>Chen</LastName>
						<ForeName>Yang</ForeName>
						<Initials>Y</Initials>
						<AffiliationInfo>
							<Affiliation>Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. njl3@cdc.gov.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y" EqualContrib="Y">
						<LastName>Lin</LastName>
						<ForeName>Jin-Mann S</ForeName>
						<Initials>JS</Initials>
						<AffiliationInfo>
							<Affiliation>Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. dwe3@cdc.gov.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Issa</LastName>
						<ForeName>Anindita</ForeName>
						<Initials>A</Initials>
						<AffiliationInfo>
							<Affiliation>Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Brimmer</LastName>
						<ForeName>Dana J</ForeName>
						<Initials>DJ</Initials>
						<AffiliationInfo>
							<Affiliation>Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Bateman</LastName>
						<ForeName>Lucinda</ForeName>
						<Initials>L</Initials>
						<AffiliationInfo>
							<Affiliation>Bateman Horne Center, Salt Lake City, UT, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Lapp</LastName>
						<ForeName>Charles W</ForeName>
						<Initials>CW</Initials>
						<AffiliationInfo>
							<Affiliation>Hunter-Hopkins Center, Charlotte, NC, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Podell</LastName>
						<ForeName>Richard N</ForeName>
						<Initials>RN</Initials>
						<AffiliationInfo>
							<Affiliation>Richard N. Podell Medical, Summit, NJ, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Natelson</LastName>
						<ForeName>Benjamin H</ForeName>
						<Initials>BH</Initials>
						<AffiliationInfo>
							<Affiliation>Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Kogelnik</LastName>
						<ForeName>Andreas M</ForeName>
						<Initials>AM</Initials>
						<AffiliationInfo>
							<Affiliation>Basis Diagnostics, Redwood City, CA, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Klimas</LastName>
						<ForeName>Nancy G</ForeName>
						<Initials>NG</Initials>
						<AffiliationInfo>
							<Affiliation>Institute for Neuro Immune Medicine, Nova Southeastern University, Fort Lauderdale, FL, USA.</Affiliation>
						</AffiliationInfo>
						<AffiliationInfo>
							<Affiliation>Geriatric Research and Education Clinical Center, VA Medical Center, Miami, FL, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Peterson</LastName>
						<ForeName>Daniel L</ForeName>
						<Initials>DL</Initials>
						<AffiliationInfo>
							<Affiliation>Sierra Internal Medicine, Incline Village, NV, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Unger</LastName>
						<ForeName>Elizabeth R</ForeName>
						<Initials>ER</Initials>
						<AffiliationInfo>
							<Affiliation>Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<CollectiveName>MCAM Study Group</CollectiveName>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
					<PublicationType UI="D016448">Multicenter Study</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>18</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>England</Country>
				<MedlineTA>BMC Neurol</MedlineTA>
				<NlmUniqueID>100968555</NlmUniqueID>
				<ISSNLinking>1471-2377</ISSNLinking>
			</MedlineJournalInfo>
			<CitationSubset>IM</CitationSubset>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
					<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
					<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D005356" MajorTopicYN="Y">Fibromyalgia</DescriptorName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
					<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
					<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D059350" MajorTopicYN="Y">Chronic Pain</DescriptorName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
					<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D018856" MajorTopicYN="N">Cystitis, Interstitial</DescriptorName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
					<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
					<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D043183" MajorTopicYN="N">Irritable Bowel Syndrome</DescriptorName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
					<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
					<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D017116" MajorTopicYN="N">Low Back Pain</DescriptorName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
					<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D008881" MajorTopicYN="N">Migraine Disorders</DescriptorName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
					<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D013705" MajorTopicYN="N">Temporomandibular Joint Disorders</DescriptorName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
					<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
					<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName>
				</MeshHeading>
			</MeshHeadingList>
			<KeywordList Owner="NOTNLM">
				<Keyword MajorTopicYN="N">Chronic low back pain (cLBP)</Keyword>
				<Keyword MajorTopicYN="N">Chronic migraine/Headache (cMHA)</Keyword>
				<Keyword MajorTopicYN="N">Endometriosis</Keyword>
				<Keyword MajorTopicYN="N">Fibromyalgia (FM)</Keyword>
				<Keyword MajorTopicYN="N">Interstitial cystitis/Irritable bladder (IC/IB)</Keyword>
				<Keyword MajorTopicYN="N">Irritable bowel syndrome (IBS)</Keyword>
				<Keyword MajorTopicYN="N">Multimorbidity</Keyword>
				<Keyword MajorTopicYN="N">Myalgic encephalomyelitis/Chronic fatigue syndrome (ME/CFS)</Keyword>
				<Keyword MajorTopicYN="N">Temporomandibular disorder (TMD)</Keyword>
				<Keyword MajorTopicYN="N">Vulvodynia</Keyword>
			</KeywordList>
			<CoiStatement>The authors declare no competing interests.</CoiStatement>
			<InvestigatorList>
				<Investigator ValidYN="Y">
					<LastName>Tian</LastName>
					<ForeName>Hao</ForeName>
					<Initials>H</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Bonner</LastName>
					<ForeName>Kathleen</ForeName>
					<Initials>K</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Cornelius</LastName>
					<ForeName>Monica</ForeName>
					<Initials>M</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Dimulescu</LastName>
					<ForeName>Irina</ForeName>
					<Initials>I</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Helton</LastName>
					<ForeName>Britany</ForeName>
					<Initials>B</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Khin</LastName>
					<ForeName>Maung</ForeName>
					<Initials>M</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Rajeevan</LastName>
					<ForeName>Mangalathu</ForeName>
					<Initials>M</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Bland</LastName>
					<ForeName>Jennifer</ForeName>
					<Initials>J</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Jeys</LastName>
					<ForeName>Patricia</ForeName>
					<Initials>P</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Parkinson</LastName>
					<ForeName>Veronica</ForeName>
					<Initials>V</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Springs</LastName>
					<ForeName>Wendy</ForeName>
					<Initials>W</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Balbin</LastName>
					<ForeName>Elizabeth</ForeName>
					<Initials>E</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Cournoyer</LastName>
					<ForeName>Jeffry</ForeName>
					<Initials>J</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Fernandez</LastName>
					<ForeName>Melissa</ForeName>
					<Initials>M</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Parnell</LastName>
					<ForeName>Shuntae</ForeName>
					<Initials>S</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Leaks-Gutierrez</LastName>
					<ForeName>Precious</ForeName>
					<Initials>P</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Blate</LastName>
					<ForeName>Michelle</ForeName>
					<Initials>M</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Lange</LastName>
					<ForeName>Gudrun</ForeName>
					<Initials>G</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Khan</LastName>
					<ForeName>Sarah</ForeName>
					<Initials>S</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Vu</LastName>
					<ForeName>Diana</ForeName>
					<Initials>D</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Danver</LastName>
					<ForeName>Joan</ForeName>
					<Initials>J</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Kaufman</LastName>
					<ForeName>David</ForeName>
					<Initials>D</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Pa</LastName>
					<ForeName>Macy</ForeName>
					<Initials>M</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Phan</LastName>
					<ForeName>Catt</ForeName>
					<Initials>C</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Taleghani</LastName>
					<ForeName>Sophia</ForeName>
					<Initials>S</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Fitzpatrick</LastName>
					<ForeName>Trisha</ForeName>
					<Initials>T</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Licata</LastName>
					<ForeName>Beverly</ForeName>
					<Initials>B</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Lascu</LastName>
					<ForeName>Elena</ForeName>
					<Initials>E</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Gottschalk</LastName>
					<ForeName>Gunnar</ForeName>
					<Initials>G</Initials>
				</Investigator>
				<Investigator ValidYN="Y">
					<LastName>Maynard</LastName>
					<ForeName>Marco</ForeName>
					<Initials>M</Initials>
				</Investigator>
			</InvestigatorList>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="received">
					<Year>2024</Year>
					<Month>6</Month>
					<Day>12</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="accepted">
					<Year>2024</Year>
					<Month>9</Month>
					<Day>19</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>19</Day>
					<Hour>16</Hour>
					<Minute>24</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>19</Day>
					<Hour>16</Hour>
					<Minute>23</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>18</Day>
					<Hour>23</Hour>
					<Minute>44</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pmc-release">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>18</Day>
				</PubMedPubDate>
			</History>
			<PublicationStatus>epublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pubmed">39425035</ArticleId>
				<ArticleId IdType="pmc">PMC11488184</ArticleId>
				<ArticleId IdType="doi">10.1186/s12883-024-03872-0</ArticleId>
				<ArticleId IdType="pii">10.1186/s12883-024-03872-0</ArticleId>
			</ArticleIdList>
			<ReferenceList>
				<Reference>
					<Citation>Institute of Medicine. Beyond myalgic Encephalomyelitis/Chronic fatigue syndrome: redefining an illness. Natl Acad Press. 2015. 10.17226/19012.</Citation>
				</Reference>
				<Reference>
					<Citation>Bateman L, Darakjy S, Klimas N, Peterson D, Levine SM, Allen A, et al. Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study. Fatigue: Biomed Health Behav. 2014;3:1&#x2013;15. 10.1080/21641846.2014.978109.</Citation>
				</Reference>
				<Reference>
					<Citation>Bateman L, Bested AC, Bonilla HF, Chheda BV, Chu L, Curtin JM, et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: essentials of diagnosis and management. Mayo Clin Proc. 2021;96:96. 10.1016/j.mayocp.2021.07.004.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">34454716</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Glette M, Stiles TC, Woodhouse A, Ivar T, Landmark T. Chronic fatigue in the general population: prevalence, natural course and associations with chronic pain (the HUNT pain study). Eur J Pain. 2024. 10.1002/ejp.2307.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">38940382</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Maixner W, Fillingim RB, Williams DA, Smith SB, Slade GD. Overlapping chronic pain conditions: implications for diagnosis and classification. J Pain. 2016;17:T93&#x2013;107. 10.1016/j.jpain.2016.06.002.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC6193199</ArticleId>
						<ArticleId IdType="pubmed">27586833</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Tietjen GE, Brandes JL, Peterlin BL, Eloff A, Dafer RM, Stein MR, Drexler E, Martin VT, Hutchinson S, Aurora SK, Recober A. Allodynia in migraine: association with comorbid pain conditions. Headache: J Head Face Pain. 2009;49(9):1333&#x2013;44. 10.1111/j.1526-4610.2009.01521.x.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">19788473</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Bourke JH, Johnson AL, Sharpe M, Chalder T, White PD. Pain in chronic fatigue syndrome: response to rehabilitative treatments in the PACE trial. Psychol Med. 2013;44:1545&#x2013;52. 10.1017/s0033291713002201.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">23967878</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Ciccone DS, Natelson BH. Comorbid Illness in Women with chronic fatigue syndrome: a test of the single syndrome hypothesis. Psychosom Med. 2003;65:268&#x2013;75. 10.1097/01.PSY.0000033125.08272.A9.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">12651994</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Castro-Marrero J, Faro M, Aliste L, S&#xe1;ez-Franc&#xe0;s N, Calvo N, Mart&#xed;nez-Mart&#xed;nez A, de Sevilla TF, Alegre J. Comorbidity in chronic fatigue syndrome/myalgic encephalomyelitis: a nationwide population-based cohort study. Psychosomatics. 2017;58(5):533&#x2013;43. 10.1016/j.psym.2017.04.010.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">28596045</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Natelson BH, Lin J-MS, Lange G, Khan S, Stegner A, Unger ER. The effect of comorbid medical and psychiatric diagnoses on chronic fatigue syndrome. Ann Med. 2019;51:371&#x2013;8. 10.1080/07853890.2019.1683601.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC7877877</ArticleId>
						<ArticleId IdType="pubmed">31642345</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Robinson LJ, Durham J, Newton JL. A systematic review of the comorbidity between Temporomandibular disorders and chronic fatigue syndrome. J Rehabil. 2015;43:306&#x2013;16. 10.1111/joor.12367.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">26549386</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Chu L, Valencia IJ, Garvert DW, Montoya JG. Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome. Front Pead. 2019;7:12. 10.3389/fped.2019.00012.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC6370741</ArticleId>
						<ArticleId IdType="pubmed">30805319</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Ravindran MK, Zheng Y, Timbol C, Merck SJ, Baraniuk JN. Migraine headaches in chronic fatigue syndrome (CFS): comparison of two prospective cross-sectional studies. BMC Neurol. 2011;11:1&#x2013;9. 10.1186/1471-2377-11-30.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC3058027</ArticleId>
						<ArticleId IdType="pubmed">21375763</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Boneva RS, Lin JMS, Unger ER. Early menopause and other gynecologic risk indicators for chronic fatigue syndrome in women. Menopause. 2015;22:826&#x2013;34. 10.1097/GME.0000000000000411.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC5745581</ArticleId>
						<ArticleId IdType="pubmed">25647777</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Boneva RS, Lin J-MS, Wieser F, Nater UM, Ditzen B, Taylor RN, et al. Endometriosis as a comorbid condition in Chronic Fatigue Syndrome (CFS): secondary analysis of data from a CFS case-control study. Front Pead. 2019;7:195.10.3389/fped.2019.00195</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC6537603</ArticleId>
						<ArticleId IdType="pubmed">31179251</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Rusu C, Gee ME, Lagac&#xe9; C, Parlor M. Chronic fatigue syndrome and fibromyalgia in Canada: prevalence and associations with six health status indicators. Health Promot Chronic Dis Prev Can. 2015;35(1):3&#x2013;11. 10.24095/hpcdp.35.1.02.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC4939456</ArticleId>
						<ArticleId IdType="pubmed">25811400</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Schmaling KB, Betterton KL. Neurocognitive complaints and functional status among patients with chronic fatigue syndrome and fibromyalgia. Qual Life Res. 2016;25:1257&#x2013;63. 10.1007/s11136-015-1160-y.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC6115195</ArticleId>
						<ArticleId IdType="pubmed">26471263</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Brown MM, Jason LA. Functioning in individuals with chronic fatigue syndrome: increased impairment with co-occurring multiple chemical sensitivity and fibromyalgia. Dynamic Med. 2007;6:6. 10.1186/1476-5918-6-6.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC1890280</ArticleId>
						<ArticleId IdType="pubmed">17540028</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Jason LA, McManimen S, Sunnquist M, Newton JL, Strand EB. Examining those meeting IOM criteria versus IOM plus Fibromyalgia. Neurol (E-Cronicon). 2017;5(1):19.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC5510658</ArticleId>
						<ArticleId IdType="pubmed">28713879</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Reynolds KJ, Vernon SD, Bouchery E, Reeves WC. The economic impact of chronic fatigue syndrome. Cost Eff Resourc Alloc. 2004;2(1):4. 10.1186/1478-7547-2-4.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC449736</ArticleId>
						<ArticleId IdType="pubmed">15210053</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Bombardier CH, Buchwald D. Chronic fatigue, chronic fatigue syndrome, and fibromyalgia: disability and health-care use. Med Care. 1996;34(9):924. 10.1097/00005650-199609000-00005.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">8792781</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37&#x2013;43. 10.1016/S0140-6736(12)60240-2.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">22579043</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Unger ER, Lin J-MS, Tian H, Natelson BH, Lange G, Vu D, et al. Multi-site Clinical Assessment of myalgic Encephalomyelitis/Chronic fatigue syndrome (MCAM): design and implementation of a prospective/retrospective rolling cohort study. Am J Epidemiol. 2017;185:617&#x2013;26. 10.1093/aje/kwx029.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC5565838</ArticleId>
						<ArticleId IdType="pubmed">28338983</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Unger ER, Lin JM, Chen Y, Cornelius ME, Helton B, Issa AN, Bertolli J, Klimas NG, Balbin EG, Bateman L, Lapp CW. Heterogeneity in measures of illness among patients with myalgic Encephalomyelitis/Chronic fatigue syndrome is not explained by clinical practice: a study in seven US Specialty Clinics. J Clin Med. 2024;13(5):1369. 10.3390/jcm13051369.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC10931716</ArticleId>
						<ArticleId IdType="pubmed">38592199</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Cleeland C, Ryan K. Pain assessment: global use of the brief Pain Inventory. Ann Acad Med Singapore. 1994;23(2):129&#x2013;38.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">8080219</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Wagner D, Nisenbaum R, Heim C, Jones JF, Unger ER, Reeves WC. Psychometric properties of the CDC Symptom Inventory for assessment of chronic fatigue syndrome. Popul Health Metrics. 2005;3(1):1&#x2013;8. 10.1186/1478-7954-3-8.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC1183246</ArticleId>
						<ArticleId IdType="pubmed">16042777</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Smets E, Garssen B, Bonke B, De de J. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39(3):315&#x2013;25. 10.1016/0022-3999(94)00125-O.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">7636775</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Lin JMS, Brimmer DJ, Maloney EM, Nyarko E, BeLue R, Reeves WC. Further validation of the multidimensional fatigue inventory in a US adult population sample. Popul Health Metrics. 2009;7(1):1&#x2013;13. 10.1186/1478-7954-7-18.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC2801470</ArticleId>
						<ArticleId IdType="pubmed">20003524</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Lai J-S, Cella D, Choi S, Junghaenel DU, Christodoulou C, Gershon R, et al. How item banks and their application can influence measurement practice in rehabilitation medicine: a PROMIS fatigue item bank example. Arch Phys Med Rehabil. 2011;92:S20&#x2013;7. 10.1016/j.apmr.2010.08.033.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC3696589</ArticleId>
						<ArticleId IdType="pubmed">21958919</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Yang M, Keller S, Lin JMS. Psychometric properties of the PROMIS&#xae; fatigue short form 7a among adults with myalgic encephalomyelitis/chronic fatigue syndrome. Qual Life Res. 2019;28:3375&#x2013;84. 10.1007/s11136-019-02289-4.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">31506915</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Revicki DA, Chen WH, Harnam N, et al. Development and psychometric analysis of the PROMIS pain behavior item bank. Pain. 2009;146(1&#x2013;2):158&#x2013;69. 10.1016/j.pain.2009.07.029.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC2775487</ArticleId>
						<ArticleId IdType="pubmed">19683873</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Yang M, Keller S, Lin JMS. Assessing sleep and pain among adults with myalgic encephalomyelitis/chronic fatigue syndrome: psychometric evaluation of the PROMIS&#xae; sleep and pain short forms. Qual Life Res. 2022;31(12):3483&#x2013;99. 10.1007/s11136-022-03199-8.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC9331042</ArticleId>
						<ArticleId IdType="pubmed">35896905</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Amtmann D, Cook KF, Jensen MP, et al. Development of a PROMIS item bank to measure pain interference. Pain. 2010;150(1):173&#x2013;82. 10.1016/j.pain.2010.04.025.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC2916053</ArticleId>
						<ArticleId IdType="pubmed">20554116</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Buysse DJ, Yu L, Moul DE, et al. Development and validation of patient-reported outcome measures for sleep disturbance and sleep-related impairments. Sleep. 2010;33(6):781&#x2013;92. 10.1093/sleep/33.6.781.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC2880437</ArticleId>
						<ArticleId IdType="pubmed">20550019</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Ware JE Jr. SF-36 health survey update. Spine. 2000;25(24):3130&#x2013;9. 10.1097/00007632-200012150-00008.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">11124729</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Moriarty DG, Zack MM, Kobau R. The Centers for Disease Control and Prevention&#x2019;s Healthy days measures&#x2013;Population tracking of perceived physical and mental health over time. Health Qual Life Outcomes. 2003;1(1):1&#x2013;8. 10.1186/1477-7525-1-37.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC201011</ArticleId>
						<ArticleId IdType="pubmed">14498988</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>SAS Institute Inc. SAS [software]. Version 9.4. Cary: SAS Institute Inc; 2013.</Citation>
				</Reference>
				<Reference>
					<Citation>Wickham H. Ggplot2: elegant graphics for data analysis. New York: Springer; 2016.</Citation>
				</Reference>
				<Reference>
					<Citation>Conway JR, Lex A, Gehlenborg N. UpSetR: an R package for the visualization of intersecting sets and their properties. Bioinformatics. 2017;33(18):2938&#x2013;40. 10.1093/bioinformatics/btx364.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC5870712</ArticleId>
						<ArticleId IdType="pubmed">28645171</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Faro M, S&#xe0;ez-Franc&#xe1;s N, Castro-Marrero J, Aliste L, Fern&#xe1;ndez de Sevilla T, Alegre J. Gender differences in chronic fatigue syndrome. Reumatol Cl&#xed;n (English Edition). 2016;12(2):72&#x2013;7. 10.1016/j.reuma.2015.05.007.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">26190206</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Schmaling KB, Fales JL, McPherson S. Longitudinal outcomes associated with significant other responses to chronic fatigue and pain. J Health Psychol. 2020;25(5):692&#x2013;702. 10.1177/1359105317731824.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">28925285</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Aaron LA, Burke MM, Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med. 2000;160(2):221&#x2013;7. 10.1001/archinte.160.2.221.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">10647761</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Haider S, Janowski AJ, Lesnak JB, Hayashi K, Dailey DL, Chimenti R, Frey-Law LA, Sluka KA, Berardi G. A comparison of pain, fatigue, and function between post&#x2013;COVID-19 condition, fibromyalgia, and chronic fatigue syndrome: a survey study. Pain. 2023;164(2):385&#x2013;401. 10.1097/j.pain.0000000000002711.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC9797623</ArticleId>
						<ArticleId IdType="pubmed">36006296</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Robinson LJ, Durham J, MacLachlan LL, Newton JL. Autonomic function in chronic fatigue syndrome with and without painful temporomandibular disorder. Fatigue: Biomed Health Behav. 2015;3(4):205&#x2013;19. 10.1080/21641846.2015.1091152.</Citation>
				</Reference>
				<Reference>
					<Citation>Ciccone DS, Chandler HK, Natelson BH. Illness trajectories in the chronic fatigue syndrome. J Nerv Mental Disease. 2010;198:486&#x2013;93. 10.1097/NMD.0b013e3181e4ce0b.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">20611051</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Terkawi AS, Popat RA, Mackey S. Characterization and burden of localized back pain versus back pain with chronic overlapping pain conditions. Pain Pract. 2023;23(8):904&#x2013;13. 10.1111/papr.13267.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">37392043</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Ickmans K, Meeus M, De Kooning M, Lambrecht L, Pattyn N, Nijs J. Associations between cognitive performance and pain in chronic fatigue syndrome: comorbidity with fibromyalgia does matter. Physiotherapy. 2015;101:e635&#x2013;6. 10.1016/j.physio.2015.03.3465.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">26431138</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>McDonagh MS, Selph SS, Buckley DI, Holmes RS, Mauer K, Ramirez S, Hsu FC, Dana T, Fu R, Chou R. Nonopioid pharmacologic treatments for chronic pain. Comparative effectiveness review No. 228. (prepared by the Pacific Northwest Evidence-based Practice Center under contract No. 290-2015-00009-I.) AHRQ publication No. 20-EHC010. Rockville: Agency for Healthcare Research and Quality; 2020. 10.23970/AHRQEPCCER228.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">32338847</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC clinical practice guideline for prescribing opioids for pain&#x2014;United States, 2022. MMWR Recommend Rep. 2022;71(3):1. 10.15585/mmwr.rr7103a1.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC9639433</ArticleId>
						<ArticleId IdType="pubmed">36327391</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Lacy BE, Pimentel M, Brenner DM, et al. ACG Clinical Guideline: management of irritable bowel syndrome. Official J Am Coll Gastroenterol | ACG. 2021;116(1). 10.14309/ajg.0000000000001036.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">33315591</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Clemens JQ, Erickson DR, Varela NP, Lai HH. Diagnosis and treatment of interstitial Cystitis/Bladder Pain Syndrome. J Urol. 2022;208(1):34&#x2013;42. 10.1097/JU.0000000000002756.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">35536143</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Busse JW, Casassus R, Carrasco-Labra A, Durham J, Mock D, Zakrzewska JM, et al. Management of chronic pain associated with temporomandibular disorders: a clinical practice guideline. BMJ. 2023;383:e076227. 10.1136/bmj-2023-076227.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">38101929</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Hovaguimian A, Roth J. Management of chronic migraine. BMJ. 2022;379:e067670. 10.1136/bmj-2021-067670.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">36216384</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Becker CM, Bokor A, Heikinheimo O, Horne A, Jansen F, Kiesel L, King K, Kvaskoff M, Nap A, Petersen K, Saridogan E. ESHRE guideline: endometriosis. Hum Reprod open. 2022;2022(2):hoac009. 10.1093/hropen/hoac009.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC8951218</ArticleId>
						<ArticleId IdType="pubmed">35350465</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Schlaeger JM, Glayzer JE, Villegas-Downs M, Li H, Glayzer EJ, He Y, et al. Evaluation and treatment of Vulvodynia: state of the Science. J Midwifery Women&#x2019;s Health. 2022;68:9&#x2013;34. 10.1111/jmwh.13456.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC10107324</ArticleId>
						<ArticleId IdType="pubmed">36533637</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Unger ER, Lin JMS, Brimmer DJ, et al. CDC grand rounds: chronic fatigue syndrome&#x2014;advancing research and clinical education. MMWR Morbidity Mortal Wkly Rep. 2016;65:1434&#x2013;8. 10.15585/mmwr.mm655051a4.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">28033311</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Skelly AC, Chou R, Dettori JR, Turner JA, Friedly JL, Rundell SD, Fu R, Brodt ED, Wasson N, Kantner S, Ferguson AJR. April. Noninvasive Nonpharmacological Treatment for Chronic Pain: A Systematic Review Update. Comparative Effectiveness Review No. 227. (Prepared by the Pacific Northwest Evidence-based Practice Center under Contract No. 290-2015-00009-I.) AHRQ Publication No. 20-EHC009. Rockville, MD: Agency for Healthcare Research and Quality; 2020. 10.23970/AHRQEPCCER227</Citation>
				</Reference>
			</ReferenceList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Status="Publisher" Owner="NLM">
			<PMID Version="1">39423465</PMID>
			<DateRevised>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>18</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1879-1360</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>187</Volume>
						<PubDate>
							<Year>2024</Year>
							<Month>Oct</Month>
							<Day>11</Day>
						</PubDate>
					</JournalIssue>
					<Title>Journal of psychosomatic research</Title>
					<ISOAbbreviation>J Psychosom Res</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Predictors of treatment response trajectories to cognitive behavioral therapy for chronic fatigue syndrome: A cohort study.</ArticleTitle>
				<Pagination>
					<StartPage>111954</StartPage>
					<MedlinePgn>111954</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jpsychores.2024.111954</ELocationID>
				<ELocationID EIdType="pii" ValidYN="Y">S0022-3999(24)00366-0</ELocationID>
				<Abstract>
					<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The response to cognitive behavioral therapy (CBT) for chronic fatigue syndrome (CFS) varies greatly between patients, but predictors of treatment success remain to be elucidated. We aimed to identify patient subgroups based on fatigue trajectory during CBT, identify pre-treatment predictors of subgroup membership, and disentangle the direction of predictor - outcome relationships over time.</AbstractText>
					<AbstractText Label="METHODS" NlmCategory="METHODS">297 individuals with CFS were enrolled in a standardized CBT program consisting of 17 sessions, with session timing variable between participants. Self-reported levels of fatigue, depressive, anxiety, and somatic symptoms, perceived stress, and positive affect were collected pre-treatment, and after 3, 10, and 15 sessions. Latent Class Growth Analysis (LCGA) was used to identify subgroups based on fatigue trajectories and baseline predictors of group membership. Cross-lagged structural equation models were used to disentangle predictor-outcome relationships.</AbstractText>
					<AbstractText Label="RESULTS" NlmCategory="RESULTS">LCGA identified four fatigue trajectory subgroups, which were labelled as "no improvement" (23&#xa0;%), "weak improvement" (45&#xa0;%), "moderate improvement" (23&#xa0;%), and "strong improvement" (9&#xa0;%) classes. Higher pre-treatment levels of depressive, anxiety, and somatic symptoms, stress, and lower levels of positive affect predicted membership of the "no improvement" subgroup. Reductions in anxiety preceded reductions in fatigue, while the depressive symptoms - fatigue relationship was bidirectional.</AbstractText>
					<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">On a group level, there were statistically significant reductions in fatigue after 15 sessions of CBT, with important individual differences in treatment response. Higher pre-treatment levels of anxious, depressive, and somatic symptoms and perceived stress are predictors of lack of response, with reductions in anxiety and stress preceding improvements in fatigue.</AbstractText>
					<CopyrightInformation>Copyright &#xa9; 2024. Published by Elsevier Inc.</CopyrightInformation>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Van Oudenhove</LastName>
						<ForeName>Lukas</ForeName>
						<Initials>L</Initials>
						<AffiliationInfo>
							<Affiliation>Laboratory for Brain-Gut Axis Studies (LaBGAS), Translational Research in Gastrointestinal Disorders (TARGID), Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, Leuven, Belgium; Leuven Brain Institute, KU Leuven, Leuven, Belgium; Cognitive &amp; Affective Neuroscience Lab (CANLab), Department of Psychological and Brain Sciences, Dartmouth College, Hanover, NH, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Debyser</LastName>
						<ForeName>Soetkin</ForeName>
						<Initials>S</Initials>
						<AffiliationInfo>
							<Affiliation>Laboratory for Brain-Gut Axis Studies (LaBGAS), Translational Research in Gastrointestinal Disorders (TARGID), Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, Leuven, Belgium.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Vergaelen</LastName>
						<ForeName>Elfi</ForeName>
						<Initials>E</Initials>
						<AffiliationInfo>
							<Affiliation>University Psychiatric Center KU Leuven, University Hospital Leuven, Leuven, Belgium; Mind Body Research, Psychiatry Research Group, Department of Neurosciences, KULeuven, Leuven, Belgium.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Claes</LastName>
						<ForeName>Stephan</ForeName>
						<Initials>S</Initials>
						<AffiliationInfo>
							<Affiliation>University Psychiatric Center KU Leuven, University Hospital Leuven, Leuven, Belgium; Mind Body Research, Psychiatry Research Group, Department of Neurosciences, KULeuven, Leuven, Belgium.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Van Den Houte</LastName>
						<ForeName>Maaike</ForeName>
						<Initials>M</Initials>
						<AffiliationInfo>
							<Affiliation>Laboratory for Brain-Gut Axis Studies (LaBGAS), Translational Research in Gastrointestinal Disorders (TARGID), Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, Leuven, Belgium; Leuven Brain Institute, KU Leuven, Leuven, Belgium; REVAL - Rehabilitation Research Center, Faculty of Rehabilitation Sciences, Hasselt University, Diepenbeek, Belgium. Electronic address: maaike.vandenhoute@kuleuven.be.</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>11</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>England</Country>
				<MedlineTA>J Psychosom Res</MedlineTA>
				<NlmUniqueID>0376333</NlmUniqueID>
				<ISSNLinking>0022-3999</ISSNLinking>
			</MedlineJournalInfo>
			<CitationSubset>IM</CitationSubset>
			<KeywordList Owner="NOTNLM">
				<Keyword MajorTopicYN="N">Chronic fatigue syndrome</Keyword>
				<Keyword MajorTopicYN="N">Cognitive behavioral therapy</Keyword>
				<Keyword MajorTopicYN="N">Cross-lagged panel models</Keyword>
				<Keyword MajorTopicYN="N">Predictors</Keyword>
			</KeywordList>
			<CoiStatement>Declaration of competing interest Elfi Vergaelen has been coordinator of the multidisciplinary diagnostic CFS center and Stephan Claes is coordinator of the multidisciplinary diagnostic CFS center which is subsidized by the Belgian social security system (RIZIV).</CoiStatement>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="received">
					<Year>2024</Year>
					<Month>6</Month>
					<Day>10</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="revised">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>8</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="accepted">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>9</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>18</Day>
					<Hour>18</Hour>
					<Minute>22</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>18</Day>
					<Hour>18</Hour>
					<Minute>22</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>18</Day>
					<Hour>18</Hour>
					<Minute>0</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>aheadofprint</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pubmed">39423465</ArticleId>
				<ArticleId IdType="doi">10.1016/j.jpsychores.2024.111954</ArticleId>
				<ArticleId IdType="pii">S0022-3999(24)00366-0</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
			<PMID Version="1">39418958</PMID>
			<DateCompleted>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>26</Day>
			</DateCompleted>
			<DateRevised>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>26</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1876-035X</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>17</Volume>
						<Issue>11</Issue>
						<PubDate>
							<Year>2024</Year>
							<Month>Nov</Month>
						</PubDate>
					</JournalIssue>
					<Title>Journal of infection and public health</Title>
					<ISOAbbreviation>J Infect Public Health</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Risk of chronic fatigue syndrome after COVID-19: A retrospective cohort study of 3227281 patients.</ArticleTitle>
				<Pagination>
					<StartPage>102559</StartPage>
					<MedlinePgn>102559</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jiph.2024.102559</ELocationID>
				<ELocationID EIdType="pii" ValidYN="Y">S1876-0341(24)00293-4</ELocationID>
				<Abstract>
					<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Many patients who recovered from COVID-19 still suffer from chronic fatigue syndrome (CFS). It was observed that patients with comorbidities were more prone to developing CFS. This research investigates the risk of post-COVID-19 CFS to assist healthcare professionals in reducing the risk of CFS.</AbstractText>
					<AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective cohort study is conducted to investigate the risk of post-COVID-19 CFS based on the TriNetX-sourced electronic health records. Factors including age, sex, race, vaccination, and severity of COVID-19 are analysed. Propensity score matching was applied to balance COVID-19 and non-COVID-19 cohorts. Kaplan-Meier analysis and Cox proportional hazard model were used to perform the relationship between COVID-19 and CFS risk.</AbstractText>
					<AbstractText Label="RESULTS" NlmCategory="RESULTS">This research involved 3227281 patients with COVID-19 and 3227281 with non-COVID-19 between 1st January 2020 and 31st December 2023. The incidence of CFS was higher in the COVID-19 group compared to the non-COVID-19 group at 1 follow-up intervals (HR 1.59, 95&#xa0;% CI = 1.54-1.63). Subgroup analysis revealed increased CFS risk across different age groups (&gt;18), sexes, races, and comorbid conditions, with notable variations.</AbstractText>
					<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">COVID-19 patients have a higher risk of developing CFS compared to individuals without COVID-19. The increased risk is particularly significant in adults aged 18 years and older.</AbstractText>
					<CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Chen</LastName>
						<ForeName>Chih-Wei</ForeName>
						<Initials>CW</Initials>
						<AffiliationInfo>
							<Affiliation>National Yang Ming Chiao Tung University, Hsinchu, Taiwan; National Council for Sustainable Development (NCSD), Executive Yuan, Taiwan Govt, Taiwan; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; University College London, London, UK.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Lee</LastName>
						<ForeName>Hsun-Hua</ForeName>
						<Initials>HH</Initials>
						<AffiliationInfo>
							<Affiliation>Department of Neurology, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan; Department of Neurology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Dizziness and Balance Disorder Center, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan; Department of Neurology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan; Dizziness and Balance Disorder Center, Taipei Medical University Hospital, Taipei Medical University, Taipei City, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Chang</LastName>
						<ForeName>Shu-Hao</ForeName>
						<Initials>SH</Initials>
						<AffiliationInfo>
							<Affiliation>Division of Pulmonary Medicine, Department of Internal Medicine, Cheng Ching Hospital, Taichung, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Chen</LastName>
						<ForeName>Yi-Ling</ForeName>
						<Initials>YL</Initials>
						<AffiliationInfo>
							<Affiliation>Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Cheng Ching Hospital, Taichung, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Wang</LastName>
						<ForeName>Yu-Hsun</ForeName>
						<Initials>YH</Initials>
						<AffiliationInfo>
							<Affiliation>Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Leong</LastName>
						<ForeName>Pui-Ying</ForeName>
						<Initials>PY</Initials>
						<AffiliationInfo>
							<Affiliation>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Division of Allergy, Immunology &amp; Rheumatology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan. Electronic address: fiona.leong@gmail.com.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Wei</LastName>
						<ForeName>James Cheng-Chung</ForeName>
						<Initials>JC</Initials>
						<AffiliationInfo>
							<Affiliation>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Division of Allergy, Immunology &amp; Rheumatology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan; Department of Nursing, Chung Shan Medical University, Taichung, Taiwan; Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan; Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan. Electronic address: jccwei@gmail.com.</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>03</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>England</Country>
				<MedlineTA>J Infect Public Health</MedlineTA>
				<NlmUniqueID>101487384</NlmUniqueID>
				<ISSNLinking>1876-0341</ISSNLinking>
			</MedlineJournalInfo>
			<CitationSubset>IM</CitationSubset>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
					<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName>
				</MeshHeading>
			</MeshHeadingList>
			<KeywordList Owner="NOTNLM">
				<Keyword MajorTopicYN="N">COVID-19</Keyword>
				<Keyword MajorTopicYN="N">Chronic fatigue syndrome</Keyword>
				<Keyword MajorTopicYN="N">Hypertensive disease</Keyword>
				<Keyword MajorTopicYN="N">Ischemic heart diseases</Keyword>
				<Keyword MajorTopicYN="N">Overweight and obesity</Keyword>
			</KeywordList>
			<CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="received">
					<Year>2024</Year>
					<Month>4</Month>
					<Day>30</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="revised">
					<Year>2024</Year>
					<Month>9</Month>
					<Day>5</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="accepted">
					<Year>2024</Year>
					<Month>9</Month>
					<Day>30</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>27</Day>
					<Hour>17</Hour>
					<Minute>12</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>18</Day>
					<Hour>7</Hour>
					<Minute>19</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>17</Day>
					<Hour>18</Hour>
					<Minute>9</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pubmed">39418958</ArticleId>
				<ArticleId IdType="doi">10.1016/j.jiph.2024.102559</ArticleId>
				<ArticleId IdType="pii">S1876-0341(24)00293-4</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Status="Publisher" Owner="NLM">
			<PMID Version="1">39405447</PMID>
			<DateRevised>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>15</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1469-7793</ISSN>
					<JournalIssue CitedMedium="Internet">
						<PubDate>
							<Year>2024</Year>
							<Month>Oct</Month>
							<Day>15</Day>
						</PubDate>
					</JournalIssue>
					<Title>The Journal of physiology</Title>
					<ISOAbbreviation>J Physiol</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Sweet relief: make the brain Glo against diabetic cognitive fog.</ArticleTitle>
				<ELocationID EIdType="doi" ValidYN="Y">10.1113/JP287622</ELocationID>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Dabertrand</LastName>
						<ForeName>Fabrice</ForeName>
						<Initials>F</Initials>
						<Identifier Source="ORCID">0000-0003-2541-9185</Identifier>
						<AffiliationInfo>
							<Affiliation>Department of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation>
						</AffiliationInfo>
						<AffiliationInfo>
							<Affiliation>Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<GrantList CompleteYN="Y">
					<Grant>
						<GrantID>MDBR-23-025-CADASIL</GrantID>
						<Agency>Orphan Disease Center, Perelman School of Medicine, University of Pennsylvania (ODC)</Agency>
						<Country/>
					</Grant>
					<Grant>
						<GrantID>RF1NS140137</GrantID>
						<Agency>National Institute of Neurological Disorders and Stroke (NINDS)</Agency>
						<Country/>
					</Grant>
					<Grant>
						<GrantID>RF1NS129022</GrantID>
						<Agency>National Institute of Neurological Disorders and Stroke (NINDS)</Agency>
						<Country/>
					</Grant>
					<Grant>
						<GrantID>R01HL136636</GrantID>
						<Agency>National Heart, Lung, and Blood Institute (NHLBI)</Agency>
						<Country/>
					</Grant>
					<Grant>
						<Agency>Leducq Foundation for Cardiovascular Research (Leducq Transatlantic Network of Excellence 22CVD01 BRENDA)</Agency>
						<Country/>
					</Grant>
				</GrantList>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>15</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>England</Country>
				<MedlineTA>J Physiol</MedlineTA>
				<NlmUniqueID>0266262</NlmUniqueID>
				<ISSNLinking>0022-3751</ISSNLinking>
			</MedlineJournalInfo>
			<CitationSubset>IM</CitationSubset>
			<KeywordList Owner="NOTNLM">
				<Keyword MajorTopicYN="N">diabetes</Keyword>
				<Keyword MajorTopicYN="N">methylglyoxal</Keyword>
				<Keyword MajorTopicYN="N">neurovascular coupling</Keyword>
				<Keyword MajorTopicYN="N">vascular contribution to cognitive impairment and dementia</Keyword>
			</KeywordList>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="received">
					<Year>2024</Year>
					<Month>9</Month>
					<Day>30</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="accepted">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>3</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>15</Day>
					<Hour>18</Hour>
					<Minute>22</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>15</Day>
					<Hour>18</Hour>
					<Minute>22</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>15</Day>
					<Hour>15</Hour>
					<Minute>13</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>aheadofprint</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pubmed">39405447</ArticleId>
				<ArticleId IdType="doi">10.1113/JP287622</ArticleId>
			</ArticleIdList>
			<ReferenceList>
				<Title>References</Title>
				<Reference>
					<Citation>Barbiellini Amidei, C., Fayosse, A., Dumurgier, J., Machado&#x2010;Fragua, M. D., Tabak, A. G., van Sloten, T., Kivimaki, M., Dugravot, A., Sabia, S., &amp; Singh&#x2010;Manoux, A. (2021). Association between age at diabetes onset and subsequent risk of dementia. Journal of the American Medical Association, 325(16), 1640&#x2013;1649.</Citation>
				</Reference>
				<Reference>
					<Citation>Berends, E., Pencheva, M. G., van de Waarenburg, M. P. H., Scheijen, J., Hermes, D., Wouters, K., van Oostenbrugge, R. J., Foulquier, S., &amp; Schalkwijk, C. G. (2024). Glyoxalase 1 overexpression improves neurovascular coupling and limits development of mild cognitive impairment in a mouse model of type 1 diabetes. The Journal of Physiology. Advance online publication. https://doi.org/10.1113/JP286723</Citation>
				</Reference>
				<Reference>
					<Citation>Bosetti, F., Galis, Z. S., Bynoe, M. S., Charette, M., Cipolla, M. J., del Zoppo, G. J., Gould, D., Hatsukami, T. S., Jones, T. L., Koenig, J. I., Lutty, G. A., Maric&#x2010;Bilkan, C., Stevens, T., Tolunay, H. E., Koroshetz, W., &amp; &#x201c;Small Blood Vessels: Big Health Problems&#x201d; Workshop P. (2016). &#x201c;Small Blood Vessels: Big Health Problems?&#x201d;: Scientific recommendations of the national institutes of health workshop. Journal of the American Heart Association, 5(11), e004389.</Citation>
				</Reference>
				<Reference>
					<Citation>Dabertrand, F., Harraz, O. F., Koide, M., Longden, T. A., Rosehart, A. C., Hill&#x2010;Eubanks, D. C., Joutel, A., &amp; Nelson, M. T. (2021). PIP2 corrects cerebral blood flow deficits in small vessel disease by rescuing capillary Kir2.1 activity. Proceedings of the National Academy of Sciences of the United States of America, 118(17), e2025998118.</Citation>
				</Reference>
				<Reference>
					<Citation>Schalkwijk, C. G., &amp; Stehouwer, C. D. A. (2020). Methylglyoxal, a highly reactive Dicarbonyl compound, in diabetes, its vascular complications, and other age&#x2010;related diseases. Physiological Reviews, 100(1), 407&#x2013;461.</Citation>
				</Reference>
			</ReferenceList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
			<PMID Version="1">39399822</PMID>
			<DateRevised>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>15</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Print">2213-4220</ISSN>
					<JournalIssue CitedMedium="Print">
						<Volume>13</Volume>
						<Issue>4</Issue>
						<PubDate>
							<Year>2024</Year>
							<Month>Dec</Month>
						</PubDate>
					</JournalIssue>
					<Title>Integrative medicine research</Title>
					<ISOAbbreviation>Integr Med Res</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Long-term follow-up of the treatment for severe COVID-19 with qigong exercise and acupressure: A randomized controlled trial.</ArticleTitle>
				<Pagination>
					<StartPage>101084</StartPage>
					<MedlinePgn>101084</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="pii" ValidYN="Y">101084</ELocationID>
				<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.imr.2024.101084</ELocationID>
				<Abstract>
					<AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Most clinical trials have reported significant short-term effects of traditional medicine therapies on COVID-19 patients. However, there is no clinical trial to determine the long-term effects of traditional medicine therapies on severe COVID-19 patients.</AbstractText>
					<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A total of 128 patients with severe COVID-19, who were recruited in our previous clinical trial following hospital discharge, were monitored at months 14 and 28. This trial aims to evaluate the long-term effect of an early Qigong exercise and acupressure rehabilitation program on patients with severe COVID-19.The intervention group received qigong exercise and acupressure therapy, plus standard therapies. The control group received standard therapies.The study was a single-center, parallel, randomized, prospective follow-up study. The outcomes of the study included changes in the modified Borg dyspnea scale (MBS), the modified Medical Research Council dyspnea scale (mMRC), the patient health questionnaire-9 scale (PHQ-9), the activity of daily living (ADL), the remaining clinical symptoms and any intervention related adverse events.</AbstractText>
					<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The intervention group showed a statistically significant improvement in the mMRC scores (-0.4, 95 % CI (-0.6, 0.2), 
						<i>P</i> &lt; 0.001) and the MBS scores (-0.6, 95 % CI (-0.9, -0.3), 
						<i>P</i> &lt; 0.001) after 14 months of discharge compared with the control group. At 28 months of discharge, the intervention group, compared with the control group alone, significantly increased their MBS scores (-0.4, 95 % CI (-0.7, -0.1), 
						<i>P</i> = 0.024) and a significantly decreased positive rate of dyspnea symptoms after 14 months of discharge (
						<i>P</i> &lt; 0.05). However, ADL and PHQ-9 scores showed no significant difference between the two groups during the follow-up (
						<i>P</i> &gt; 0.05).
					</AbstractText>
					<AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">QARP had long-term sustained efficacy for dyspnea, chest tightness, and cough in patients with COVID-19, especially in young and middle-aged patients, and the effect was significant at the 14th month of follow-up.</AbstractText>
					<AbstractText Label="TRIAL REGISTRATION" NlmCategory="UNASSIGNED">This trial was registered at the China Clinical Trial Registry (ChiCTR2100044572).</AbstractText>
					<CopyrightInformation>&#xa9; 2024 Korea Institute of Oriental Medicine. Published by Elsevier B.V.</CopyrightInformation>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Liu</LastName>
						<ForeName>Shuting</ForeName>
						<Initials>S</Initials>
						<AffiliationInfo>
							<Affiliation>School of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation>
						</AffiliationInfo>
						<AffiliationInfo>
							<Affiliation>Department of Rehabilitation Medicine, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China.</Affiliation>
						</AffiliationInfo>
						<AffiliationInfo>
							<Affiliation>Department of Rehabilitation Medicine, Suzhou Hospital of Traditional Chinese Medicine, Suzhou, China.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Zhu</LastName>
						<ForeName>Ranran</ForeName>
						<Initials>R</Initials>
						<AffiliationInfo>
							<Affiliation>School of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Yao</LastName>
						<ForeName>Chongjie</ForeName>
						<Initials>C</Initials>
						<AffiliationInfo>
							<Affiliation>School of Acupuncture-Moxibustion and Tuina, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation>
						</AffiliationInfo>
						<AffiliationInfo>
							<Affiliation>Department of Rehabilitation Medicine, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Zhan</LastName>
						<ForeName>Chao</ForeName>
						<Initials>C</Initials>
						<AffiliationInfo>
							<Affiliation>Department of Rehabilitation Medicine, Huangshi Hospital of Traditional Chinese Medicine, Hubei, China.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Wang</LastName>
						<ForeName>Jinxiang</ForeName>
						<Initials>J</Initials>
						<AffiliationInfo>
							<Affiliation>School of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Fang</LastName>
						<ForeName>Min</ForeName>
						<Initials>M</Initials>
						<AffiliationInfo>
							<Affiliation>Department of Rehabilitation Medicine, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Fang</LastName>
						<ForeName>Lei</ForeName>
						<Initials>L</Initials>
						<AffiliationInfo>
							<Affiliation>School of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, Shanghai, China.</Affiliation>
						</AffiliationInfo>
						<AffiliationInfo>
							<Affiliation>Department of Rehabilitation Medicine, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai, China.</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2024</Year>
					<Month>09</Month>
					<Day>05</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>Netherlands</Country>
				<MedlineTA>Integr Med Res</MedlineTA>
				<NlmUniqueID>101612707</NlmUniqueID>
				<ISSNLinking>2213-4220</ISSNLinking>
			</MedlineJournalInfo>
			<KeywordList Owner="NOTNLM">
				<Keyword MajorTopicYN="N">Acupressure</Keyword>
				<Keyword MajorTopicYN="N">COVID-19</Keyword>
				<Keyword MajorTopicYN="N">Qigong</Keyword>
				<Keyword MajorTopicYN="N">Randomized controlled trial</Keyword>
			</KeywordList>
			<CoiStatement>The authors declare no conflict of interests.</CoiStatement>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="received">
					<Year>2024</Year>
					<Month>4</Month>
					<Day>12</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="revised">
					<Year>2024</Year>
					<Month>7</Month>
					<Day>30</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="accepted">
					<Year>2024</Year>
					<Month>9</Month>
					<Day>2</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>14</Day>
					<Hour>16</Hour>
					<Minute>19</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>14</Day>
					<Hour>16</Hour>
					<Minute>18</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>14</Day>
					<Hour>7</Hour>
					<Minute>29</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pmc-release">
					<Year>2024</Year>
					<Month>9</Month>
					<Day>5</Day>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pubmed">39399822</ArticleId>
				<ArticleId IdType="pmc">PMC11465148</ArticleId>
				<ArticleId IdType="doi">10.1016/j.imr.2024.101084</ArticleId>
				<ArticleId IdType="pii">S2213-4220(24)00064-7</ArticleId>
			</ArticleIdList>
			<ReferenceList>
				<Reference>
					<Citation>Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J] Lancet. 2020;395(10223):497&#x2013;506.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pmc">PMC7159299</ArticleId>
						<ArticleId IdType="pubmed">31986264</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. Accessed 17 February 2023. https://Covid19.who.int/.</Citation>
				</Reference>
				<Reference>
					<Citation>Yang X., Hou C., Shen Y., et al. Two-year health outcomes in hospitalized COVID-19 survivors in China. JAMA Netw Open. 2022;5(9) doi: 10.1001/jamanetworkopen.2022.31790.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1001/jamanetworkopen.2022.31790</ArticleId>
						<ArticleId IdType="pmc">PMC9478774</ArticleId>
						<ArticleId IdType="pubmed">36107425</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Feng F., Tuchman S., Denninger J.W., Fricchione G.L., Yeung A. Qigong for the prevention, treatment, and rehabilitation of COVID-19 infection in older adults. Am J Geriatr Psychiatry. 2020;28(8):812&#x2013;819. doi: 10.1016/j.jagp.2020.05.012.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/j.jagp.2020.05.012</ArticleId>
						<ArticleId IdType="pmc">PMC7227578</ArticleId>
						<ArticleId IdType="pubmed">32425471</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Polkey M.I., Qiu Z.H., Zhou L., et al. Tai Chi and pulmonary rehabilitation compared for treatment-naive patients with COPD: a randomized controlled trial. Chest. 2018;153(5):1116&#x2013;1124. doi: 10.1016/j.chest.2018.01.053.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/j.chest.2018.01.053</ArticleId>
						<ArticleId IdType="pubmed">29625777</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Xiao C.M., Zhuang Y.C. Efficacy of liuzijue qigong in individuals with chronic obstructive pulmonary disease in remission. J Am Geriatr Soc. 2015;63(7):1420&#x2013;1425. doi: 10.1111/jgs.13478.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1111/jgs.13478</ArticleId>
						<ArticleId IdType="pubmed">26131612</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Bi J., Yang W., Hao P., et al. WeChat as a platform for baduanjin intervention in patients with stable chronic obstructive pulmonary disease in China: retrospective randomized controlled trial. JMIR Mhealth Uhealth. 2021;9(2):e23548. doi: 10.2196/23548.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.2196/23548</ArticleId>
						<ArticleId IdType="pmc">PMC7886617</ArticleId>
						<ArticleId IdType="pubmed">33528369</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Wu H.S., Wu S.C., Lin J.G., Lin L.C. Effectiveness of acupressure in improving dyspnoea in chronic obstructive pulmonary disease. J Adv Nurs. 2004;45(3):252&#x2013;259. doi: 10.1046/j.1365-2648.2003.02886.x.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1046/j.1365-2648.2003.02886.x</ArticleId>
						<ArticleId IdType="pubmed">14720242</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Qingguang Z., Shuaipan Z., Jingxian L.I., et al. Effectiveness of Liu-zi-jue exercise on coronavirus disease 2019 in the patients: a randomized controlled trial. J Tradit Chin Med. 2022;42(6):997&#x2013;10053. doi: 10.19852/j.cnki.jtcm.2022.06.009.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.19852/j.cnki.jtcm.2022.06.009</ArticleId>
						<ArticleId IdType="pmc">PMC9924758</ArticleId>
						<ArticleId IdType="pubmed">36378059</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Tang Y., Jiang J., Shen P., et al. Liuzijue is a promising exercise option for rehabilitating discharged COVID-19 patients. Medicine (Baltimore) 2021;100(6):e24564. doi: 10.1097/MD.0000000000024564.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1097/MD.0000000000024564</ArticleId>
						<ArticleId IdType="pmc">PMC7886442</ArticleId>
						<ArticleId IdType="pubmed">33578552</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Zha L., Xu X., Wang D., Qiao G., Zhuang W., Huang S. Modified rehabilitation exercises for mild cases of COVID-19. Ann Palliat Med. 2020;9(5):3100&#x2013;3106. doi: 10.21037/apm-20-753.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.21037/apm-20-753</ArticleId>
						<ArticleId IdType="pubmed">32787373</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Liu S.T., Zhan C., Ma Y.J., et al. Effect of qigong exercise and acupressure rehabilitation program on pulmonary function and respiratory symptoms in patients hospitalized with severe COVID-19: a randomized controlled trial. Integr Med Res. 2021;10 doi: 10.1016/j.imr.2021.100796. Suppl.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/j.imr.2021.100796</ArticleId>
						<ArticleId IdType="pmc">PMC8553411</ArticleId>
						<ArticleId IdType="pubmed">34733607</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Junfang J., Yingchun H., Qiang L., Meng S. The effect of Liuzijue breathingexercises combined with acupoint massage on improving lung function and quality of life in elderly patients with COPD. Chin Mod Doct. 2019;57(27):100&#x2013;103.</Citation>
				</Reference>
				<Reference>
					<Citation>Zhang S., Zhu Q., Zhan C., et al. Acupressure therapy and Liu Zi Jue Qigong for pulmonary function and quality of life in patients with severe novel coronavirus pneumonia (COVID-19): a study protocol for a randomized controlled trial. Trials. 2020;21(1):751. doi: 10.1186/s13063-020-04693-5.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1186/s13063-020-04693-5</ArticleId>
						<ArticleId IdType="pmc">PMC7450683</ArticleId>
						<ArticleId IdType="pubmed">32854761</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Hygiene Emergency Office. Revision of "New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Eighth Edition)" National Health Commission of the People's Republic of China home page 2020. https://www.nhc.gov.cn. Assessed by 15 March 2021.</Citation>
				</Reference>
				<Reference>
					<Citation>Bestall J.C., Paul E.A., Garrod R., Garnham R., Jones P.W., Wedzicha J.A. Usefulness of the medical research council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581&#x2013;586. doi: 10.1136/thx.54.7.581.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1136/thx.54.7.581</ArticleId>
						<ArticleId IdType="pmc">PMC1745516</ArticleId>
						<ArticleId IdType="pubmed">10377201</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Yasui H., Inui N., Karayama M., et al. Correlation of the modified medical research council dyspnea scale with airway structure assessed by three-dimensional CT in patients with chronic obstructive pulmonary disease. Respir Med. 2019;146:76&#x2013;80. doi: 10.1016/j.rmed.2018.11.020.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/j.rmed.2018.11.020</ArticleId>
						<ArticleId IdType="pubmed">30665522</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Kendrick K.R., Baxi S.C., Smith R.M. Usefulness of the modified 0-10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma. J Emerg Nurs. 2000;26(3):216&#x2013;222. doi: 10.1016/s0099-1767(00)90093-x.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/s0099-1767(00)90093-x</ArticleId>
						<ArticleId IdType="pubmed">10839848</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Levis B., Benedetti A., Thombs B.D. DEPRESsion screening data (DEPRESSD) collaboration. accuracy of patient health questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. BMJ. 2019;365:l1476. doi: 10.1136/bmj.l1476.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1136/bmj.l1476</ArticleId>
						<ArticleId IdType="pmc">PMC6454318</ArticleId>
						<ArticleId IdType="pubmed">30967483</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606&#x2013;613. doi: 10.1046/j.1525-1497.2001.016009606.x.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1046/j.1525-1497.2001.016009606.x</ArticleId>
						<ArticleId IdType="pmc">PMC1495268</ArticleId>
						<ArticleId IdType="pubmed">11556941</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Desveaux L., Janaudis-Ferreira T., Goldstein R., Brooks D. An international comparison of pulmonary rehabilitation: a systematic review. COPD. 2015;12(2):144&#x2013;153. doi: 10.3109/15412555.2014.922066.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.3109/15412555.2014.922066</ArticleId>
						<ArticleId IdType="pubmed">24984085</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>World Health Organization. The Who Global Report on Traditional and Complementary Medicine 2019 Is Released. Published 2019. Accessed Oct 01, 2022. https://www.who.int/news/item/20-05-2019-the-who-global-report-on-traditional-and-complementary-medicine-2019-is-released.</Citation>
				</Reference>
				<Reference>
					<Citation>Ara&#xfa;jo Oliveira Ana Luisa, L&#xed;lia Andrade, Alda Marques. Minimal clinically important difference and predictive validity of the mMRC and mBorg in acute exacerbations of COPD[J] Eur Respiratory J. 2017;50(61) s.</Citation>
				</Reference>
				<Reference>
					<Citation>Jones P.W., Beeh K.M., Chapman K.R., et al. Minimal clinically important differences in pharmacological trials[J] Am J Respir Crit Care Med. 2014;189(3):250&#x2013;255.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">24383418</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Hu X.Y. Clinical efficacy of acupressure combined with traditional Chinese medicine application in the treatment of acute exacerbation of chronic obstructive pulmonary disease and its effect on inflammatory indexes. Chinese Folk Therapy. 2023;31(10):42&#x2013;45. doi: 10.19621/j.cnki.11-3555/r.2023.1014.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.19621/j.cnki.11-3555/r.2023.1014</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Jiang L.Y., Fang Y., Li Q. Clinical study of Xuanfei decoction combined with traditional Chinese medicine acupoint patch for the treatment of acute exacerbation of chronic obstructive pulmonary disease combined with respiratory failure. New Chinese Medicine. 2023;55(20):153&#x2013;157. doi: 10.13457/j.cnki.jncm.2023.20.031.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.13457/j.cnki.jncm.2023.20.031</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Hu J., Gao R., Wang Y., et al. Effect of Liuzijue on pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: study protocol for a multicenter, non-randomized, prospective study. BMC Complement Med Ther. 2022;22(1):296. doi: 10.1186/s12906-022-03789-6.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1186/s12906-022-03789-6</ArticleId>
						<ArticleId IdType="pmc">PMC9670448</ArticleId>
						<ArticleId IdType="pubmed">36397066</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>de Torres J.P., Pinto-Plata V., Ingenito E., et al. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest. 2002;121(4):1092&#x2013;1098. doi: 10.1378/chest.121.4.1092.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1378/chest.121.4.1092</ArticleId>
						<ArticleId IdType="pubmed">11948037</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Sunjaya A., Poulos L., Reddel H., Jenkins C. Qualitative validation of the modified Medical Research Council (mMRC) dyspnoea scale as a patient-reported measure of breathlessness severity. Respir Med. 2022;203 doi: 10.1016/j.rmed.2022.106984.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/j.rmed.2022.106984</ArticleId>
						<ArticleId IdType="pubmed">36179385</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Janssens J.P., Pache J.C., Nicod L.P. Physiological changes in respiratory func-tion associated with ageing. Eur Respir J. 1999;13(1):197&#x2013;205. doi: 10.1034/j.1399-3003.1999.13a36.x.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1034/j.1399-3003.1999.13a36.x</ArticleId>
						<ArticleId IdType="pubmed">10836348</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Lowery E.M., Brubaker A.L., Kuhlmann E., Kovacs E.J. The aging lung. Clin Interv Aging. 2013;8:1489&#x2013;1496. doi: 10.2147/CIA.S51152.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.2147/CIA.S51152</ArticleId>
						<ArticleId IdType="pmc">PMC3825547</ArticleId>
						<ArticleId IdType="pubmed">24235821</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Damayanthi H.D.W.T., Prabani K.I.P. Nutritional determinants and COVID-19 outcomes of older patients with COVID-19: a systematic review. Arch Gerontol Geriatr. 2021;95 doi: 10.1016/j.archger.2021.104411.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/j.archger.2021.104411</ArticleId>
						<ArticleId IdType="pmc">PMC8010373</ArticleId>
						<ArticleId IdType="pubmed">33836322</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Bencivenga L., Rengo G., Varricchi G. Elderly at time of COronaVIrus disease 2019 (COVID-19): possible role of immunosenescence and malnutrition. Geroscience. 2020;42(4):1089&#x2013;1092. doi: 10.1007/s11357-020-00218-9.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1007/s11357-020-00218-9</ArticleId>
						<ArticleId IdType="pmc">PMC7308600</ArticleId>
						<ArticleId IdType="pubmed">32578073</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Song W.J., Hui C.K.M., Hull J.H., et al. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir Med. 2021;9(5):533&#x2013;544. doi: 10.1016/S2213-2600(21)00125-9.</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/S2213-2600(21)00125-9</ArticleId>
						<ArticleId IdType="pmc">PMC8041436</ArticleId>
						<ArticleId IdType="pubmed">33857435</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>World Health Organization. WHO Director-General's opening remarks at the media briefing. Accessed 17 February 2023. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing, 5-may-2023.</Citation>
				</Reference>
			</ReferenceList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
			<PMID Version="1">39372835</PMID>
			<DateRevised>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>08</Day>
			</DateRevised>
			<Article PubModel="Electronic-eCollection">
				<Journal>
					<ISSN IssnType="Electronic">2769-2558</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>3</Volume>
						<Issue>4</Issue>
						<PubDate>
							<Year>2024</Year>
							<Month>Dec</Month>
						</PubDate>
					</JournalIssue>
					<Title>PCN reports : psychiatry and clinical neurosciences</Title>
					<ISOAbbreviation>PCN Rep</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Comparing personality traits of healthcare workers with and without long COVID: Cross-sectional study.</ArticleTitle>
				<Pagination>
					<StartPage>e70017</StartPage>
					<MedlinePgn>e70017</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="pii" ValidYN="Y">e70017</ELocationID>
				<ELocationID EIdType="doi" ValidYN="Y">10.1002/pcn5.70017</ELocationID>
				<Abstract>
					<AbstractText Label="AIM" NlmCategory="UNASSIGNED">Pathological mechanisms of "long COVID" after recovery from the main symptoms of COVID-19 are unclear. We compared psychological differences between individuals with and without long COVID symptoms after initial COVID-19 infections.</AbstractText>
					<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This study includes medical workers with and without history of COVID-19. We assessed the degree of depression, health-related quality of life (HRQOL), the degree of anxiety and fear of COVID-19, and we used an original questionnaire. In the COVID-19 group, we also assessed personality traits and anxiety. The COVID-19 group was subclassified into those with and without long COVID to examine differences in circumstantial and psychological examinations.</AbstractText>
					<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Of 310 participants (141 men, 169 women, median age: 40 years), 167 had history of COVID-19 (83/84, 37 years) and 143 did not (58 men/85 women, 46 years). In the COVID-19 group, 26 had long COVID (12/14, 32 years) and 141 did not (58/85, 46 years). Fewer participants in the COVID-19 group had had COVID-19 vaccinations. The long COVID group had higher number of symptoms at the time of illness and higher NEO Five Factor Inventory Neuroticism scores than the non-long COVID group. They also had poorer mental health according to HRQOL than those without.</AbstractText>
					<AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Risk factors for long COVID may include the number of symptoms at the time of illness and neurotic tendency on NEO Five Factor Inventory. Participants with long COVID had poorer mental health according to HRQOL. People with long COVID might be especially sensitive to and pessimistic about the symptoms that interfere with their daily lives, resulting in certain cognitive and behavioral patterns. They may benefit from early psychiatric intervention.</AbstractText>
					<CopyrightInformation>&#xa9; 2024 The Author(s). Psychiatry and Clinical Neurosciences Reports published by John Wiley &amp; Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.</CopyrightInformation>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Sakai</LastName>
						<ForeName>Keiko</ForeName>
						<Initials>K</Initials>
						<Identifier Source="ORCID">0009-0005-8594-678X</Identifier>
						<AffiliationInfo>
							<Affiliation>Department of Rehabilitation Osaka Kawasaki Rehabilitation University Kaizuka Osaka Japan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Tarutani</LastName>
						<ForeName>Seiichiro</ForeName>
						<Initials>S</Initials>
						<AffiliationInfo>
							<Affiliation>Osaka Institute of Clinical Psychiatry Shin-Abuyama Hospital Takatsuki Osaka Japan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Okamura</LastName>
						<ForeName>Takehiko</ForeName>
						<Initials>T</Initials>
						<AffiliationInfo>
							<Affiliation>Osaka Institute of Clinical Psychiatry Shin-Abuyama Hospital Takatsuki Osaka Japan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Yoneda</LastName>
						<ForeName>Hiroshi</ForeName>
						<Initials>H</Initials>
						<AffiliationInfo>
							<Affiliation>Osaka Institute of Clinical Psychiatry Shin-Abuyama Hospital Takatsuki Osaka Japan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Kawasaki</LastName>
						<ForeName>Tatsuhito</ForeName>
						<Initials>T</Initials>
						<AffiliationInfo>
							<Affiliation>Mizuma Hospital Kaizuka Osaka Japan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Takeda</LastName>
						<ForeName>Masatoshi</ForeName>
						<Initials>M</Initials>
						<AffiliationInfo>
							<Affiliation>Department of Rehabilitation Osaka Kawasaki Rehabilitation University Kaizuka Osaka Japan.</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>05</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>Australia</Country>
				<MedlineTA>PCN Rep</MedlineTA>
				<NlmUniqueID>9918451287106676</NlmUniqueID>
				<ISSNLinking>2769-2558</ISSNLinking>
			</MedlineJournalInfo>
			<KeywordList Owner="NOTNLM">
				<Keyword MajorTopicYN="N">COVID&#x2010;19</Keyword>
				<Keyword MajorTopicYN="N">healthcare workers</Keyword>
				<Keyword MajorTopicYN="N">long COVID</Keyword>
				<Keyword MajorTopicYN="N">mental health</Keyword>
				<Keyword MajorTopicYN="N">personality traits</Keyword>
			</KeywordList>
			<CoiStatement>The authors declare no conflict of interest.</CoiStatement>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="received">
					<Year>2024</Year>
					<Month>5</Month>
					<Day>8</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="revised">
					<Year>2024</Year>
					<Month>8</Month>
					<Day>28</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="accepted">
					<Year>2024</Year>
					<Month>9</Month>
					<Day>14</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>7</Day>
					<Hour>16</Hour>
					<Minute>24</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>7</Day>
					<Hour>16</Hour>
					<Minute>23</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>7</Day>
					<Hour>6</Hour>
					<Minute>8</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pmc-release">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>5</Day>
				</PubMedPubDate>
			</History>
			<PublicationStatus>epublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pubmed">39372835</ArticleId>
				<ArticleId IdType="pmc">PMC11452823</ArticleId>
				<ArticleId IdType="doi">10.1002/pcn5.70017</ArticleId>
				<ArticleId IdType="pii">PCN570017</ArticleId>
			</ArticleIdList>
			<ReferenceList>
				<Reference>
					<Citation>
World Health Organization (WHO)
. Coronavirus disease (COVID&#x2010;19) pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (2019). Accessed 26 Dec 2023.</Citation>
				</Reference>
				<Reference>
					<Citation>
World Health Organization (WHO)
. COVID&#x2010;19 epidemiological update&#x2014;22 December 2023. https://www.who.int/publications/m/item/covid-19-epidemiological-update---22-december-2023 (2023). Accessed 26 Dec 2023.</Citation>
				</Reference>
				<Reference>
					<Citation>Alimoradi Z, Brostr&#xf6;m A, Potenza MN, Lin C&#x2010;Y, Pakpour AH. Associations between behavioral addictions and mental health concerns during the COVID&#x2010;19 pandemic: a systematic review and meta&#x2010;analysis. Curr Addict Rep. 2024;11(3):565&#x2013;587. 10.1007/s40429-024-00555-1</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1007/s40429-024-00555-1</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Kar B, Kar N, Panda MC. Social trust and COVID&#x2010;appropriate behavior: learning from the pandemic. Asian J Soc Health Behav. 2023;6(3):93&#x2013;104.</Citation>
				</Reference>
				<Reference>
					<Citation>Lopez&#x2010;Leon S, Wegman&#x2010;Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long&#x2010;term effects of COVID&#x2010;19: a systematic review and meta&#x2010;analysis. Sci Rep. 2021;11(1):16144. 10.1038/s41598-021-95565-8</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId>
						<ArticleId IdType="pmc">PMC8352980</ArticleId>
						<ArticleId IdType="pubmed">34373540</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>
World Health Organization (WHO)
. Post COVID&#x2010;19 condition (Long COVID). https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition (2022). Accessed 1 Feb 2024.</Citation>
				</Reference>
				<Reference>
					<Citation>Starcevic V, Janca A. Personality dimensions and disorders and coping with the COVID&#x2010;19 pandemic. Curr Opin Psychiatry. 2022;35(1):73&#x2013;77. 10.1097/YCO.0000000000000755</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1097/YCO.0000000000000755</ArticleId>
						<ArticleId IdType="pmc">PMC8654116</ArticleId>
						<ArticleId IdType="pubmed">34855697</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Radloff LS. The CES&#x2010;D Scale: a self&#x2010;report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385&#x2013;401.</Citation>
				</Reference>
				<Reference>
					<Citation>Shima S, Shikano T, Kitamura T, Asai M. New self&#x2010;rating scales for depression. Clin Psychiatry. 1985;27:717&#x2013;723. (in Japanese).</Citation>
				</Reference>
				<Reference>
					<Citation>Sugawara N, Kaneda A, Takahashi I, Nakaji S, Yasui&#x2010;Furukori N. Application of a stratum&#x2010;specific likelihood ratio analysis in a screen for depression among a community&#x2010;dwelling population in Japan. Neuropsychiatr Dis Treat. 2017;13:2369&#x2013;2374. 10.2147/NDT.S142517</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.2147/NDT.S142517</ArticleId>
						<ArticleId IdType="pmc">PMC5602451</ArticleId>
						<ArticleId IdType="pubmed">28979124</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Ware JE Jr., Kosinski M, Keller SD. A 12&#x2010;Item Short&#x2010;Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220&#x2013;233.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">8628042</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Fukuhara S, Suzukamo Y. Manual of SF&#x2010;36v2 Japanese version. Kyoto: Qualitest Inc.; 2004; (in Japanese).</Citation>
				</Reference>
				<Reference>
					<Citation>Fukuhara S, Ware JE Jr., Kosinski M, Wada S, Gandek B. Psychometric and clinical tests of validity of the Japanese SF&#x2010;36 Health Survey. J Clin Epidemiol. 1998;51(11):1045&#x2013;1053. 10.1016/s0895-4356(98)00096-1</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/s0895-4356(98)00096-1</ArticleId>
						<ArticleId IdType="pubmed">9817122</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Ahorsu DK, Lin C&#x2010;Y, Imani V, Saffari M, Griffiths MD, Pakpour AH. The fear of COVID&#x2010;19 scale: development and initial validation. Int J Ment Health Addict. 2022;20:1537&#x2013;1545. 10.1007/s11469-020-00270-8</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1007/s11469-020-00270-8</ArticleId>
						<ArticleId IdType="pmc">PMC7100496</ArticleId>
						<ArticleId IdType="pubmed">32226353</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Lin C&#x2010;Y, Hou W&#x2010;L, Mamun MA, Aparecido da Silva J, Broche&#x2010;P&#xe9;rez Y, Ullah I, et al. Fear of COVID&#x2010;19 Scale (FCV&#x2010;19S) across countries: measurement invariance issues. Nurs Open. 2021;8(4):1892&#x2013;1908. 10.1002/nop2.855</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1002/nop2.855</ArticleId>
						<ArticleId IdType="pmc">PMC8186712</ArticleId>
						<ArticleId IdType="pubmed">33745219</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Wakashima K, Asai K, Kobayashi D, Koiwa K, Kamoshida S, Sakuraba M. The Japanese version of the Fear of COVID&#x2010;19 scale: reliability, validity, and relation to coping behavior. PLoS One. 2020;15:e024. 10.1371/journal.pone.0241958</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1371/journal.pone.0241958</ArticleId>
						<ArticleId IdType="pmc">PMC7644080</ArticleId>
						<ArticleId IdType="pubmed">33152038</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Koiwa K, Wakashima K, Ikuta M, Asai K, Takagi G. Fear of COVID&#x2010;19 infection and related factors in Japan: a comparison of college students, pregnant women, hospital nurses and the general public. PLoS One. 2022;17(7):e0271176. 10.1371/journal.pone.0271176</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1371/journal.pone.0271176</ArticleId>
						<ArticleId IdType="pmc">PMC9278735</ArticleId>
						<ArticleId IdType="pubmed">35830424</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Costa PT Jr., McCrae RR. Revised NEO Personality Inventory (NEO PI&#x2010;R) and NEO Five&#x2010;Factor Inventory (NEO&#x2010;FFI). Florida: Psychological Assessment Resources, Inc; 1992.</Citation>
				</Reference>
				<Reference>
					<Citation>Shimonaka Y, Nakazato K, Gondo Y, Takayama M. NEO&#x2010;PI&#x2010;R, NEO&#x2010;FFI Manual for the Japanese version Revised and enlarged edition. Tokyo: Tokyo Shinri, Inc; 2011. (in Japanese).</Citation>
				</Reference>
				<Reference>
					<Citation>Narumoto J, Nakamura K, Kitabayashi Y, Shibata K, Nakamae T, Fukui K. Relationships among burnout, coping style and personality: study of Japanese professional caregivers for elderly. Psychiatry Clin Neurosci. 2008;62(2):174&#x2013;176. 10.1111/j.1440-1819.2008.01751.x</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1111/j.1440-1819.2008.01751.x</ArticleId>
						<ArticleId IdType="pubmed">18412839</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Spielberger CD. Manual for the State&#x2010;Trait Anxiety Inventory, STAI&#x2010;form Y. Palto Alto, CA: Consulting Psychologists Press; 1983.</Citation>
				</Reference>
				<Reference>
					<Citation>Hidano N, Fukuhara M, Iwawaki S, Soga S, Spielberger CD. Manual of State&#x2010;Trait Anxiety Inventory&#x2010;Form JYZ. Tokyo: Jitsumu Kyoiku&#x2010;Shuppan; 2022. (in Japanese).</Citation>
				</Reference>
				<Reference>
					<Citation>Iwata N, Mishima N, Shimizu T, Mizoue T, Fukuhara M, Hidano T, et al. The Japanese adaptation of the STAI Form Y in Japanese working adults&#x2014;the presence or absence of anxiety. Ind Health. 1998;36:8&#x2013;13.</Citation>
					<ArticleIdList>
						<ArticleId IdType="pubmed">9473852</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>
Ministry of Health, Labour and Welfare
. The domestic occurrence status of novel coronavirus infection in Japan. (2023). https://www.mhlw.go.jp/stf/covid-19/kokunainohasseijoukyou.html. Accessed 25 Mar 2024.</Citation>
				</Reference>
				<Reference>
					<Citation>
National Institute of Infectious Diseases
. Current Situation of Infection, January 11, 2023. https://www.niid.go.jp/niid/en/2019-ncov-e/11761-covid19-ab113th-en.html (2023). Accessed 25 Mar 2024.</Citation>
				</Reference>
				<Reference>
					<Citation>Guedes AR, Oliveira MS, Tavares BM, Luna&#x2010;Muschi A, Lazari CS, Montal AC, et al. Reinfection rate in a cohort of healthcare workers over 2 years of the COVID&#x2010;19 pandemic. Sci Rep. 2023;13(1):712. 10.1038/s41598-022-25908-6</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1038/s41598-022-25908-6</ArticleId>
						<ArticleId IdType="pmc">PMC9837751</ArticleId>
						<ArticleId IdType="pubmed">36639411</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA&#x2010;1273 SARS&#x2010;CoV&#x2010;2 Vaccine. N Engl J Med. 2021;384(5):403&#x2013;416. 10.1056/NEJMoa2035389</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1056/NEJMoa2035389</ArticleId>
						<ArticleId IdType="pmc">PMC7787219</ArticleId>
						<ArticleId IdType="pubmed">33378609</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Lin C&#x2010;Y, Fan C&#x2010;W, Ahorsu DK, Lin YC, Weng H&#x2010;C, Griffiths MD. Associations between vaccination and quality of life among Taiwan general population: a comparison between COVID&#x2010;19 vaccines and flu vaccines. Hum Vaccines Immunother. 2022;18(5):2079344. 10.1080/21645515.2022.2079344</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1080/21645515.2022.2079344</ArticleId>
						<ArticleId IdType="pmc">PMC9621022</ArticleId>
						<ArticleId IdType="pubmed">35679589</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;146. 10.1038/s41579-022-00846-2</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId>
						<ArticleId IdType="pmc">PMC9839201</ArticleId>
						<ArticleId IdType="pubmed">36639608</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Renaud&#x2010;Charest O, Lui LMW, Eskander S, Ceban F, Ho R, Di Vincenzo JD, et al. Onset and frequency of depression in post&#x2010;COVID&#x2010;19 syndrome: a systematic review. J Psychiatr Res. 2021;144:129&#x2013;137. 10.1016/j.jpsychires.2021.09.054</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/j.jpsychires.2021.09.054</ArticleId>
						<ArticleId IdType="pmc">PMC8482840</ArticleId>
						<ArticleId IdType="pubmed">34619491</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Rass V, Beer R, Schiefecker AJ, Kofler M, Lindner A, Mahlknecht P, et al. Neurological outcome and quality of life 3 months after COVID&#x2010;19: a prospective observational cohort study. Eur J Neurol. 2021;28(10):3348&#x2013;3359. 10.1111/ene.14803</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1111/ene.14803</ArticleId>
						<ArticleId IdType="pmc">PMC8250725</ArticleId>
						<ArticleId IdType="pubmed">33682276</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Takao M, Ohira M. Neurological post&#x2010;acute sequelae of SARS&#x2010;CoV&#x2010;2 infection. Psychiatry Clin Neurosci. 2023;77(2):72&#x2013;83. 10.1111/pcn.13481</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1111/pcn.13481</ArticleId>
						<ArticleId IdType="pmc">PMC9538807</ArticleId>
						<ArticleId IdType="pubmed">36148558</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Yong SJ. Long COVID or post&#x2010;COVID&#x2010;19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis. 2021;53(10):737&#x2013;754. 10.1080/23744235.2021.1924397</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId>
						<ArticleId IdType="pmc">PMC8146298</ArticleId>
						<ArticleId IdType="pubmed">34024217</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Watanabe A, Iwagami M, Yasuhara J, Takagi H, Kuno T. Protective effect of COVID&#x2010;19 vaccination against long COVID syndrome: a systematic review and meta&#x2010;analysis. Vaccine. 2023;41(11):1783&#x2013;1790. 10.1016/j.vaccine.2023.02.008</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/j.vaccine.2023.02.008</ArticleId>
						<ArticleId IdType="pmc">PMC9905096</ArticleId>
						<ArticleId IdType="pubmed">36774332</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Fergusson DM, Horwood LJ, Lawton JM. The relationships between neuroticism and depressive symptoms. Soc Psychiatry Psychiatr Epidemiol. 1989;24(6):275&#x2013;281. 10.1007/BF01788029</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1007/BF01788029</ArticleId>
						<ArticleId IdType="pubmed">2512644</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Sado M, Yamauchi K, Kawakami N, Ono Y, Furukawa TA, Tsuchiya M, et al. Cost of depression among adults in Japan in 2005. Psychiatry Clin Neurosci. 2011;65(5):442&#x2013;450. 10.1111/j.1440-1819.2011.02237.x</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1111/j.1440-1819.2011.02237.x</ArticleId>
						<ArticleId IdType="pubmed">21851453</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>
Ministry of Health, Labour and Welfare
. It's turned to the analysis of labor economy&#x2010;continuous pay raise. 2023. https://www.mhlw.go.jp/wp/hakusyo/roudou/23/dl/23-1.pdf. Accessed 26 Sep 2024.</Citation>
				</Reference>
				<Reference>
					<Citation>
Ministry of Health, Labour and Welfare
. Suicide Prevention Whitepaper. 2020. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hukushi_kaigo/seikatsuhogo/jisatsutoukei-jisatsusyasu.html. Accessed 15 Jan 2024.</Citation>
				</Reference>
				<Reference>
					<Citation>Dragioti E, Tsartsalis D, Mentis M, Mantzoukas S, Gouva M. Impact of the COVID&#x2010;19 pandemic on the mental health of hospital staff: an umbrella review of 44 meta&#x2010;analyses. Int J Nurs Stud. 2022;131:104272. 10.1016/j.ijnurstu.2022.104272</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/j.ijnurstu.2022.104272</ArticleId>
						<ArticleId IdType="pmc">PMC9045868</ArticleId>
						<ArticleId IdType="pubmed">35576637</ArticleId>
					</ArticleIdList>
				</Reference>
				<Reference>
					<Citation>Andhavarapu S, Yardi I, Bzhilyanskaya V, Lurie T, Bhinder M, Patel P, et al. Post&#x2010;traumatic stress in healthcare workers during the COVID&#x2010;19 pandemic: a systematic review and meta&#x2010;analysis. Psychiatry Res. 2022;317:114890. 10.1016/j.psychres.2022.114890</Citation>
					<ArticleIdList>
						<ArticleId IdType="doi">10.1016/j.psychres.2022.114890</ArticleId>
						<ArticleId IdType="pmc">PMC9573911</ArticleId>
						<ArticleId IdType="pubmed">36260970</ArticleId>
					</ArticleIdList>
				</Reference>
			</ReferenceList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
			<PMID Version="1">39369845</PMID>
			<DateCompleted>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>17</Day>
			</DateCompleted>
			<DateRevised>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>17</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1879-0631</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>357</Volume>
						<PubDate>
							<Year>2024</Year>
							<Month>Nov</Month>
							<Day>15</Day>
						</PubDate>
					</JournalIssue>
					<Title>Life sciences</Title>
					<ISOAbbreviation>Life Sci</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Exploring the characteristics and antecedents of clinically significant long COVID: A longitudinal cohort study.</ArticleTitle>
				<Pagination>
					<StartPage>123114</StartPage>
					<MedlinePgn>123114</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.lfs.2024.123114</ELocationID>
				<ELocationID EIdType="pii" ValidYN="Y">S0024-3205(24)00704-5</ELocationID>
				<Abstract>
					<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A significant number of coronavirus disease 2019 (COVID-19) survivors are experiencing long COVID, with symptoms lasting beyond three months. While diverse long COVID symptoms are established, there are gaps in understanding its long-term trends, intensity, and risk factors, requiring further investigation.</AbstractText>
					<AbstractText Label="AIMS" NlmCategory="OBJECTIVE">This study aimed to investigate the long COVID characteristics and associated factors by following COVID-19 survivors for one year post-infection and comparing them with healthy counterparts.</AbstractText>
					<AbstractText Label="MAIN METHODS" NlmCategory="METHODS">In this longitudinal, correlational study, COVID-19 survivors diagnosed between November 2021 and February 2023 were monitored every three months for a year. Participants aged &#x2265;18&#xa0;years who had reported a positive COVID-19 test were recruited via social media and healthcare provider referrals.</AbstractText>
					<AbstractText Label="KEY FINDINGS" NlmCategory="RESULTS">Out of 182 survivors who initially agreed to participate, 176 completed the study. The mean age was 47.56&#xa0;years (SD&#xa0;=&#xa0;16.2), and 51.1&#xa0;% were female. There was a clinically significant decline in cognitive function and health-related quality of life over time, with symptoms like shortness of breath, reduced physical fitness, and increased health concerns. Those with severe acute COVID-19 symptoms experienced greater cognitive and physical declines and more shortness of breath a year later. Lower financial status was linked to poorer health-related quality of life and increased health concerns.</AbstractText>
					<AbstractText Label="SIGNIFICANCE" NlmCategory="CONCLUSIONS">A year post-infection, COVID-19's impact on cognitive function and health-related quality of life remains significant, affecting individuals and communities. Survivors with severe initial symptoms and economic disadvantages need more attention. Future research should identify additional predictors of severe long COVID.</AbstractText>
					<CopyrightInformation>Copyright &#xa9; 2024. Published by Elsevier Inc.</CopyrightInformation>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Tang</LastName>
						<ForeName>Chia-Chun</ForeName>
						<Initials>CC</Initials>
						<AffiliationInfo>
							<Affiliation>School of Nursing, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Nursing, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Chang</LastName>
						<ForeName>Jung Chen</ForeName>
						<Initials>JC</Initials>
						<AffiliationInfo>
							<Affiliation>School of Nursing, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Nursing, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Ho</LastName>
						<ForeName>Sung-Jung</ForeName>
						<Initials>SJ</Initials>
						<AffiliationInfo>
							<Affiliation>Division of Chest Medicine, Department of Internal Medicine, Min-Sheng General Hospital, Taoyuan, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Liu</LastName>
						<ForeName>Wang-Da</ForeName>
						<Initials>WD</Initials>
						<AffiliationInfo>
							<Affiliation>Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Department of Internal Medicine, College of Medicine, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Pan</LastName>
						<ForeName>Mei-Yan</ForeName>
						<Initials>MY</Initials>
						<AffiliationInfo>
							<Affiliation>Department of Nursing, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Chang</LastName>
						<ForeName>Shih-Chieh</ForeName>
						<Initials>SC</Initials>
						<AffiliationInfo>
							<Affiliation>Division of Chest Medicine, Department of Internal Medicine, National Yang Ming Chiao Tung University Hospital, Yilan, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Wang</LastName>
						<ForeName>Wei-Shin</ForeName>
						<Initials>WS</Initials>
						<AffiliationInfo>
							<Affiliation>School of Nursing, College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Yeh</LastName>
						<ForeName>Yi-Chen</ForeName>
						<Initials>YC</Initials>
						<AffiliationInfo>
							<Affiliation>Department of Nursing, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Chen</LastName>
						<ForeName>Cheng-Hsuan</ForeName>
						<Initials>CH</Initials>
						<AffiliationInfo>
							<Affiliation>Department of Nursing, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Wu</LastName>
						<ForeName>Wei-Wen</ForeName>
						<Initials>WW</Initials>
						<AffiliationInfo>
							<Affiliation>School of Nursing, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Nursing, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: weiwen@ntu.edu.tw.</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>04</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>Netherlands</Country>
				<MedlineTA>Life Sci</MedlineTA>
				<NlmUniqueID>0375521</NlmUniqueID>
				<ISSNLinking>0024-3205</ISSNLinking>
			</MedlineJournalInfo>
			<CitationSubset>IM</CitationSubset>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
					<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
					<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
					<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D017741" MajorTopicYN="Y">Survivors</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName>
					<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
				</MeshHeading>
			</MeshHeadingList>
			<KeywordList Owner="NOTNLM">
				<Keyword MajorTopicYN="N">Long COVID</Keyword>
				<Keyword MajorTopicYN="N">Longitudinal study</Keyword>
				<Keyword MajorTopicYN="N">Post-COVID condition</Keyword>
				<Keyword MajorTopicYN="N">Symptom assessment</Keyword>
			</KeywordList>
			<CoiStatement>Declaration of competing interest None to declare.</CoiStatement>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="received">
					<Year>2024</Year>
					<Month>6</Month>
					<Day>3</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="revised">
					<Year>2024</Year>
					<Month>9</Month>
					<Day>24</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="accepted">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>3</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>18</Day>
					<Hour>10</Hour>
					<Minute>18</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>7</Day>
					<Hour>4</Hour>
					<Minute>17</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>6</Day>
					<Hour>19</Hour>
					<Minute>18</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pubmed">39369845</ArticleId>
				<ArticleId IdType="doi">10.1016/j.lfs.2024.123114</ArticleId>
				<ArticleId IdType="pii">S0024-3205(24)00704-5</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
			<PMID Version="1">39357795</PMID>
			<DateCompleted>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>17</Day>
			</DateCompleted>
			<DateRevised>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>17</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1879-0631</ISSN>
					<JournalIssue CitedMedium="Internet">
						<Volume>357</Volume>
						<PubDate>
							<Year>2024</Year>
							<Month>Nov</Month>
							<Day>15</Day>
						</PubDate>
					</JournalIssue>
					<Title>Life sciences</Title>
					<ISOAbbreviation>Life Sci</ISOAbbreviation>
				</Journal>
				<ArticleTitle>Gastrointestinal manifestations of long COVID.</ArticleTitle>
				<Pagination>
					<StartPage>123100</StartPage>
					<MedlinePgn>123100</MedlinePgn>
				</Pagination>
				<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.lfs.2024.123100</ELocationID>
				<ELocationID EIdType="pii" ValidYN="Y">S0024-3205(24)00690-8</ELocationID>
				<Abstract>
					<AbstractText>Long COVID is estimated to have affected 6.9&#xa0;% of US adults, 17.8 million people in the US alone, as of early 2023. While SARS-CoV-2 is primarily considered a respiratory virus, gastrointestinal (GI) symptoms are also frequent in patients with coronavirus disease 2019 (COVID-19) and in patients with Long COVID. The risk of developing GI symptoms is increased with increasing severity of COVID-19, the presence of GI symptoms in the acute infection, and psychological distress both before and after COVID-19. Persistence of the virus in the GI tract, ensuing inflammation, and alteration of the microbiome are all likely mediators of the effects of SARS Co-V-2 virus on the gut. These factors may all increase intestinal permeability and systemic inflammation. GI inflammation and dysbiosis can change the absorption and metabolism of tryptophan, an important neurotransmitter. Long COVID GI symptoms resemble a Disorder of Gut Brain Interaction (DGBI) such as post infection Irritable Bowel Syndrome (IBS). Current standards of treatment for IBS can guide our treatment of Long COVID patients. Dysautonomia, a frequent Long COVID condition affecting the autonomic nervous system, can also affect the GI tract, and must be considered in Long COVID patients with GI symptoms. Long COVID symptoms fall within the broader category of Infection Associated Chronic Conditions (IACCs). Research into the GI symptoms of Long COVID may further our understanding of other post infection chronic GI conditions, and elucidate the roles of therapeutic options including antivirals, probiotics, neuromodulators, and treatments of dysautonomia.</AbstractText>
					<CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>King</LastName>
						<ForeName>Louise R</ForeName>
						<Initials>LR</Initials>
						<AffiliationInfo>
							<Affiliation>University of North Carolina School of Medicine, Department of Medicine, Division of General Medicine and Clinical Epidemiology, 5034 Old Clinic Building, 101 Manning Drive, Chapel Hill, NC 27599, United States of America. Electronic address: louise_king@med.unc.edu.</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
					<PublicationType UI="D016454">Review</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2024</Year>
					<Month>09</Month>
					<Day>30</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>Netherlands</Country>
				<MedlineTA>Life Sci</MedlineTA>
				<NlmUniqueID>0375521</NlmUniqueID>
				<ISSNLinking>0024-3205</ISSNLinking>
			</MedlineJournalInfo>
			<CitationSubset>IM</CitationSubset>
			<MeshHeadingList>
				<MeshHeading>
					<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
					<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D005767" MajorTopicYN="Y">Gastrointestinal Diseases</DescriptorName>
					<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
					<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
					<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName>
					<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D041981" MajorTopicYN="N">Gastrointestinal Tract</DescriptorName>
					<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
					<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
				</MeshHeading>
				<MeshHeading>
					<DescriptorName UI="D043183" MajorTopicYN="N">Irritable Bowel Syndrome</DescriptorName>
					<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
					<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
					<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
				</MeshHeading>
			</MeshHeadingList>
			<KeywordList Owner="NOTNLM">
				<Keyword MajorTopicYN="N">COVID-19</Keyword>
				<Keyword MajorTopicYN="N">Clinical</Keyword>
				<Keyword MajorTopicYN="N">Gastrointestinal</Keyword>
				<Keyword MajorTopicYN="N">Long COVID</Keyword>
				<Keyword MajorTopicYN="N">Microbiome</Keyword>
				<Keyword MajorTopicYN="N">Post COVID</Keyword>
			</KeywordList>
			<CoiStatement>Declaration of competing interest No competing interests.</CoiStatement>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="received">
					<Year>2024</Year>
					<Month>6</Month>
					<Day>30</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="revised">
					<Year>2024</Year>
					<Month>9</Month>
					<Day>15</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="accepted">
					<Year>2024</Year>
					<Month>9</Month>
					<Day>28</Day>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="medline">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>18</Day>
					<Hour>0</Hour>
					<Minute>30</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>3</Day>
					<Hour>4</Hour>
					<Minute>22</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>2</Day>
					<Hour>19</Hour>
					<Minute>18</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>ppublish</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pubmed">39357795</ArticleId>
				<ArticleId IdType="doi">10.1016/j.lfs.2024.123100</ArticleId>
				<ArticleId IdType="pii">S0024-3205(24)00690-8</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
	<PubmedArticle>
		<MedlineCitation Status="Publisher" Owner="NLM">
			<PMID Version="1">39350480</PMID>
			<DateRevised>
				<Year>2024</Year>
				<Month>10</Month>
				<Day>01</Day>
			</DateRevised>
			<Article PubModel="Print-Electronic">
				<Journal>
					<ISSN IssnType="Electronic">1728-7731</ISSN>
					<JournalIssue CitedMedium="Internet">
						<PubDate>
							<Year>2024</Year>
							<Month>Oct</Month>
							<Day>01</Day>
						</PubDate>
					</JournalIssue>
					<Title>Journal of the Chinese Medical Association : JCMA</Title>
					<ISOAbbreviation>J Chin Med Assoc</ISOAbbreviation>
				</Journal>
				<ArticleTitle>The neuropsychological impacts of COVID-19 in non-hospitalized patients with long COVID and brain fog.</ArticleTitle>
				<ELocationID EIdType="doi" ValidYN="Y">10.1097/JCMA.0000000000001175</ELocationID>
				<Abstract>
					<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Coronavirus disease 2019 (COVID-19) causes persistent symptoms, including brain fog. Based on limited research on the long-term consequences of mild COVID-19, which has yielded inconsistent results, we investigated which cognitive functions were most affected by COVID-19 in non-hospitalized Asian patients with long-term COVID and subjective cognitive complaints.</AbstractText>
					<AbstractText Label="METHODS" NlmCategory="METHODS">Fifty-five non-hospitalized patients with long COVID and brain fog (24 males and 31 females, mean age: 45.6 &#xb1; 14.6 years, mean duration of education: 14.4 &#xb1; 3.0 years) were recruited. Neuropsychological assessments included screening tests for overall cognition, and comprehensive tests for memory, executive function, processing speed, and subjective emotional and disease symptoms. Cognitive test scores were converted into Z-scores. Moreover, principal component analysis (PCA) was employed to define cognitive domains across subtest scores.</AbstractText>
					<AbstractText Label="RESULTS" NlmCategory="RESULTS">Comprehensive assessments revealed cognitive impairment in 69.1% of patients (&lt;1.5 standard deviation in at least one test). The processing speed (27.3%), memory recall (21.8%), memory learning (20.0%), and inhibitory control (18.2%) were the most affected areas. Self-reported anxiety and depression were observed in 35% and 33% of patients, respectively. Furthermore, the degree of self-anxiety can be used to predict learning performance.</AbstractText>
					<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Nearly 70% of patients with subjective cognitive complaints and long COVID had objective cognitive impairments. A comprehensive evaluation is essential for patients with long COVID and brain fog, including those with mild symptoms.</AbstractText>
					<CopyrightInformation>Copyright &#xa9; 2024, the Chinese Medical Association.</CopyrightInformation>
				</Abstract>
				<AuthorList CompleteYN="Y">
					<Author ValidYN="Y">
						<LastName>Chuang</LastName>
						<ForeName>Yu-Chen</ForeName>
						<Initials>YC</Initials>
						<AffiliationInfo>
							<Affiliation>Division of General Neurology, Department of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Cheng</LastName>
						<ForeName>Yu-Hsiang</ForeName>
						<Initials>YH</Initials>
						<AffiliationInfo>
							<Affiliation>Division of General Neurology, Department of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Tsai</LastName>
						<ForeName>Meng-Ju</ForeName>
						<Initials>MJ</Initials>
						<AffiliationInfo>
							<Affiliation>Division of General Neurology, Department of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Lu</LastName>
						<ForeName>Yi-Jiun</ForeName>
						<Initials>YJ</Initials>
						<AffiliationInfo>
							<Affiliation>Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.</Affiliation>
						</AffiliationInfo>
					</Author>
					<Author ValidYN="Y">
						<LastName>Fuh</LastName>
						<ForeName>Jong-Ling</ForeName>
						<Initials>JL</Initials>
						<AffiliationInfo>
							<Affiliation>Division of General Neurology, Department of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.</Affiliation>
						</AffiliationInfo>
						<AffiliationInfo>
							<Affiliation>School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.</Affiliation>
						</AffiliationInfo>
						<AffiliationInfo>
							<Affiliation>Brain Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.</Affiliation>
						</AffiliationInfo>
					</Author>
				</AuthorList>
				<Language>eng</Language>
				<PublicationTypeList>
					<PublicationType UI="D016428">Journal Article</PublicationType>
				</PublicationTypeList>
				<ArticleDate DateType="Electronic">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>01</Day>
				</ArticleDate>
			</Article>
			<MedlineJournalInfo>
				<Country>Netherlands</Country>
				<MedlineTA>J Chin Med Assoc</MedlineTA>
				<NlmUniqueID>101174817</NlmUniqueID>
				<ISSNLinking>1726-4901</ISSNLinking>
			</MedlineJournalInfo>
			<CitationSubset>IM</CitationSubset>
			<CoiStatement>Conflicts of interest: Dr. Jong-Ling Fuh, an editorial board member at Journal of the Chinese Medical Association, had no role in the peer review process of or decision to publish this article. The other authors declare that they have no conflicts of interest related to the subject matter or materials discussed in this article.</CoiStatement>
		</MedlineCitation>
		<PubmedData>
			<History>
				<PubMedPubDate PubStatus="medline">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>1</Day>
					<Hour>10</Hour>
					<Minute>19</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="pubmed">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>1</Day>
					<Hour>10</Hour>
					<Minute>19</Minute>
				</PubMedPubDate>
				<PubMedPubDate PubStatus="entrez">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>1</Day>
					<Hour>1</Hour>
					<Minute>23</Minute>
				</PubMedPubDate>
			</History>
			<PublicationStatus>aheadofprint</PublicationStatus>
			<ArticleIdList>
				<ArticleId IdType="pubmed">39350480</ArticleId>
				<ArticleId IdType="doi">10.1097/JCMA.0000000000001175</ArticleId>
				<ArticleId IdType="pii">02118582-990000000-00454</ArticleId>
			</ArticleIdList>
		</PubmedData>
	</PubmedArticle>
</PubmedArticleSet>`

module.exports = {pubmedData1, pubmedData2};